Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
cellular response to cytokine stimulus (GO:0071345),36/482,1.8632506522352762E-21,4.537015338192898E-18,0,0,9.644245142002989,460.3387650889875,CCL11;CXCR4;F13A1;CIB1;PIK3R1;FOXO1;GHR;SOCS3;ZFP36;MUC1;CCND1;LEPR;S1PR1;SIRPA;CCL2;CD36;TIMP1;STAT5A;STAT5B;EGR1;ANXA1;MME;DUSP1;STAT1;HGF;LIFR;FOS;CXCL10;COL1A2;CXCL12;BCL6;KIT;SAA1;PRTN3;VIM;TLR4
"positive regulation of transcription, DNA-templated (GO:0045893)",47/1183,1.2131991765049808E-16,1.4770699973948142E-13,0,0,5.114389982277773,187.43267893539814,YAP1;CALCOCO1;THRB;MAML2;EPAS1;PIK3R1;MEOX2;NR3C1;PKD2;EGFR;ETS2;FOXO1;RPS6KA3;SPP1;E2F2;FADD;TEAD1;STAT5B;EGR1;SREBF1;TCF7L2;MEF2C;JUN;FZD4;STAT1;HGF;ZBTB16;LMO2;FOS;KLF4;SOX10;ESR1;RUNX2;FLI1;DCN;ACTA2;PER1;NR4A1;CXCL10;ZEB2;KLF6;BCL3;PPARG;BMPR1B;TLR4;MET;RHOQ
positive regulation of transcription by RNA polymerase II (GO:0045944),40/908,1.14388939595163E-15,9.284568930474063E-13,0,0,5.522370646911276,189.99352942799482,YAP1;CALCOCO1;THRB;MAML2;EPAS1;PIK3R1;MEOX2;NR3C1;PKD2;EGFR;FOXO1;RPS6KA3;MUC1;E2F2;FADD;TEAD1;STAT5B;EGR1;SREBF1;TCF7L2;MEF2C;JUN;STAT1;HGF;LMO2;FOS;KLF4;ESR1;RUNX2;DCN;PER1;NR4A1;CXCL10;ZEB2;KLF6;PPARG;BMPR1B;TLR4;MET;RHOQ
cytokine-mediated signaling pathway (GO:0019221),33/621,2.6051507743986048E-15,1.5858855339151508E-12,0,0,6.535374149659864,219.46626740762525,YAP1;ARF1;CCL11;F13A1;IRS2;PIK3R1;FOXO1;GHR;SOCS3;MUC1;CCND1;LEPR;S1PR1;CCL2;CD36;TIMP1;STAT5A;STAT5B;EGR1;ANXA1;STAT1;HGF;LIFR;FOS;CXCL10;COL1A2;CXCL12;BCL6;LEP;KIT;SAA1;PRTN3;VIM
cellular response to growth factor stimulus (GO:0071363),17/158,3.414713208753101E-13,1.6629653326627602E-10,0,0,13.096547940911407,375.9431232347407,STAT5B;NRP1;MEF2C;ANXA1;HGF;CIB1;NR3C1;KLF4;RUNX2;EGFR;TGFBR2;NR4A1;ZFP36;MAPKAPK2;KDR;CCL2;BMPR1B
regulation of transcription by RNA polymerase II (GO:0006357),56/2206,1.6612858360160016E-11,6.742051684498273E-9,0,0,3.237838191942352,80.36587704929238,CALCOCO1;THRB;MAML2;MEOX2;NR3C1;PKD2;ETS2;RPS6KA3;ZFP36;CCND1;TEAD1;SREBF1;MEF2C;HGF;LMO2;RFX2;FOS;SOX10;RUNX2;DCN;ZEB2;MAF;KIT;PPARG;EZR;TLR4;MET;RHOQ;YAP1;EPAS1;PIK3R1;EGFR;FOXO1;MUC1;E2F2;FADD;STAT5A;STAT5B;EGR1;TCF7L2;JUN;STAT1;ZBTB16;CAV1;PLK1;KLF4;ESR1;FLI1;EFNA1;PER1;NR4A1;CXCL10;KLF6;BCL6;CALR;BMPR1B
cellular response to oxygen-containing compound (GO:1901701),19/323,5.702825317180006E-10,1.9837685210476161E-7,0,0,6.807960893854749,144.90669335961238,EGR1;MEF2C;JUN;FZD4;LPL;FOS;PKD2;ESR1;EGFR;FOXO1;AQP1;CXCL10;ZFP36;GNG2;SIRPA;CCL2;VIM;EZR;TLR4
positive regulation of cellular process (GO:0048522),26/625,6.560276814009289E-10,1.996784255264077E-7,0,0,4.846041852700237,102.46867362870586,LRP1;IRS2;CIB1;EGFR;RPS6KA3;ZFP36;CCND2;CCND1;MDK;KDR;SIRPA;CD36;TIMP1;CAV1;LIFR;CDC25B;TGFBR2;MMP14;CXCL12;SAA1;PRTN3;CALR;BMPR1B;TLR4;FGFR3;S100A8
extracellular matrix organization (GO:0030198),18/300,1.2072729311675645E-9,3.266343985992244E-7,0,0,6.921985815602837,142.1422989623002,COL17A1;GSN;DST;VWF;LAMA4;LAMA3;BGN;LAMC1;DCN;MMP14;VCAN;COL1A2;ADAM12;KDR;SPP1;PECAM1;TIMP1;A2M
positive regulation of nucleic acid-templated transcription (GO:1903508),23/511,1.5494495723387639E-9,3.77290970864489E-7,0,0,5.201662763466042,105.51763340087766,YAP1;EGR1;MEF2C;JUN;CALCOCO1;FZD4;STAT1;ZBTB16;FOS;KLF4;SOX10;ESR1;RUNX2;FLI1;EGFR;ETS2;FOXO1;ACTA2;KLF6;BCL3;SPP1;PPARG;TEAD1
regulation of apoptotic process (GO:0042981),27/742,5.3846793076922415E-9,1.186085183454888E-6,0,0,4.215016562384983,80.2526849043923,MAGED1;ITSN1;CIB1;PIK3R1;EGFR;FOXO1;AQP1;RPS6KA3;CCND2;KDR;MAP3K20;FADD;CTSD;MEF2C;JUN;ANXA1;STAT1;HGF;PLK1;CXCL10;KRT18;BCL6;BCL3;CALR;SGK1;CRYAB;ARHGEF6
positive regulation of cell motility (GO:2000147),15/221,5.845183655629839E-9,1.186085183454888E-6,0,0,7.797230622314181,147.81715212112599,CCL11;HGF;CAV1;NEDD9;CIB1;EGFR;MYLK;CDH5;MMP14;CXCL12;PLAU;MDK;KIT;KDR;PECAM1
positive regulation of cell migration (GO:0030335),16/269,1.181881206935155E-8,2.2137544145285404E-6,0,0,6.792859314598445,123.99395563139248,NRP1;CCL11;HGF;CAV1;NEDD9;CIB1;EGFR;MYLK;CDH5;MMP14;CXCL12;PLAU;MDK;KIT;KDR;PECAM1
response to lipid (GO:0033993),11/114,1.794272371742721E-8,2.9251782101998497E-6,0,0,11.250142775556824,200.65845969783697,RPS6KA3;STAT5B;ANXA1;MAPKAPK2;SPP1;PPARG;CD36;ESR1;TLR4;S100A8;FOXO1
receptor signaling pathway via JAK-STAT (GO:0007259),7/31,1.8019578296918992E-8,2.9251782101998497E-6,0,0,30.202006980802793,538.5563591013042,GHR;STAT5A;STAT5B;STAT1;LEP;CCL2;PKD2
regulation of cell migration (GO:0030334),19/408,2.6027545067831027E-8,3.961067015010534E-6,0,0,5.297166491936063,92.51030060263835,ANXA1;CCL11;HGF;CAV1;NEDD9;CIB1;EGFR;MYLK;CDH5;MMP14;PARD6B;CXCL12;PLAU;MDK;KIT;KDR;PECAM1;AMOTL2;SGK1
positive regulation of cell-substrate adhesion (GO:0010811),9/70,2.9401758056364662E-8,4.012140609435341E-6,0,0,15.410616705698672,267.2541721991754,NRP1;MDK;AGR2;NEDD9;CIB1;CD36;CALR;UTRN;FBLN2
positive regulation of cellular biosynthetic process (GO:0031328),13/180,2.989674329992258E-8,4.012140609435341E-6,0,0,8.26201650752549,143.1437015250784,EGR1;SREBF1;HGF;IRS2;SORBS1;PKD2;KLF4;EGFR;ZEB2;BCL3;CD36;VIM;TLR4
extracellular structure organization (GO:0043062),14/216,3.420473666274007E-8,4.012140609435341E-6,0,0,7.382694791218253,126.91518046319828,COL17A1;VWF;LAMA4;LAMA3;BGN;LAMC1;DCN;MMP14;VCAN;COL1A2;ADAM12;KDR;SPP1;PECAM1
positive regulation of phosphorylation (GO:0042327),15/253,3.588416898479148E-8,4.012140609435341E-6,0,0,6.737842678054829,115.50663229424025,NRP1;HGF;CIB1;EGFR;C3;EFNA1;CCND2;CCND1;LEP;KIT;KDR;LEPR;PECAM1;FGFR3;MET
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),7/34,3.595040249153743E-8,4.012140609435341E-6,0,0,26.84215629241807,460.10477122819685,EGR1;JUN;PPARG;FOS;NR3C1;KLF4;TEAD1
external encapsulating structure organization (GO:0045229),14/217,3.6249319674569815E-8,4.012140609435341E-6,0,0,7.345952023988006,125.85705904565475,COL17A1;VWF;LAMA4;LAMA3;BGN;LAMC1;DCN;MMP14;VCAN;COL1A2;ADAM12;KDR;SPP1;PECAM1
cellular response to lipid (GO:0071396),14/219,4.067394310681299E-8,4.210635095488911E-6,0,0,7.273541887592789,123.77879498474726,MEF2C;FZD4;LPL;NR3C1;ESR1;EGFR;AQP1;CXCL10;ZFP36;SPP1;SIRPA;CCL2;VIM;TLR4
positive regulation of protein localization to cell periphery (GO:1904377),8/52,4.150112619783731E-8,4.210635095488911E-6,0,0,18.90717703349282,321.37559760727345,LRP1;EPB41L2;AGR2;CIB1;PIK3R1;SORBS1;EGFR;SPTBN1
platelet degranulation (GO:0002576),11/125,4.704241454335557E-8,4.5819311765228325E-6,0,0,10.158926728586172,171.4036081764266,TF;F8;VWF;PROS1;HGF;PECAM1;F13A1;SERPING1;CD36;TIMP1;A2M
hemidesmosome assembly (GO:0031581),5/12,6.767389153245409E-8,6.3379202262125276E-6,0,0,73.26054774241302,1209.4265422430078,COL17A1;DST;LAMA3;KRT5;LAMC1
negative regulation of apoptotic process (GO:0043066),20/485,8.143904095958841E-8,7.344594990244363E-6,0,0,4.672465869276308,76.27058104918562,YAP1;MEF2C;ANXA1;HGF;CAV1;PLK1;CIB1;PIK3R1;KLF4;EGFR;FOXO1;AQP1;RPS6KA3;KRT18;CCND2;MDK;BCL3;KDR;CCL2;CRYAB
regulation of protein localization to plasma membrane (GO:1903076),9/80,9.628199695090452E-8,8.373095091980445E-6,0,0,13.233400402414487,213.79861156097772,MMP14;LRP1;AGR2;CIB1;PIK3R1;SORBS1;RHOQ;EGFR;SPTBN1
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),18/404,1.1964917684351198E-7,1.0046405021170748E-5,0,0,5.030051813471503,80.17249640814084,NRP1;CAV2;HGF;ITSN1;NEDD9;IRS2;PIK3R1;SORBS1;EGFR;FOXO1;EFNA1;GHR;KIT;MAPKAPK2;KDR;FGFR3;MET;RHOQ
receptor signaling pathway via STAT (GO:0097696),6/25,1.3212136053676267E-7,1.0723850430233903E-5,0,0,32.53782894736842,515.3844038209337,GHR;STAT5A;STAT5B;STAT1;CCL2;PKD2
regulation of cell population proliferation (GO:0042127),25/764,1.6113679172050436E-7,1.2657035091594455E-5,0,0,3.7276979514576016,58.30496911684861,YAP1;IRS2;CIB1;PKD2;EGFR;CCND2;KDR;TIMP1;TNS2;STAT5A;STAT5B;TCF7L2;JUN;STAT1;LIFR;KLF4;CDC25B;TGFBR2;CXCL10;BCL6;KIT;PRTN3;CALR;SGK1;FGFR3
actin cytoskeleton reorganization (GO:0031532),8/63,1.9461643841090182E-7,1.480909461032956E-5,0,0,15.11732057416268,233.59639307464127,NRP1;ANXA1;GSN;KIT;S1PR1;NEDD9;PARVA;EZR
"negative regulation of transcription, DNA-templated (GO:0045892)",28/948,2.2578025654371003E-7,1.6659846202543452E-5,0,0,3.3804092071611254,51.732780643897264,YAP1;THRB;NR3C1;ETS2;FOXO1;ZFP36;MUC1;CCND1;TCF7L2;MEF2C;JUN;STAT1;ZBTB16;CAV1;PLK1;KLF4;SOX10;ESR1;RUNX2;EFNA1;PER1;ZEB2;BCL6;BCL3;PPARG;CALR;EZR;CRYAB
regulated exocytosis (GO:0045055),12/180,2.469351013187657E-7,1.7684910932682193E-5,0,0,7.539938556067589,114.71368291374411,SNAP25;TF;F8;VWF;PROS1;HGF;PECAM1;F13A1;SERPING1;CD36;TIMP1;A2M
positive regulation of cell population proliferation (GO:0008284),19/474,2.7011308903267113E-7,1.870860314863552E-5,0,0,4.513389403892197,68.26242006470478,YAP1;TCF7L2;MEF2C;STAT1;IRS2;CIB1;LIFR;LAMC1;EGFR;AQP1;CDC25B;TGFBR2;CCND2;MDK;KDR;PRTN3;CALR;TIMP1;FGFR3
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),7/45,2.7659536482582286E-7,1.870860314863552E-5,0,0,19.06144943510609,287.841423445167,EGR1;JUN;PPARG;FOS;NR3C1;KLF4;TEAD1
cellular response to organic cyclic compound (GO:0071407),11/150,3.046510929920091E-7,1.9706255799569373E-5,0,0,8.32120186203978,124.85213381234281,EGR1;MEF2C;GNG2;SPP1;CCL2;NR3C1;EZR;PKD2;ESR1;EGFR;AQP1
positive regulation of cell differentiation (GO:0045597),14/258,3.07530891327982E-7,1.9706255799569373E-5,0,0,6.098806129722024,91.44970908529766,YAP1;MEF2C;HGF;ZBTB16;LPL;RUNX2;TGFBR2;RPS6KA3;ZFP36;MDK;KDR;PPARG;CD36;BMPR1B
regulation of endothelial cell proliferation (GO:0001936),9/92,3.2566676648169297E-7,1.9895506211728285E-5,0,0,11.313253012048193,168.99048561307973,STAT5A;NRP1;NR4A1;CCL11;CAV2;STAT1;CAV1;LEP;KDR
negative regulation of transcription by RNA polymerase II (GO:0000122),23/684,3.268255640530314E-7,1.9895506211728285E-5,0,0,3.80586124918954,56.83612010945585,YAP1;TCF7L2;MEF2C;JUN;THRB;STAT1;ZBTB16;CAV1;PLK1;NR3C1;KLF4;SOX10;ESR1;ETS2;EFNA1;PER1;ZEB2;ZFP36;CCND1;BCL6;PPARG;CALR;EZR
positive regulation of epithelial cell proliferation (GO:0050679),10/123,4.0966617146029477E-7,2.433017384160531E-5,0,0,9.268028619845603,136.3134533864239,STAT5A;YAP1;NR4A1;NRP1;TCF7L2;CCL11;MDK;KDR;LAMC1;EGFR
regulation of G1/S transition of mitotic cell cycle (GO:2000045),8/71,4.996837587712732E-7,2.8969760776382145E-5,0,0,13.192314118629907,191.411116873356,CCND2;ANXA1;CCND1;FHL1;CCL2;PKD2;KLF4;EGFR
regulation of developmental growth (GO:0048638),6/31,5.227947078375185E-7,2.9604770083357152E-5,0,0,24.72125,357.5700629917922,GHR;STAT5A;STAT5B;LEP;AGR2;FGFR3
positive regulation of macromolecule biosynthetic process (GO:0010557),10/129,6.379283417189701E-7,3.530353436558392E-5,0,0,8.798051135347755,125.50455028530905,HGF;BCL3;KDR;CCL2;IRS2;SORBS1;VIM;KLF4;TLR4;EGFR
positive regulation of protein localization to plasma membrane (GO:1903078),7/52,7.69087244863321E-7,4.1616165360937484E-5,0,0,16.09063408958697,226.52493502437633,LRP1;AGR2;CIB1;PIK3R1;SORBS1;EGFR;SPTBN1
cellular response to hormone stimulus (GO:0032870),8/76,8.489805890601577E-7,4.494060292090182E-5,0,0,12.219195046439628,170.81493203288497,GHR;STAT5B;MEF2C;THRB;CAV1;LEP;LMO2;NR3C1
cell-substrate junction assembly (GO:0007044),6/34,9.316464805649271E-7,4.82672165994808E-5,0,0,22.069196428571427,306.45975617675214,COL17A1;DST;LAMA3;LAMC1;KRT5;SORBS1
cellular protein modification process (GO:0006464),28/1025,1.0743940619917934E-6,5.4304526746735294E-5,0,0,3.1066139595256357,42.69653715837936,CCL11;EPAS1;F13A1;UBE2L6;LAMC1;PRSS23;C3;SOCS3;GRK3;PPP2R1B;SPP1;MAP3K20;CCL2;ELOB;TIMP1;ANXA1;DUSP1;GOLM1;ZBTB16;PLK1;CDC25B;TGFBR2;TF;PTPRB;VCAN;MAPKAPK2;SGK1;BMPR1B
cellular response to peptide hormone stimulus (GO:0071375),9/106,1.0927810310431333E-6,5.4304526746735294E-5,0,0,9.673539518900343,132.78659432483192,NR4A1;PRKAR2B;CAV1;IRS2;PPARG;PIK3R1;SORBS1;FOXO1;RHOQ
positive regulation of gene expression (GO:0010628),18/482,1.5583660123192646E-6,7.357230953415468E-5,0,0,4.167672413793103,55.729585029387465,YAP1;EGR1;MEF2C;CALCOCO1;GSN;ANK2;PIK3R1;KLF4;EGFR;ACTA2;CDH5;BCL3;AGR2;SAA1;CD36;VIM;EZR;TLR4
positive regulation of protein modification process (GO:0031401),12/214,1.5614096860567374E-6,7.357230953415468E-5,0,0,6.259980836793357,83.69545237840438,C3;EFNA1;CDH5;CCND2;CCND1;HGF;LEP;KDR;LEPR;PECAM1;CIB1;EGFR
negative regulation of endothelial cell proliferation (GO:0001937),6/37,1.5711540434398533E-6,7.357230953415468E-5,0,0,19.930443548387096,266.3444714194521,MEF2C;CAV2;STAT1;CAV1;CCL2;PPARG
positive regulation of multicellular organismal process (GO:0051240),15/345,1.9051577083735967E-6,8.752941546961713E-5,0,0,4.836562344759066,63.70210033797829,ABCA1;LRP1;EPAS1;ZBTB16;CAV1;CXCR4;TGFBR2;GHR;FABP4;MDK;LEP;SAA1;LEPR;CD36;BMPR1B
MAPK cascade (GO:0000165),14/303,2.090269192979483E-6,9.425565712787113E-5,0,0,5.1373175868812995,67.18695779431147,MEF2C;HGF;IRS2;PIK3R1;EGFR;ZFP36;KIT;MAPKAPK2;KDR;MAP3K20;CCL2;FGFR3;MET;SPTBN1
cellular component assembly (GO:0022607),13/261,2.141989234595486E-6,9.483170520436379E-5,0,0,5.540584132519617,72.32554202430556,YAP1;GSN;NEDD9;PARVA;LAMC1;EPS8;PARD6B;ELOB;EZR;TEAD1;SPTBN1;RHOQ;SKAP2
positive regulation of intracellular signal transduction (GO:1902533),19/546,2.2367852132245814E-6,9.726021418217598E-5,0,0,3.8822575344789203,50.50999866160695,TCF7L2;VWF;CAV2;HGF;CAV1;IRS2;PIK3R1;ESR1;EGFR;DCN;LEP;KIT;KDR;S100A4;FADD;TLR4;FGFR3;MET;S100A8
regulation of nitric oxide biosynthetic process (GO:0045428),6/40,2.5308392617206704E-6,1.0811567723315495E-4,0,0,18.169117647058822,234.14468483515662,CAV1;SIRPA;CD36;PKD2;KLF4;TLR4
regulation of protein phosphorylation (GO:0001932),13/266,2.6409054525779766E-6,1.1087249615564437E-4,0,0,5.429697681871595,69.74114768598825,HGF;CIB1;EGFR;C3;EFNA1;CDH5;CCND2;CCND1;LEP;KDR;LEPR;PECAM1;SIRPA
cellular response to reactive oxygen species (GO:0034614),7/63,2.901377094648817E-6,1.1974327500796389E-4,0,0,12.922774869109947,164.76958043227262,JUN;ANXA1;SIRPA;FOS;PKD2;EGFR;AQP1
negative regulation of cell differentiation (GO:0045596),11/191,3.3191045330051363E-6,1.347003256311251E-4,0,0,6.412418300653595,80.89788638474869,ABCA1;EFNA1;YAP1;EFEMP1;CAV1;ZBTB16;DTX1;PPARG;CALR;FOXO1;EGFR
cellular response to organic substance (GO:0071310),9/123,3.789879562301891E-6,1.512845366263132E-4,0,0,8.223893065998329,102.66030715609328,GHR;STAT5B;MME;CXCR4;CCL2;CIB1;BMPR1B;KLF4;TGFBR2
regulation of epithelial cell proliferation (GO:0050678),8/93,3.972591110229302E-6,1.5602031215174758E-4,0,0,9.766934984520123,121.46250206029545,YAP1;TCF7L2;NR4A1;ZFP36;MAGED1;LEP;LAMC1;EGFR
response to lipopolysaccharide (GO:0032496),10/159,4.2796211505512765E-6,1.654107539935295E-4,0,0,7.015921747822362,86.72834149097507,RPS6KA3;CXCL10;ZFP36;MEF2C;MAPKAPK2;SIRPA;CCL2;VIM;TLR4;S100A8
positive regulation of protein phosphorylation (GO:0001934),15/371,4.626240134224852E-6,1.7601398010683614E-4,0,0,4.477343893903113,54.99864507844684,NRP1;HGF;CAV1;PLK1;CIB1;EGFR;C3;EFNA1;GHR;CCND2;CCND1;LEP;KDR;LEPR;PECAM1
positive regulation of protein kinase B signaling (GO:0051897),10/161,4.784797954236005E-6,1.7924589259330262E-4,0,0,6.922291108919262,84.79852820790728,TCF7L2;HGF;LEP;KIT;IRS2;PIK3R1;ESR1;FGFR3;MET;EGFR
regulation of receptor signaling pathway via JAK-STAT (GO:0046425),6/45,5.1541183941627675E-6,1.9015573166342937E-4,0,0,15.835737179487179,192.81141439354064,GHR;SOCS3;CAV1;LEP;BCL3;KIT
cell chemotaxis (GO:0060326),7/69,5.3814519193431955E-6,1.9270346211177475E-4,0,0,11.668637054551596,141.5703498791774,NRP1;NR4A1;CXCL12;HGF;KIT;CXCR4;PARVA
peptidyl-tyrosine phosphorylation (GO:0018108),7/69,5.3814519193431955E-6,1.9270346211177475E-4,0,0,11.668637054551596,141.5703498791774,GHR;EFEMP1;LEP;KIT;KDR;FGFR3;EGFR
negative regulation of programmed cell death (GO:0043069),15/381,6.372204888602424E-6,2.2487418701082465E-4,0,0,4.352772552181313,52.074677410092754,ANXA1;HGF;PLK1;CIB1;PIK3R1;EGFR;FOXO1;AQP1;RPS6KA3;KRT18;CCND2;BCL3;KDR;CRYAB;MET
gland development (GO:0048732),7/71,6.523628249812715E-6,2.2692906840419944E-4,0,0,11.302846858638743,134.95689410099627,ANXA1;MDK;CAV1;FADD;PKD2;EZR;MET
regulation of inflammatory response (GO:0050727),11/206,6.851249384549403E-6,2.3496890494898302E-4,0,0,5.914630467571644,70.33134128291896,CDH5;ANXA1;BCL6;MDK;SAA1;SIRPA;LPL;PPARG;KLF4;TLR4;S100A8
regulation of protein kinase B signaling (GO:0051896),11/207,7.173988571095833E-6,2.4262030792525488E-4,0,0,5.884153661464586,69.69808710173218,TCF7L2;HGF;LEP;KIT;IRS2;CIB1;PIK3R1;ESR1;FGFR3;MET;EGFR
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),9/134,7.651800354139615E-6,2.552347104428762E-4,0,0,7.496,88.30714970213764,EFNA1;GHR;SOCS3;NRP1;HGF;KIT;PECAM1;NEDD9;FGFR3
cellular response to low-density lipoprotein particle stimulus (GO:0071404),4/14,8.63062059498524E-6,2.802074819838542E-4,0,0,40.80824742268041,475.8320876289387,ABCA1;LPL;PPARG;CD36
response to UV-A (GO:0070141),4/14,8.63062059498524E-6,2.802074819838542E-4,0,0,40.80824742268041,475.8320876289387,MME;CCND1;TIMP1;EGFR
"regulation of blood coagulation, intrinsic pathway (GO:2000266)",3/5,9.41803553508877E-6,2.902605310906772E-4,0,0,152.30769230769232,1762.6392604178561,F8;SERPING1;A2M
renal tubule development (GO:0061326),3/5,9.41803553508877E-6,2.902605310906772E-4,0,0,152.30769230769232,1762.6392604178561,MEF2C;STAT1;PKD2
"negative regulation of blood coagulation, intrinsic pathway (GO:2000267)",3/5,9.41803553508877E-6,2.902605310906772E-4,0,0,152.30769230769232,1762.6392604178561,F8;SERPING1;A2M
negative regulation of vascular endothelial cell proliferation (GO:1905563),3/5,9.41803553508877E-6,2.902605310906772E-4,0,0,152.30769230769232,1762.6392604178561,MEF2C;CCL2;PPARG
protein phosphorylation (GO:0006468),17/496,9.536280282239908E-6,2.902605310906772E-4,0,0,3.788867230302541,43.80084746366326,CCL11;PLK1;EGFR;CDC25B;TGFBR2;RPS6KA3;GRK3;EFEMP1;KIT;MAPKAPK2;KDR;MAP3K20;CCL2;SGK1;BMPR1B;TLR4;FGFR3
positive regulation of growth (GO:0045927),7/76,1.0286135113750025E-5,3.0921900002446064E-4,0,0,10.481144244631611,120.3729406360067,RPS6KA3;MMP14;LEP;AGR2;CIB1;S100A8;EGFR
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),8/106,1.054295531516663E-5,3.13074343810131E-4,0,0,8.465735767991408,97.01777773831829,HGF;LEP;KIT;KDR;IRS2;PIK3R1;DCN;EGFR
transcription initiation from RNA polymerase II promoter (GO:0006367),9/140,1.0916097002758431E-5,3.2024935182791304E-4,0,0,7.150490730643402,81.6963020235062,YAP1;NR4A1;THRB;MAML2;E2F2;PPARG;NR3C1;ESR1;TEAD1
neutrophil migration (GO:1990266),7/77,1.1220811621420046E-5,3.214432505665625E-4,0,0,10.33089005235602,117.74880212697992,CXCL10;CCL11;PECAM1;SAA1;CCL2;PRTN3;S100A8
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),7/77,1.1220811621420046E-5,3.214432505665625E-4,0,0,10.33089005235602,117.74880212697992,HGF;LEP;KIT;KDR;IRS2;PIK3R1;DCN
response to peptide hormone (GO:0043434),6/52,1.2162633529714132E-5,3.4437224005644083E-4,0,0,13.421195652173912,151.88957877310764,STAT5A;STAT5B;ANXA1;STAT1;CAV1;LEP
regulation of fat cell differentiation (GO:0045598),7/80,1.4456481401863516E-5,4.0079084118714207E-4,0,0,9.90482679480743,110.38303184624559,YAP1;ZFP36;ZBTB16;LEP;LPL;PPARG;FOXO1
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),5/32,1.4649028692261044E-5,4.0079084118714207E-4,0,0,18.97428516599501,211.20535865776438,ANXA1;KDR;CIB1;MEOX2;KLF4
positive regulation of glucose transmembrane transport (GO:0010828),5/32,1.4649028692261044E-5,4.0079084118714207E-4,0,0,18.97428516599501,211.20535865776438,C3;IRS2;PIK3R1;SORBS1;RHOQ
"regulation of transcription, DNA-templated (GO:0006355)",43/2244,1.4981205149760956E-5,4.053248282185326E-4,0,0,2.21847254180651,24.644377277787594,YAP1;CALCOCO1;MAGED1;EPAS1;MEOX2;NR3C1;EGFR;ETS2;FOXO1;RPS6KA3;EFEMP1;SPP1;E2F2;TEAD1;STAT5A;STAT5B;EGR1;SREBF1;TCF7L2;MEF2C;JUN;FZD4;STAT1;ZBTB16;RFX2;FOS;KLF4;SOX10;ESR1;RUNX2;FLI1;ACTA2;PER1;NR4A1;ZEB2;KLF6;MAF;BCL6;KIT;BCL3;PPARG;CALR;CRYAB
regulation of interleukin-1 production (GO:0032652),4/16,1.545021824146898E-5,4.1342067492282386E-4,0,0,34.00343642611684,376.686240929682,ANXA1;SAA1;SIRPA;TLR4
taurine metabolic process (GO:0019530),3/6,1.8698571000277073E-5,4.949023954964638E-4,0,0,101.53333333333333,1105.399842708434,GHR;STAT5A;STAT5B
cellular response to vascular endothelial growth factor stimulus (GO:0035924),5/34,1.9919104580258435E-5,5.138596113090491E-4,0,0,17.66392710380561,191.19136631828698,NRP1;NR4A1;ANXA1;MAPKAPK2;KDR
response to insulin (GO:0032868),7/84,1.9936428780458723E-5,5.138596113090491E-4,0,0,9.38838648262732,101.61014927663982,LEP;IRS2;PPARG;PIK3R1;SORBS1;RHOQ;FOXO1
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),4/17,2.004791091349473E-5,5.138596113090491E-4,0,0,31.38620142743854,339.51664346912577,CCND2;CCND1;PKD2;EGFR
cellular response to glucocorticoid stimulus (GO:0071385),4/18,2.5576635816114396E-5,6.420526619818407E-4,0,0,29.142857142857142,308.15165463929964,ZFP36;ANXA1;NR3C1;AQP1
regulation of vascular endothelial cell proliferation (GO:1905562),4/18,2.5576635816114396E-5,6.420526619818407E-4,0,0,29.142857142857142,308.15165463929964,MEF2C;MDK;CCL2;PPARG
regulation of ERK1 and ERK2 cascade (GO:0070372),11/238,2.6460220438317998E-5,6.532028065842856E-4,0,0,5.072557657424203,53.46408847814661,NRP1;CCL11;KDR;SIRPA;CCL2;CIB1;CD36;EZR;TLR4;FGFR3;EGFR
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),5/36,2.6557321499730707E-5,6.532028065842856E-4,0,0,16.52264750125355,174.08600263012104,NRP1;MDK;NEDD9;CIB1;CALR
axonogenesis (GO:0007409),11/240,2.8575496414199508E-5,6.95813337685758E-4,0,0,5.027742101207295,52.605069402871464,EFNA1;NRP1;PARD6B;CXCL12;MAP1B;LAMA3;CXCR4;IRS2;PIK3R1;EZR;SPTBN1
regulation of glucose import (GO:0046324),5/37,3.046144302868773E-5,7.132078247582175E-4,0,0,16.00550518134715,166.4420300428516,LEP;IRS2;PIK3R1;SORBS1;RHOQ
negative regulation of epithelial cell apoptotic process (GO:1904036),5/37,3.046144302868773E-5,7.132078247582175E-4,0,0,16.00550518134715,166.4420300428516,YAP1;CDH5;TCF7L2;MDK;KDR
negative regulation of stress-activated MAPK cascade (GO:0032873),5/37,3.046144302868773E-5,7.132078247582175E-4,0,0,16.00550518134715,166.4420300428516,PER1;DUSP1;SIRPA;EZR;FOXO1
positive regulation of calcium ion transport (GO:0051928),5/37,3.046144302868773E-5,7.132078247582175E-4,0,0,16.00550518134715,166.4420300428516,CXCL12;CAV1;CCL2;ANK2;MYLK
regulation of bone remodeling (GO:0046850),3/7,3.248368268258101E-5,7.533120698293787E-4,0,0,76.14615384615385,786.9531893913111,MDK;LEP;LEPR
regulation of angiogenesis (GO:0045765),10/203,3.605353283345724E-5,8.282108721647961E-4,0,0,5.404310439863301,55.28882876435041,CDH5;CXCL10;STAT1;LEP;ADAM12;KDR;PPARG;KLF4;DCN;AQP1
growth hormone receptor signaling pathway (GO:0060396),4/20,3.987293076362928E-5,8.989869111984935E-4,0,0,25.49742268041237,258.2841209624788,STAT5A;GHR;STAT5B;PIK3R1
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),4/20,3.987293076362928E-5,8.989869111984935E-4,0,0,25.49742268041237,258.2841209624788,CCND2;CCND1;PKD2;EGFR
negative regulation of MAPK cascade (GO:0043409),7/94,4.145494513554313E-5,9.260806550921791E-4,0,0,8.30504904615755,83.80544748983375,RGS2;DUSP1;CAV1;SIRPA;EZR;TLR4;FOXO1
muscle contraction (GO:0006936),8/129,4.390709481251722E-5,9.719434169861766E-4,0,0,6.848542844715094,68.7144069973048,ACTA2;TPM3;DMD;SORBS1;VIM;UTRN;CRYAB;MYLK
"DNA-templated transcription, initiation (GO:0006352)",9/168,4.644070805748099E-5,0.0010187668839636596,0,0,5.882899071578317,58.69564983454075,YAP1;NR4A1;THRB;MAML2;E2F2;PPARG;NR3C1;ESR1;TEAD1
positive regulation of cell cycle (GO:0045787),6/66,4.839104306610398E-5,0.0010520731238032428,0,0,10.282291666666667,102.16686349876662,CCND2;CCND1;CALR;PKD2;EGFR;CDC25B
response to growth factor (GO:0070848),5/41,5.0715867096644145E-5,0.0010744570351914205,0,0,14.224237190558433,140.66734681251603,STAT5B;CIB1;KLF4;BMPR1B;TGFBR2
T cell differentiation (GO:0030217),5/41,5.0715867096644145E-5,0.0010744570351914205,0,0,14.224237190558433,140.66734681251603,ANXA1;LEP;KIT;LEPR;FADD
positive regulation of cold-induced thermogenesis (GO:0120162),7/97,5.074437743203834E-5,0.0010744570351914205,0,0,8.026992437463642,79.37659826470869,FABP4;EPAS1;CAV1;LEP;LEPR;CXCR4;CD36
positive regulation of protein localization to membrane (GO:1905477),7/101,6.571781121905406E-5,0.0013795075027447986,0,0,7.683858750139245,73.9966398837878,LRP1;AGR2;CIB1;PIK3R1;SORBS1;SPTBN1;EGFR
positive regulation of developmental process (GO:0051094),9/177,6.960768449910884E-5,0.0014438890714097866,0,0,5.565192743764173,53.273562108854726,RPS6KA3;FZD4;MDK;ZBTB16;LEP;KDR;AGR2;BMPR1B;DCN
blood vessel endothelial cell migration (GO:0043534),4/23,7.11989385445473E-5,0.0014438890714097866,0,0,21.468258274552362,205.0225674120824,NRP1;CDH5;NR4A1;KDR
branching morphogenesis of an epithelial tube (GO:0048754),5/44,7.174972387703662E-5,0.0014438890714097866,0,0,13.128072273149993,125.27235262518337,NRP1;KDR;PKD2;MET;TGFBR2
positive regulation of cell-matrix adhesion (GO:0001954),5/44,7.174972387703662E-5,0.0014438890714097866,0,0,13.128072273149993,125.27235262518337,NRP1;KDR;CIB1;CD36;UTRN
positive regulation of osteoblast differentiation (GO:0045669),5/44,7.174972387703662E-5,0.0014438890714097866,0,0,13.128072273149993,125.27235262518337,YAP1;MEF2C;HGF;BMPR1B;RUNX2
protein-containing complex assembly (GO:0065003),11/267,7.50378989083797E-5,0.0014730326929006184,0,0,4.491268382352941,42.655898950508494,YAP1;TCF7L2;F8;PARD6B;CXCL12;ELOB;DMD;FADD;LAMC1;TEAD1;SKAP2
cellular response to interleukin-9 (GO:0071355),3/9,7.682757782274273E-5,0.0014730326929006184,0,0,50.758974358974356,480.8878275740263,STAT5A;STAT5B;STAT1
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),3/9,7.682757782274273E-5,0.0014730326929006184,0,0,50.758974358974356,480.8878275740263,ZFP36;MAPKAPK2;SIRPA
response to leptin (GO:0044321),3/9,7.682757782274273E-5,0.0014730326929006184,0,0,50.758974358974356,480.8878275740263,CCND1;LEP;LEPR
interleukin-9-mediated signaling pathway (GO:0038113),3/9,7.682757782274273E-5,0.0014730326929006184,0,0,50.758974358974356,480.8878275740263,STAT5A;STAT5B;STAT1
negative regulation of protein activation cascade (GO:2000258),3/9,7.682757782274273E-5,0.0014730326929006184,0,0,50.758974358974356,480.8878275740263,F8;SERPING1;A2M
cell morphogenesis involved in differentiation (GO:0000904),6/72,7.922093534847752E-5,0.001507054512293303,0,0,9.344696969696969,88.24449616864777,EFNA1;NRP1;MEF2C;PARVA;LAMC1;PIK3R1
granulocyte chemotaxis (GO:0071621),6/73,8.561147615331676E-5,0.0016035688033332791,0,0,9.204757462686567,86.20891611913531,CXCL10;ANXA1;CCL11;SAA1;CCL2;S100A8
insulin receptor signaling pathway (GO:0008286),6/73,8.561147615331676E-5,0.0016035688033332791,0,0,9.204757462686567,86.20891611913531,CAV2;IRS2;PIK3R1;SORBS1;RHOQ;FOXO1
transcription by RNA polymerase II (GO:0006366),12/320,8.718751041484454E-5,0.001620622808092721,0,0,4.083368244658567,38.169078320037094,YAP1;NR4A1;MAF;THRB;MAML2;DTX1;E2F2;ELOB;PPARG;NR3C1;TEAD1;ESR1
positive regulation of MAPK cascade (GO:0043410),11/274,9.446172460441175E-5,0.0017425325713010802,0,0,4.370163274435249,40.499683319747106,NRP1;CCL11;CAV2;LEP;KIT;KDR;CCL2;CIB1;CD36;FGFR3;EGFR
inflammatory response (GO:0006954),10/230,1.0256814700679627E-4,0.001877845398207135,0,0,4.734526112185686,43.48654247584977,CXCL10;ANXA1;CCL11;KIT;MAPKAPK2;CXCR4;CCL2;FOS;TLR4;S100A8
regulation of epithelial cell apoptotic process (GO:1904035),3/10,1.0895350177156852E-4,0.001961609540063577,0,0,43.505494505494504,396.96977209243323,YAP1;ZFP36;MDK
lipoprotein transport (GO:0042953),3/10,1.0895350177156852E-4,0.001961609540063577,0,0,43.505494505494504,396.96977209243323,LRP1;PPARG;CD36
substrate adhesion-dependent cell spreading (GO:0034446),5/48,1.0956012215550163E-4,0.001961609540063577,0,0,11.904446318833594,108.55708761980242,EFNA1;NRP1;PARVA;LAMC1;PIK3R1
positive regulation of endothelial cell proliferation (GO:0001938),6/77,1.1539742088493834E-4,0.0020282205606216726,0,0,8.684419014084508,78.74274361308272,STAT5A;NRP1;NR4A1;CCL11;MDK;KDR
regulation of chondrocyte differentiation (GO:0032330),4/26,1.1744521521464305E-4,0.0020282205606216726,0,0,18.53795688847235,167.75995617900264,EFEMP1;MDK;ZBTB16;BMPR1B
lamellipodium assembly (GO:0030032),4/26,1.1744521521464305E-4,0.0020282205606216726,0,0,18.53795688847235,167.75995617900264,ABLIM1;KIT;S1PR1;ARHGEF6
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),4/26,1.1744521521464305E-4,0.0020282205606216726,0,0,18.53795688847235,167.75995617900264,CCND2;ANXA1;CCND1;EGFR
positive regulation of glucose import (GO:0046326),4/26,1.1744521521464305E-4,0.0020282205606216726,0,0,18.53795688847235,167.75995617900264,IRS2;PIK3R1;SORBS1;RHOQ
positive regulation of macromolecule metabolic process (GO:0010604),13/384,1.2401908429550854E-4,0.0021266652835180513,0,0,3.6803817294383334,33.10531004778574,YAP1;EGR1;MEF2C;CALCOCO1;GSN;ANK2;KLF4;ACTA2;CDH5;AGR2;CD36;EZR;TLR4
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),5/50,1.334135398804602E-4,0.002258464255669678,0,0,11.374208405296487,101.48133494028836,NRP1;MDK;NEDD9;CIB1;CALR
positive regulation of metabolic process (GO:0009893),7/113,1.3356010382605077E-4,0.002258464255669678,0,0,6.809838980539366,60.750294107158076,FABP4;EPAS1;CAV1;LEP;LEPR;CXCR4;CD36
positive regulation of nitric oxide biosynthetic process (GO:0045429),4/27,1.3680740129395734E-4,0.0022974208424192144,0,0,17.731062303899595,157.752134530299,CD36;PKD2;KLF4;TLR4
cellular response to transforming growth factor beta stimulus (GO:0071560),7/114,1.4112108282510704E-4,0.0023411419608814453,0,0,6.745853109556197,59.808007091395865,CDH5;MEF2C;JUN;COL1A2;FOS;NR3C1;TGFBR2
positive regulation of cell adhesion (GO:0045785),6/80,1.4271258790611913E-4,0.0023411419608814453,0,0,8.33108108108108,73.76903890688833,CXCL12;MDK;AGR2;SAA1;CIB1;FBLN2
blood circulation (GO:0008015),5/51,1.4673596946807615E-4,0.0023411419608814453,0,0,11.12637981527371,98.21117175639165,CXCL10;CXCL12;STAT1;SERPING1;MEOX2
regulation of substrate adhesion-dependent cell spreading (GO:1900024),5/51,1.4673596946807615E-4,0.0023411419608814453,0,0,11.12637981527371,98.21117175639165,NRP1;MDK;NEDD9;CIB1;CALR
regulation of phospholipase activity (GO:0010517),3/11,1.4871927424618865E-4,0.0023411419608814453,0,0,38.065384615384616,335.48736763809234,RGS2;LRP1;FGFR3
lipoprotein localization (GO:0044872),3/11,1.4871927424618865E-4,0.0023411419608814453,0,0,38.065384615384616,335.48736763809234,LRP1;PPARG;CD36
negative regulation of receptor signaling pathway via STAT (GO:1904893),3/11,1.4871927424618865E-4,0.0023411419608814453,0,0,38.065384615384616,335.48736763809234,SOCS3;CAV1;BCL3
positive regulation of lipid localization (GO:1905954),3/11,1.4871927424618865E-4,0.0023411419608814453,0,0,38.065384615384616,335.48736763809234,C3;LRP1;LPL
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),3/11,1.4871927424618865E-4,0.0023411419608814453,0,0,38.065384615384616,335.48736763809234,KDR;CCL2;TLR4
cellular response to molecule of bacterial origin (GO:0071219),7/115,1.490254636290037E-4,0.0023411419608814453,0,0,6.683052162109754,58.887001511114896,CXCL10;ZFP36;MEF2C;SIRPA;CCL2;VIM;TLR4
regulation of interleukin-8 production (GO:0032677),6/81,1.5287424163252307E-4,0.002386210117789703,0,0,8.219583333333333,72.21639549125419,ANXA1;LEP;BCL3;FADD;KLF4;TLR4
nervous system development (GO:0007399),14/447,1.5416150206190018E-4,0.0023909761625524007,0,0,3.4035294708304047,29.874513252060986,YAP1;MEF2C;GSN;ZBTB16;CXCR4;PKD2;SOX10;RPS6KA3;ZEB2;VCAN;MDK;DPYSL2;TEAD1;MET
positive regulation of nitric oxide metabolic process (GO:1904407),4/28,1.583783086794461E-4,0.002440830263509185,0,0,16.991408934707902,148.68373215470842,CD36;PKD2;KLF4;TLR4
regulation of osteoblast differentiation (GO:0045667),6/83,1.749122149454496E-4,0.002678687065359558,0,0,8.005275974025974,69.25545435571036,YAP1;MEF2C;HGF;PPARG;BMPR1B;RUNX2
post-translational protein modification (GO:0043687),12/345,1.7619205898531442E-4,0.002681422897682754,0,0,3.771965513900998,32.60462817071684,C3;SOCS3;TF;VCAN;EPAS1;GOLM1;ZBTB16;SPP1;ELOB;TIMP1;LAMC1;PRSS23
skeletal system development (GO:0001501),8/158,1.816491577613326E-4,0.0027401727591510284,0,0,5.516350877192982,47.51472108982185,RPS6KA3;MMP14;VCAN;COL1A2;ZBTB16;BMPR1B;FGFR3;ETS2
lamellipodium organization (GO:0097581),4/29,1.8230307473612593E-4,0.0027401727591510284,0,0,16.310927835051547,140.4344790755755,ABLIM1;KIT;S1PR1;ARHGEF6
regulation of cell cycle (GO:0051726),11/296,1.8585527760522983E-4,0.002776426999808188,0,0,4.0282765737874096,34.60508016022257,PPP1R15A;NR4A1;TCF7L2;JUN;CCND1;DUSP1;LEP;PLK1;MAP3K20;CALR;PKD2
cellular response to lipopolysaccharide (GO:0071222),7/120,1.9411303951523173E-4,0.0028554488453190353,0,0,6.385720242783672,54.579197217390885,CXCL10;ZFP36;MEF2C;SIRPA;CCL2;VIM;TLR4
cytoskeleton organization (GO:0007010),7/120,1.9411303951523173E-4,0.0028554488453190353,0,0,6.385720242783672,54.579197217390885,CCL11;DST;MDK;DPYSL2;NEDD9;CCL2;SH3D19
cellular response to fluid shear stress (GO:0071498),3/12,1.968478510580344E-4,0.0028554488453190353,0,0,33.83418803418803,288.709814868317,MEF2C;KLF4;PKD2
dermatan sulfate biosynthetic process (GO:0030208),3/12,1.968478510580344E-4,0.0028554488453190353,0,0,33.83418803418803,288.709814868317,VCAN;BGN;DCN
axon guidance (GO:0007411),9/203,1.970083802930587E-4,0.0028554488453190353,0,0,4.812960235640648,41.065448750501595,EFNA1;NRP1;CXCL12;LAMA3;CXCR4;IRS2;PIK3R1;EZR;SPTBN1
maintenance of blood-brain barrier (GO:0035633),4/30,2.0872919291385774E-4,0.0030074294955339856,0,0,15.682791435368754,132.90339060551977,CDH5;PECAM1;DMD;LAMC1
negative regulation of angiogenesis (GO:0016525),6/87,2.2648651197174183E-4,0.0032440862155952432,0,0,7.608410493827161,63.85605905526001,CXCL10;STAT1;E2F2;PPARG;KLF4;DCN
chemokine-mediated signaling pathway (GO:0070098),5/56,2.292542962462374E-4,0.003245547740462721,0,0,10.033018388702631,84.08350357274209,CXCL10;CCL11;CXCL12;CCL2;CIB1
peptidyl-tyrosine modification (GO:0018212),5/56,2.292542962462374E-4,0.003245547740462721,0,0,10.033018388702631,84.08350357274209,EFEMP1;KIT;KDR;FGFR3;EGFR
regulation of macrophage derived foam cell differentiation (GO:0010743),4/31,2.3780633047885922E-4,0.0033471584665666024,0,0,15.10118365788469,126.00509119616562,ABCA1;LPL;PPARG;CD36
cellular response to peptide (GO:1901653),5/57,2.4929737257387425E-4,0.0034416277633961935,0,0,9.83957752092467,81.63763755849736,LRP1;CAV1;CD36;VIM;TLR4
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),3/13,2.5403880671621715E-4,0.0034416277633961935,0,0,30.44923076923077,252.0594484817744,LPL;KLF4;TLR4
chondroitin sulfate catabolic process (GO:0030207),3/13,2.5403880671621715E-4,0.0034416277633961935,0,0,30.44923076923077,252.0594484817744,VCAN;BGN;DCN
dermatan sulfate metabolic process (GO:0030205),3/13,2.5403880671621715E-4,0.0034416277633961935,0,0,30.44923076923077,252.0594484817744,VCAN;BGN;DCN
embryonic hemopoiesis (GO:0035162),3/13,2.5403880671621715E-4,0.0034416277633961935,0,0,30.44923076923077,252.0594484817744,KIT;KDR;TGFBR2
endochondral bone morphogenesis (GO:0060350),3/13,2.5403880671621715E-4,0.0034416277633961935,0,0,30.44923076923077,252.0594484817744,MEF2C;BMPR1B;FGFR3
regulation of MAPK cascade (GO:0043408),8/166,2.5441190858780895E-4,0.0034416277633961935,0,0,5.2349100599600265,43.32702583228623,CAV2;DUSP1;CAV1;LEP;KIT;KDR;FGFR3;EGFR
chondrocyte differentiation (GO:0002062),4/32,2.696861508780195E-4,0.0035816274498160897,0,0,14.561119293078056,119.66694308191032,MEF2C;BMPR1B;FGFR3;RUNX2
fat cell differentiation (GO:0045444),5/58,2.7064453830232465E-4,0.0035816274498160897,0,0,9.653436308534559,79.3001244142105,TCF7L2;NR4A1;PPARG;KLF4;FOXO1
muscle organ development (GO:0007517),5/58,2.7064453830232465E-4,0.0035816274498160897,0,0,9.653436308534559,79.3001244142105,CXCL10;MEF2C;FHL1;DMD;UTRN
positive regulation of mitotic cell cycle phase transition (GO:1901992),5/58,2.7064453830232465E-4,0.0035816274498160897,0,0,9.653436308534559,79.3001244142105,CCND2;ANXA1;CCND1;EGFR;CDC25B
toll-like receptor signaling pathway (GO:0002224),6/91,2.8934809223322196E-4,0.003808446511285921,0,0,7.2488970588235295,59.06314426107612,RPS6KA3;MAPKAPK2;CD36;FADD;TLR4;S100A8
negative regulation of multicellular organismal process (GO:0051241),9/214,2.9137025132091015E-4,0.003814443881539872,0,0,4.552148664343786,37.058658795335084,EFNA1;MEF2C;RGS2;MDK;LAMA4;CALR;TIMP1;TLR4;EGFR
cellular response to insulin stimulus (GO:0032869),7/129,3.0268949716537357E-4,0.003941438104800452,0,0,5.91193888936572,47.90327640334856,CAV2;IRS2;PPARG;PIK3R1;SORBS1;FOXO1;RHOQ
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),6/92,3.070183682408807E-4,0.003976541099290131,0,0,7.164244186046512,57.94872687817255,GHR;EFNA1;NRP1;HGF;PECAM1;EGFR
cellular response to chemokine (GO:1990869),5/60,3.1747328033229923E-4,0.004028654819270306,0,0,9.301460197833254,74.92434923058464,CXCL10;CCL11;CXCL12;DUSP1;CCL2
response to organic cyclic compound (GO:0014070),5/60,3.1747328033229923E-4,0.004028654819270306,0,0,9.301460197833254,74.92434923058464,STAT5B;ANXA1;SPP1;CCL2;ESR1
Notch signaling pathway (GO:0007219),5/60,3.1747328033229923E-4,0.004028654819270306,0,0,9.301460197833254,74.92434923058464,MAML2;MDK;STAT1;DTX1;SORBS2
branching involved in blood vessel morphogenesis (GO:0001569),3/14,3.2096880284946175E-4,0.004028654819270306,0,0,27.67972027972028,222.66028211721869,NRP1;KDR;TGFBR2
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),3/14,3.2096880284946175E-4,0.004028654819270306,0,0,27.67972027972028,222.66028211721869,KDR;CCL2;TLR4
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),3/14,3.2096880284946175E-4,0.004028654819270306,0,0,27.67972027972028,222.66028211721869,STAT5A;GHR;STAT5B
positive regulation of ERK1 and ERK2 cascade (GO:0070374),8/172,3.23369649212816E-4,0.004037974850426702,0,0,5.041848523748396,40.519896957562956,NRP1;CCL11;KDR;CCL2;CIB1;CD36;FGFR3;EGFR
cellular response to metal ion (GO:0071248),7/131,3.324202130741405E-4,0.004129812340997613,0,0,5.815993919945955,46.580939061759956,MEF2C;JUN;TF;FOS;PKD2;EGFR;AQP1
regulation of cell adhesion mediated by integrin (GO:0033628),4/34,3.4246944693442575E-4,0.004197846344076796,0,0,13.589003436426117,108.43111711085722,EFNA1;MUC1;PLAU;CIB1
negative regulation of blood vessel endothelial cell migration (GO:0043537),4/34,3.4246944693442575E-4,0.004197846344076796,0,0,13.589003436426117,108.43111711085722,MEF2C;PPARG;MEOX2;KLF4
pattern recognition receptor signaling pathway (GO:0002221),5/61,3.430683459840995E-4,0.004197846344076796,0,0,9.134900074019246,72.87440409099293,RPS6KA3;MAPKAPK2;CD36;TLR4;S100A8
regulation of kinase activity (GO:0043549),6/94,3.4489241279603576E-4,0.004199065125791736,0,0,7.0007102272727275,55.81160838503444,KIT;KDR;IRS2;MET;FGFR3;EGFR
regulation of cell adhesion (GO:0030155),7/133,3.644486962441993E-4,0.004393230571062502,0,0,5.723094822571262,45.31045576633903,EFNA1;CXCL12;PLAU;MDK;DUSP1;SAA1;CXCR4
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),7/133,3.644486962441993E-4,0.004393230571062502,0,0,5.723094822571262,45.31045576633903,CDH5;JUN;COL1A2;FOS;BMPR1B;RUNX2;TGFBR2
positive regulation of interleukin-1 production (GO:0032732),5/62,3.7019443631508786E-4,0.004440509617868172,0,0,8.974184165075902,70.90935632141303,EGR1;SAA1;LPL;CD36;TLR4
negative regulation of cell cycle G1/S phase transition (GO:1902807),4/35,3.836847049189318E-4,0.004557425641354141,0,0,13.149983372131693,103.43368513053977,FHL1;CCL2;PKD2;KLF4
positive regulation of cell cycle G1/S phase transition (GO:1902808),4/35,3.836847049189318E-4,0.004557425641354141,0,0,13.149983372131693,103.43368513053977,CCND2;ANXA1;CCND1;EGFR
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),3/15,3.9829204863249285E-4,0.004685222890918455,0,0,25.371794871794872,198.6186568823224,VCAN;BGN;DCN
steroid hormone mediated signaling pathway (GO:0043401),3/15,3.9829204863249285E-4,0.004685222890918455,0,0,25.371794871794872,198.6186568823224,CALCOCO1;NR3C1;ESR1
calcium ion homeostasis (GO:0055074),6/97,4.084568110574594E-4,0.004781693917908239,0,0,6.768887362637362,52.818469970612874,CDH5;CXCL12;CCL11;CAV1;ANK2;CALR
cellular calcium ion homeostasis (GO:0006874),7/136,4.1708032846210947E-4,0.004859285166532233,0,0,5.589147286821706,43.49603930613622,CDH5;CXCL12;CCL11;CAV2;CAV1;ANK2;CALR
regulation of ossification (GO:0030278),4/36,4.283258903386128E-4,0.0049665406808310575,0,0,12.73840206185567,98.79428510947568,MEF2C;MDK;ZBTB16;S1PR1
plasma membrane bounded cell projection assembly (GO:0120031),10/278,4.6988840263495333E-4,0.005418014802132595,0,0,3.87702445220705,29.70969782234494,NRP1;ABLIM1;GSN;KIT;RFX2;S1PR1;PARVA;EZR;MYLK;ARHGEF6
negative regulation of cytokine production (GO:0001818),8/182,4.717121716846448E-4,0.005418014802132595,0,0,4.749667271627344,36.37837401595044,ZFP36;ANXA1;BCL3;SIRPA;UBE2L6;EZR;KLF4;TLR4
regulation of p38MAPK cascade (GO:1900744),4/37,4.7655216121314E-4,0.005422450993242972,0,0,12.351765073414558,94.47782809126898,PER1;DUSP1;LEP;EZR
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),4/37,4.7655216121314E-4,0.005422450993242972,0,0,12.351765073414558,94.47782809126898,FHL1;CCL2;PKD2;KLF4
regulation of cholesterol storage (GO:0010885),3/16,4.8664075397796566E-4,0.005460692331503901,0,0,23.418934911242605,178.63926966636978,ABCA1;LPL;PPARG
cellular response to corticosteroid stimulus (GO:0071384),3/16,4.8664075397796566E-4,0.005460692331503901,0,0,23.418934911242605,178.63926966636978,ZFP36;ANXA1;NR3C1
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),3/16,4.8664075397796566E-4,0.005460692331503901,0,0,23.418934911242605,178.63926966636978,SOCS3;CAV1;BCL3
cellular component disassembly (GO:0022411),5/66,4.952035006375699E-4,0.005495620672823933,0,0,8.384014269939692,63.80689078052438,MMP14;GSN;LAMC1;TIMP1;A2M
extracellular matrix disassembly (GO:0022617),5/66,4.952035006375699E-4,0.005495620672823933,0,0,8.384014269939692,63.80689078052438,MMP14;GSN;LAMC1;TIMP1;A2M
enzyme linked receptor protein signaling pathway (GO:0007167),7/140,4.96524249700725E-4,0.005495620672823933,0,0,5.419950399559108,41.23432267623175,KIT;KDR;NEDD9;LIFR;FGFR3;MET;EGFR
response to cAMP (GO:0051591),4/38,5.285237104607266E-4,0.005797095653026439,0,0,11.987871437234688,90.45355954451936,STAT1;PKD2;EZR;AQP1
response to estradiol (GO:0032355),4/38,5.285237104607266E-4,0.005797095653026439,0,0,11.987871437234688,90.45355954451936,STAT5B;ANXA1;ESR1;EGFR
positive regulation of cellular protein metabolic process (GO:0032270),6/102,5.343550611785118E-4,0.005834773874303481,0,0,6.414713541666667,48.33133864532886,PLK1;BCL3;FADD;VIM;EZR;KLF4
receptor-mediated endocytosis (GO:0006898),7/143,5.636701275238861E-4,0.006127396252324387,0,0,5.2995842315983985,39.646408816009014,GRK3;LRP1;CAV2;CAV1;SAA1;CALR;CD36
cellular response to ketone (GO:1901655),4/39,5.844016218584863E-4,0.006265058226961128,0,0,11.644771723122238,86.69441838396985,GNG2;SPP1;NR3C1;AQP1
endothelial cell migration (GO:0043542),4/39,5.844016218584863E-4,0.006265058226961128,0,0,11.644771723122238,86.69441838396985,NRP1;CDH5;NR4A1;STAT1
response to peptide (GO:1901652),4/39,5.844016218584863E-4,0.006265058226961128,0,0,11.644771723122238,86.69441838396985,STAT5A;STAT5B;ANXA1;STAT1
cellular response to gamma radiation (GO:0071480),3/17,5.866255752554979E-4,0.006265058226961128,0,0,21.745054945054946,161.80764595422264,YAP1;MAP3K20;CRYAB
cellular metal ion homeostasis (GO:0006875),6/104,5.924128475713669E-4,0.006299237047319993,0,0,6.283163265306122,46.69211382660217,CDH5;CXCL12;CCL11;CAV1;ANK2;CALR
negative regulation of cellular catabolic process (GO:0031330),5/69,6.08016016401652E-4,0.006437039130165316,0,0,7.989799222797927,59.1669347580093,HGF;LEP;LEPR;TIMP1;MET
lymphocyte migration (GO:0072676),4/40,6.443477302225934E-4,0.0067628738064311,0,0,11.32073310423826,83.17650562591072,CCL11;S1PR1;SAA1;CCL2
negative regulation of blood coagulation (GO:0030195),4/40,6.443477302225934E-4,0.0067628738064311,0,0,11.32073310423826,83.17650562591072,F8;PLAU;SERPING1;A2M
neutrophil chemotaxis (GO:0030593),5/70,6.495881958179432E-4,0.0067886148361231404,0,0,7.866480669589478,57.733454202659594,CXCL10;CCL11;SAA1;CCL2;S100A8
positive regulation of protein serine/threonine kinase activity (GO:0071902),6/106,6.552522701550386E-4,0.006818543922339825,0,0,6.156875,45.132912165378904,CCND2;CCND1;KIT;CIB1;PKD2;EGFR
positive regulation of transferase activity (GO:0051347),7/148,6.914578180026094E-4,0.007031676818783648,0,0,5.110356095206268,37.18657117321721,PLK1;KIT;KDR;KLF4;FGFR3;MET;EGFR
regulation of cartilage development (GO:0061035),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,MDK;ZBTB16;BMPR1B
cell migration involved in sprouting angiogenesis (GO:0002042),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,NRP1;NR4A1;KDR
regulation of multicellular organism growth (GO:0040014),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,STAT5A;GHR;STAT5B
interleukin-6-mediated signaling pathway (GO:0070102),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,YAP1;SOCS3;STAT1
negative regulation of interleukin-8 production (GO:0032717),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,ANXA1;BCL3;KLF4
positive regulation of cartilage development (GO:0061036),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,MDK;ZBTB16;BMPR1B
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),3/18,6.988360534479026E-4,0.007031676818783648,0,0,20.294358974358975,147.46072784482647,ANXA1;KDR;CIB1
epithelial cell migration (GO:0010631),4/41,7.085244863093272E-4,0.007099823556227208,0,0,11.014210086375035,79.87864150321772,NRP1;ZEB2;STAT1;KIT
regulation of cytokine production (GO:0001817),7/150,7.485795420647091E-4,0.007439964020112516,0,0,5.038370006956394,36.262827176409914,PER1;ANXA1;BCL6;LEP;MAPKAPK2;SAA1;SIRPA
response to cytokine (GO:0034097),7/150,7.485795420647091E-4,0.007439964020112516,0,0,5.038370006956394,36.262827176409914,ANXA1;MME;STAT1;MAPKAPK2;CXCR4;LIFR;TIMP1
negative regulation of nucleic acid-templated transcription (GO:1903507),13/464,7.566777916582052E-4,0.007489879767023292,0,0,3.015077605321508,21.668075412714398,TCF7L2;JUN;ZBTB16;NR3C1;KLF4;RUNX2;FOXO1;PER1;BCL6;BCL3;PPARG;CALR;CRYAB
supramolecular fiber organization (GO:0097435),11/351,7.80604314923371E-4,0.007695431201774932,0,0,3.367128027681661,24.09328989968949,COL17A1;COL1A2;GSN;DST;TPM3;LAMA3;SAA1;UBE2L6;CIB1;CD36;VIM
positive regulation of DNA-binding transcription factor activity (GO:0051091),9/246,7.973218180045158E-4,0.007828542850165307,0,0,3.931082981715893,28.04533730835593,FZD4;CAV1;KIT;PPARG;CIB1;CD36;TLR4;ESR1;S100A8
regulation of signal transduction (GO:0009966),8/198,8.200958111047424E-4,0.007960527564000675,0,0,4.346149584487534,30.884127413697584,RGS4;RGS2;GRK3;DTX1;LIFR;CD36;TIMP1;ESR1
cellular response to interleukin-7 (GO:0098761),3/19,8.238410456378521E-4,0.007960527564000675,0,0,19.025,135.10666442022466,STAT5A;STAT5B;IRS2
response to fatty acid (GO:0070542),3/19,8.238410456378521E-4,0.007960527564000675,0,0,19.025,135.10666442022466,LPL;CD36;FOXO1
interleukin-7-mediated signaling pathway (GO:0038111),3/19,8.238410456378521E-4,0.007960527564000675,0,0,19.025,135.10666442022466,STAT5A;STAT5B;IRS2
cellular divalent inorganic cation homeostasis (GO:0072503),6/111,8.350206832302872E-4,0.008036661516465414,0,0,5.862202380952381,41.5516074049333,CDH5;CXCL12;CCL11;CAV1;ANK2;CALR
regulation of cytokine production involved in inflammatory response (GO:1900015),4/43,8.502220400736015E-4,0.008150750659760708,0,0,10.44832143801216,73.86976859320099,PER1;LEP;SIRPA;TLR4
protein-containing complex subunit organization (GO:0043933),6/112,8.751353506700843E-4,0.008356684623065314,0,0,5.806603773584905,40.88506362460805,YAP1;PARD6B;ELOB;LAMC1;TEAD1;SKAP2
positive regulation of T cell activation (GO:0050870),5/75,8.901712828074863E-4,0.00846705888139152,0,0,7.302738712065137,51.29514260475545,ANXA1;MDK;LEP;SIRPA;CCL2
intracellular steroid hormone receptor signaling pathway (GO:0030518),4/44,9.280696577319636E-4,0.008645500284196861,0,0,10.18659793814433,71.1269398038258,YAP1;CALCOCO1;NR3C1;ESR1
lymphocyte chemotaxis (GO:0048247),4/44,9.280696577319636E-4,0.008645500284196861,0,0,10.18659793814433,71.1269398038258,CXCL10;CCL11;SAA1;CCL2
positive regulation of biosynthetic process (GO:0009891),4/44,9.280696577319636E-4,0.008645500284196861,0,0,10.18659793814433,71.1269398038258,CD36;SORBS1;VIM;TLR4
positive regulation of signal transduction (GO:0009967),9/252,9.449728791938773E-4,0.008645500284196861,0,0,3.832843425436018,26.693279706715014,C3;YAP1;NRP1;MAML2;VWF;CAV2;PIK3R1;SORBS1;PKD2
caveola assembly (GO:0070836),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,CAV2;CAV1
regulation of germinal center formation (GO:0002634),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,MEF2C;BCL6
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,CXCL12;CXCR4
monocyte extravasation (GO:0035696),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,PECAM1;SIRPA
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,CXCL12;KLF4
negative regulation of metallopeptidase activity (GO:1905049),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,LRP1;TIMP1
positive regulation of mitochondrial depolarization (GO:0051901),2/5,9.561999058371925E-4,0.008645500284196861,0,0,67.34353741496598,468.20887737876456,KDR;DCN
regulation of protein localization to cell periphery (GO:1904375),3/20,9.621891486724228E-4,0.008645500284196861,0,0,17.90497737556561,124.3733355057115,MMP14;PLK1;SPTBN1
regulation of smooth muscle cell migration (GO:0014910),3/20,9.621891486724228E-4,0.008645500284196861,0,0,17.90497737556561,124.3733355057115,NRP1;LRP1;PLAU
fatty acid transport (GO:0015908),3/20,9.621891486724228E-4,0.008645500284196861,0,0,17.90497737556561,124.3733355057115,FABP4;PPARG;CD36
regulation of tissue remodeling (GO:0034103),3/20,9.621891486724228E-4,0.008645500284196861,0,0,17.90497737556561,124.3733355057115,MDK;LEP;LEPR
positive regulation of chemotaxis (GO:0050921),4/45,0.0010108013205496669,0.009048901527714849,0,0,9.937641438270052,68.54003101928734,NRP1;MDK;KDR;MET
positive regulation of angiogenesis (GO:0045766),6/116,0.0010506471250830189,0.009371156591857695,0,0,5.594318181818182,38.36778648026601,CDH5;MDK;ADAM12;KDR;KLF4;AQP1
regulation of gene expression (GO:0010468),22/1079,0.00106225275504336,0.009413614591488246,0,0,2.2167691579943236,15.179023966291034,YAP1;EGR1;MEF2C;CALCOCO1;GSN;MAGED1;ANK2;NR3C1;KLF4;ESR1;ACTA2;PER1;CDH5;EFEMP1;BCL6;KDR;AGR2;SIRPA;CALR;CD36;EZR;TLR4
negative regulation of blood vessel morphogenesis (GO:2000181),5/78,0.0010631392249114036,0.009413614591488246,0,0,7.0015615018809,47.936395370603826,CXCL10;STAT1;PPARG;KLF4;DCN
chondroitin sulfate biosynthetic process (GO:0030206),3/21,0.0011144091167492164,0.009796340069618563,0,0,16.90940170940171,114.97430940790971,VCAN;BGN;DCN
negative regulation of reproductive process (GO:2000242),3/21,0.0011144091167492164,0.009796340069618563,0,0,16.90940170940171,114.97430940790971,DUSP1;CALR;TIMP1
response to interferon-gamma (GO:0034341),5/80,0.0011915318967032392,0.010399555441162197,0,0,6.814162348877375,45.87645357592709,CCL11;STAT1;SIRPA;CCL2;TLR4
regulation of wound healing (GO:0061041),4/47,0.0011915712394596522,0.010399555441162197,0,0,9.474466554783026,63.78668002570477,ANXA1;PLAU;CAV1;MYLK
negative regulation of inflammatory response (GO:0050728),8/212,0.0012723852403866002,0.010982499933708771,0,0,4.04499484004128,26.96742238109023,CDH5;GNG2;PRKAR2B;MDK;SAA1;SIRPA;PPARG;KLF4
cell projection assembly (GO:0030031),3/22,0.001281010270900907,0.010982499933708771,0,0,16.018623481781376,106.68573417874663,GSN;PARVA;RHOQ
cellular response to osmotic stress (GO:0071470),3/22,0.001281010270900907,0.010982499933708771,0,0,16.018623481781376,106.68573417874663,PKD2;AQP1;MYLK
regulation of lipid storage (GO:0010883),3/22,0.001281010270900907,0.010982499933708771,0,0,16.018623481781376,106.68573417874663,C3;LPL;MEST
negative regulation of myeloid cell differentiation (GO:0045638),3/22,0.001281010270900907,0.010982499933708771,0,0,16.018623481781376,106.68573417874663,ZFP36;ZBTB16;CIB1
regulation of interleukin-2 production (GO:0032663),4/48,0.0012899363371830428,0.010982499933708771,0,0,9.25866916588566,61.59942968745832,ZFP36;ANXA1;EZR;SPTBN1
positive regulation of blood vessel endothelial cell migration (GO:0043536),4/48,0.0012899363371830428,0.010982499933708771,0,0,9.25866916588566,61.59942968745832,STAT5A;ANXA1;KDR;CIB1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/82,0.0013310512427302762,0.011293065421770809,0,0,6.636498216809097,43.945472579747886,CCND2;CCND1;PLK1;PKD2;EGFR
epithelium development (GO:0060429),6/122,0.0013631376613369012,0.011525139601928313,0,0,5.303340517241379,34.99126112234008,STAT1;KDR;PPARG;MEOX2;PKD2;SOX10
receptor internalization (GO:0031623),4/49,0.0013938389513098795,0.011604556799941738,0,0,9.0524627720504,59.52622063835553,GRK3;LRP1;CAV1;CD36
regulation of interleukin-1 beta production (GO:0032651),5/83,0.0014051630179616984,0.011604556799941738,0,0,6.551082768699349,43.0249040050253,EGR1;SIRPA;LPL;CD36;TLR4
regulation of Notch signaling pathway (GO:0008593),5/83,0.0014051630179616984,0.011604556799941738,0,0,6.551082768699349,43.0249040050253,YAP1;MMP14;MAML2;DTX1;EGFR
epidermis development (GO:0008544),5/83,0.0014051630179616984,0.011604556799941738,0,0,6.551082768699349,43.0249040050253,COL17A1;KRT15;LAMA3;SVEP1;KRT5
regulation of keratinocyte apoptotic process (GO:1902172),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,ZFP36;GSN
foam cell differentiation (GO:0090077),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,STAT1;PPARG
macrophage derived foam cell differentiation (GO:0010742),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,STAT1;PPARG
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,TAP1;CALR
negative regulation of trophoblast cell migration (GO:1901164),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,CALR;TIMP1
neutrophil extravasation (GO:0072672),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,PECAM1;PRTN3
plasma membrane raft assembly (GO:0044854),2/6,0.001424953791861429,0.011604556799941738,0,0,50.505102040816325,330.9910393896135,CAV2;CAV1
central nervous system development (GO:0007417),9/268,0.0014498689521455037,0.011752956659797292,0,0,3.5931237359808788,23.485670374619033,C3;RPS6KA3;VCAN;GSN;ZBTB16;CXCR4;PKD2;SOX10;TGFBR2
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),3/23,0.0014624829026359668,0.011752956659797292,0,0,15.216923076923077,99.33028638515556,SOCS3;STAT1;PPARG
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),3/23,0.0014624829026359668,0.011752956659797292,0,0,15.216923076923077,99.33028638515556,GRK3;RGS2;MET
positive regulation of cholesterol efflux (GO:0010875),3/23,0.0014624829026359668,0.011752956659797292,0,0,15.216923076923077,99.33028638515556,LRP1;CAV1;PPARG
regulation of cell growth (GO:0001558),8/217,0.0014751931037451911,0.011816102656643226,0,0,3.9472173256106773,25.731777040075272,RPS6KA3;MMP14;BCL6;FHL1;CIB1;SGK1;EGFR;S100A8
regulation of tumor necrosis factor production (GO:0032680),6/124,0.0014816444692735435,0.0118288665005937,0,0,5.21292372881356,33.960126895220824,ZFP36;MAPKAPK2;SIRPA;LPL;FADD;TLR4
regulation of complement activation (GO:0030449),4/50,0.0015034416443697955,0.011963661451112589,0,0,8.855221873599282,57.55892773976394,C3;CFH;PROS1;SERPING1
negative regulation of defense response (GO:0031348),5/85,0.001562453459054429,0.012392749748526171,0,0,6.386658031088083,41.26737785826921,CDH5;SAA1;SIRPA;PPARG;KLF4
negative regulation of cellular process (GO:0048523),14/566,0.0015749453628669224,0.01245127259279531,0,0,2.6533947700063014,17.123775214532003,DUSP1;FHL1;CIB1;PKD2;KLF4;NR4A1;BCL6;MDK;AGR2;TXNIP;SIRPA;PRTN3;CRYAB;TNS2
positive regulation of fat cell differentiation (GO:0045600),4/51,0.0016189064569619275,0.01275740201521778,0,0,8.66637420486949,55.690158635934715,ZFP36;ZBTB16;LPL;PPARG
glucose homeostasis (GO:0042593),5/86,0.001645778272806058,0.012826642107325275,0,0,6.307490564830807,40.42812501170669,TCF7L2;LEPR;PPARG;PIK3R1;FOXO1
positive regulation of endothelial cell migration (GO:0010595),5/86,0.001645778272806058,0.012826642107325275,0,0,6.307490564830807,40.42812501170669,STAT5A;NRP1;KDR;CALR;MET
regulation of monooxygenase activity (GO:0032768),3/24,0.0016592986709681567,0.012826642107325275,0,0,14.491575091575092,92.76579279827187,CAV1;LEP;EGFR
response to gamma radiation (GO:0010332),3/24,0.0016592986709681567,0.012826642107325275,0,0,14.491575091575092,92.76579279827187,YAP1;MAP3K20;CRYAB
positive regulation of cell-substrate junction organization (GO:0150117),3/24,0.0016592986709681567,0.012826642107325275,0,0,14.491575091575092,92.76579279827187,NRP1;KDR;PIK3R1
positive regulation of phospholipase activity (GO:0010518),3/24,0.0016592986709681567,0.012826642107325275,0,0,14.491575091575092,92.76579279827187,KIT;ESR1;FGFR3
cartilage development (GO:0051216),4/52,0.0017403948132125309,0.013368647855433794,0,0,8.485395189003436,53.913174183118734,MEF2C;ZBTB16;FGFR3;RUNX2
sprouting angiogenesis (GO:0002040),4/52,0.0017403948132125309,0.013368647855433794,0,0,8.485395189003436,53.913174183118734,NRP1;NR4A1;KDR;PARVA
regulation of immune effector process (GO:0002697),4/53,0.0018680674312188381,0.014111774813196804,0,0,8.311803071744162,52.22181892571914,C3;CFH;PROS1;SERPING1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/53,0.0018680674312188381,0.014111774813196804,0,0,8.311803071744162,52.22181892571914,RPS6KA3;HGF;KLF4;AQP1
positive regulation of phagocytosis (GO:0050766),4/53,0.0018680674312188381,0.014111774813196804,0,0,8.311803071744162,52.22181892571914,C3;SIRPA;CCL2;CALR
regulation of calcium ion import (GO:0090279),3/25,0.0018719109916478717,0.014111774813196804,0,0,13.832167832167832,86.87701677359438,CXCL12;CCL2;PKD2
response to hexose (GO:0009746),3/25,0.0018719109916478717,0.014111774813196804,0,0,13.832167832167832,86.87701677359438,TCF7L2;LPL;IRS2
outflow tract septum morphogenesis (GO:0003148),3/25,0.0018719109916478717,0.014111774813196804,0,0,13.832167832167832,86.87701677359438,NRP1;PARVA;TGFBR2
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),5/89,0.0019153545282787074,0.01435042546571893,0,0,6.0812978040957315,38.05586491730021,RPS6KA3;HGF;KLF4;CTSD;AQP1
transforming growth factor beta receptor signaling pathway (GO:0007179),5/89,0.0019153545282787074,0.01435042546571893,0,0,6.0812978040957315,38.05586491730021,CDH5;JUN;COL1A2;FOS;TGFBR2
positive regulation of cytokine production (GO:0001819),10/335,0.0019249165361196817,0.014377827501384739,0,0,3.18772504091653,19.93243878795636,C3;EGR1;ANXA1;MDK;LEP;SAA1;LPL;FADD;TLR4;SPTBN1
receptor-mediated endocytosis of virus by host cell (GO:0019065),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,CAV2;CAV1
regulation of metallopeptidase activity (GO:1905048),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,LRP1;TIMP1
hemostasis (GO:0007599),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,VWF;FLI1
sphingosine-1-phosphate receptor signaling pathway (GO:0003376),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,S1PR1;EZR
negative regulation of p38MAPK cascade (GO:1903753),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,DUSP1;EZR
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,LPL;TLR4
positive regulation of membrane depolarization (GO:1904181),2/7,0.00198194526890407,0.014492602792136369,0,0,40.40204081632653,251.4492302647478,KDR;DCN
regulation of humoral immune response (GO:0002920),4/54,0.0020020842345468454,0.014509152116433239,0,0,8.145154639175258,50.610460196958336,C3;CFH;PROS1;SERPING1
regulation of proteolysis (GO:0030162),4/54,0.0020020842345468454,0.014509152116433239,0,0,8.145154639175258,50.610460196958336,DNAJC1;CAV1;PLK1;FADD
positive regulation of leukocyte chemotaxis (GO:0002690),4/54,0.0020020842345468454,0.014509152116433239,0,0,8.145154639175258,50.610460196958336,CXCL10;CXCL12;MDK;CALR
positive regulation of binding (GO:0051099),5/90,0.002011994203174758,0.014537702922049067,0,0,6.009448338921061,37.31043467740466,TCF7L2;LRP1;CAV1;PPARG;MET
protein stabilization (GO:0050821),7/179,0.002078627692276019,0.014950817963639423,0,0,4.182698161451357,25.832541964215725,EFNA1;CCT3;ANK2;PARVA;PIK3R1;CALR;CRYAB
regulation of monocyte chemotaxis (GO:0090025),3/26,0.002100755421803523,0.014950817963639423,0,0,13.23010033444816,81.56963157644334,CXCL10;CXCL12;DUSP1
endothelial cell development (GO:0001885),3/26,0.002100755421803523,0.014950817963639423,0,0,13.23010033444816,81.56963157644334,PECAM1;EZR;MET
hippo signaling (GO:0035329),3/26,0.002100755421803523,0.014950817963639423,0,0,13.23010033444816,81.56963157644334,YAP1;AMOTL2;TEAD1
positive regulation of filopodium assembly (GO:0051491),3/26,0.002100755421803523,0.014950817963639423,0,0,13.23010033444816,81.56963157644334,NRP1;PIK3R1;RHOQ
regulation of actin cytoskeleton organization (GO:0032956),5/91,0.002112148410468978,0.014950817963639423,0,0,5.939269791541149,36.586196773903204,EPS8;LRP1;MDK;EZR;RHOQ
positive regulation of transport (GO:0051050),5/91,0.002112148410468978,0.014950817963639423,0,0,5.939269791541149,36.586196773903204,ANXA1;LRP1;SIRPA;CALR;SGK1
regulation of blood vessel endothelial cell migration (GO:0043535),4/55,0.0021426042679574256,0.01507873234819749,0,0,7.985041439256115,49.073934613463464,STAT5A;MEF2C;KDR;PPARG
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/55,0.0021426042679574256,0.01507873234819749,0,0,7.985041439256115,49.073934613463464,RPS6KA3;HGF;KLF4;AQP1
apoptotic process (GO:0006915),8/231,0.0021820895501952252,0.0152683564790959,0,0,3.6967665801274485,22.651835011506165,PPP1R15A;ZBTB16;CXCR4;CIB1;FADD;FOXO1;ARHGEF6;TGFBR2
regulation of autophagy (GO:0010506),8/231,0.0021820895501952252,0.0152683564790959,0,0,3.6967665801274485,22.651835011506165,SREBF1;HGF;LEP;LEPR;MET;FOXO1;DCN;DEPP1
blood vessel morphogenesis (GO:0048514),4/56,0.002289785616223477,0.01593036564429762,0,0,7.831086439333862,47.60750094867905,NRP1;CAV1;KDR;TGFBR2
positive regulation of interleukin-1 beta production (GO:0032731),4/56,0.002289785616223477,0.01593036564429762,0,0,7.831086439333862,47.60750094867905,EGR1;LPL;CD36;TLR4
cellular response to cadmium ion (GO:0071276),3/27,0.0023462500360106487,0.01618447262800547,0,0,12.678205128205128,76.76573275023132,JUN;FOS;EGFR
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),3/27,0.0023462500360106487,0.01618447262800547,0,0,12.678205128205128,76.76573275023132,VCAN;BGN;DCN
response to glucocorticoid (GO:0051384),3/27,0.0023462500360106487,0.01618447262800547,0,0,12.678205128205128,76.76573275023132,ZFP36;ANXA1;NR3C1
hemopoiesis (GO:0030097),5/94,0.0024344463921378494,0.0167454151549595,0,0,5.7381964254526405,34.53267210485872,ZBTB16;KIT;KDR;RUNX2;TGFBR2
receptor metabolic process (GO:0043112),4/58,0.0026047593316359794,0.017231392895720652,0,0,7.5402825505918285,44.86781035657885,GRK3;LRP1;CAV1;CD36
cellular response to epidermal growth factor stimulus (GO:0071364),3/28,0.0026087957970173737,0.017231392895720652,0,0,12.170461538461538,72.40045147812198,STAT5B;ZFP36;EGFR
cellular response to interleukin-6 (GO:0071354),3/28,0.0026087957970173737,0.017231392895720652,0,0,12.170461538461538,72.40045147812198,YAP1;SOCS3;STAT1
positive regulation of response to wounding (GO:1903036),3/28,0.0026087957970173737,0.017231392895720652,0,0,12.170461538461538,72.40045147812198,ANXA1;MDK;MYLK
actin filament reorganization (GO:0090527),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,GSN;NEDD9
regulation of actin filament length (GO:0030832),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,EPS8;CXCL12
regulation of apoptotic cell clearance (GO:2000425),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,C3;CCL2
regulation of Cdc42 protein signal transduction (GO:0032489),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,ABCA1;NRP1
cellular response to hepatocyte growth factor stimulus (GO:0035729),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,NRP1;HGF
regulation of phospholipase A2 activity (GO:0032429),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,ANXA1;LRP1
regulation of protein localization to cell cortex (GO:1904776),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,EPB41L2;PLK1
response to hepatocyte growth factor (GO:0035728),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,NRP1;HGF
negative regulation of B cell apoptotic process (GO:0002903),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,BCL6;IRS2
negative regulation of phospholipase activity (GO:0010519),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,RGS2;ANXA1
positive regulation of apoptotic cell clearance (GO:2000427),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,C3;CCL2
positive regulation of myeloid cell apoptotic process (GO:0033034),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,MEF2C;ANXA1
positive regulation of oligodendrocyte differentiation (GO:0048714),2/8,0.002625399081853126,0.017231392895720652,0,0,33.666666666666664,200.0649195648365,MDK;CXCR4
regulation of secretion by cell (GO:1903530),4/59,0.0027728623791241805,0.01800511971511301,0,0,7.402811621368323,43.58683052974644,MEF2C;DNAJC1;ANXA1;SAA1
response to reactive oxygen species (GO:0000302),4/59,0.0027728623791241805,0.01800511971511301,0,0,7.402811621368323,43.58683052974644,JUN;FOS;PKD2;EGFR
negative regulation of autophagy (GO:0010507),4/59,0.0027728623791241805,0.01800511971511301,0,0,7.402811621368323,43.58683052974644,HGF;LEP;LEPR;MET
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),4/59,0.0027728623791241805,0.01800511971511301,0,0,7.402811621368323,43.58683052974644,GHR;SOCS3;KIT;FGFR3
response to cadmium ion (GO:0046686),3/29,0.0028887769218868316,0.01865828064932211,0,0,11.701775147928995,68.4193674508354,JUN;FOS;EGFR
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),3/29,0.0028887769218868316,0.01865828064932211,0,0,11.701775147928995,68.4193674508354,PPP2R1B;CAV1;FADD
positive regulation of defense response (GO:0031349),5/98,0.002917930107031638,0.018796719075719677,0,0,5.490278009916987,32.04609820129839,MEF2C;MDK;LPL;TLR4;S100A8
"regulation of DNA-templated transcription, initiation (GO:2000142)",4/61,0.0031310682433358813,0.02010940804717658,0,0,7.142340387050099,41.18545619522775,TCF7L2;JUN;CCND1;RUNX2
neutrophil degranulation (GO:0043312),12/481,0.0031382238430912117,0.02010940804717658,0,0,2.659467638764702,15.329432880008326,C3;SNAP25;PTPRB;GSN;MME;PLAU;PECAM1;SIRPA;PRTN3;CD36;CTSD;S100A8
artery morphogenesis (GO:0048844),3/30,0.0031865612382751957,0.020206449518750263,0,0,11.267806267806268,64.77651031278889,NRP1;LRP1;PKD2
cell projection organization (GO:0030030),3/30,0.0031865612382751957,0.020206449518750263,0,0,11.267806267806268,64.77651031278889,GSN;PARVA;RHOQ
chondroitin sulfate metabolic process (GO:0030204),3/30,0.0031865612382751957,0.020206449518750263,0,0,11.267806267806268,64.77651031278889,VCAN;BGN;DCN
regulation of protein localization to membrane (GO:1905475),3/30,0.0031865612382751957,0.020206449518750263,0,0,11.267806267806268,64.77651031278889,MMP14;GSN;SPTBN1
organelle organization (GO:0006996),11/420,0.003208275160652093,0.02029129874334506,0,0,2.7891557601035526,16.01539323217958,CCL11;DST;CAV2;MDK;DPYSL2;CAV1;NEDD9;CCL2;PKD2;SYNE1;SH3D19
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),13/547,0.0032386714531718944,0.020430479244750162,0,0,2.5355197894523736,14.535100660114711,TCF7L2;JUN;ZBTB16;NR3C1;KLF4;RUNX2;FOXO1;PER1;BCL6;BCL3;PPARG;CALR;CRYAB
regulation of programmed cell death (GO:0043067),7/194,0.0032573297801898327,0.020467164238027174,0,0,3.8442478371643753,22.0154211351315,CXCL10;BCL6;MAGED1;STAT1;BCL3;CALR;SGK1
actin-mediated cell contraction (GO:0070252),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,GSN;PARVA
regulation of DNA-templated transcription in response to stress (GO:0043620),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,RPS6KA3;MUC1
cellular response to leptin stimulus (GO:0044320),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,LEP;LEPR
cellular response to nitric oxide (GO:0071732),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,FOXO1;AQP1
cellular response to reactive nitrogen species (GO:1902170),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,FOXO1;AQP1
regulation of PERK-mediated unfolded protein response (GO:1903897),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,PPP1R15A;AGR2
endochondral ossification (GO:0001958),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,MEF2C;FGFR3
endothelial cell chemotaxis (GO:0035767),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,NR4A1;NRP1
negative regulation of nitric oxide biosynthetic process (GO:0045019),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,CAV1;SIRPA
negative regulation of nitric oxide metabolic process (GO:1904406),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,CAV1;SIRPA
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),2/9,0.0033535661488557854,0.020467164238027174,0,0,28.855685131195337,164.41193104324012,CD36;TLR4
neutrophil activation involved in immune response (GO:0002283),12/485,0.0033537570969087646,0.020467164238027174,0,0,2.636431835231535,15.021529226132076,C3;SNAP25;PTPRB;GSN;MME;PLAU;PECAM1;SIRPA;PRTN3;CD36;CTSD;S100A8
regulation of cell death (GO:0010941),5/102,0.003467263580455342,0.02100195725972328,0,0,5.26280647401314,29.81058620377177,LRP1;AGR2;SNCG;CD36;CRYAB
calcium-mediated signaling (GO:0019722),5/102,0.003467263580455342,0.02100195725972328,0,0,5.26280647401314,29.81058620377177,RCAN1;KDR;CXCR4;ANK2;EGFR
positive regulation of cell growth (GO:0030307),5/102,0.003467263580455342,0.02100195725972328,0,0,5.26280647401314,29.81058620377177,RPS6KA3;MMP14;CIB1;S100A8;EGFR
regulation of cellular component size (GO:0032535),3/31,0.0035025005386860528,0.02100637638349886,0,0,10.864835164835165,61.43279981460896,PPP1R15A;EPS8;EZR
cellular response to cAMP (GO:0071320),3/31,0.0035025005386860528,0.02100637638349886,0,0,10.864835164835165,61.43279981460896,PKD2;EZR;AQP1
positive regulation of leukocyte cell-cell adhesion (GO:1903039),3/31,0.0035025005386860528,0.02100637638349886,0,0,10.864835164835165,61.43279981460896,MDK;CCL2;SIRPA
positive regulation of mononuclear cell migration (GO:0071677),3/31,0.0035025005386860528,0.02100637638349886,0,0,10.864835164835165,61.43279981460896,CXCL10;CXCL12;CALR
amyloid fibril formation (GO:1990000),4/63,0.0035196145943623474,0.02102663448742011,0,0,6.899528219465315,38.97822084193308,GSN;SAA1;UBE2L6;CD36
neutrophil mediated immunity (GO:0002446),12/488,0.003523148612265875,0.02102663448742011,0,0,2.619409053944158,14.795470616507261,C3;SNAP25;PTPRB;GSN;MME;PLAU;PECAM1;SIRPA;PRTN3;CD36;CTSD;S100A8
regulation of cytosolic calcium ion concentration (GO:0051480),6/148,0.0035981406752449803,0.02142169326215532,0,0,4.326584507042254,24.34715360588592,CAV2;CAV1;SAA1;CXCR4;CD36;ESR1
cellular response to organonitrogen compound (GO:0071417),5/103,0.0036154508321679336,0.021472250673972973,0,0,5.208840012689014,29.286904655654318,EGR1;MEF2C;EZR;PKD2;AQP1
liver development (GO:0001889),3/32,0.003836930926271927,0.022567456051865078,0,0,10.489655172413793,58.354816804882354,ANXA1;PKD2;MET
long-chain fatty acid transport (GO:0015909),3/32,0.003836930926271927,0.022567456051865078,0,0,10.489655172413793,58.354816804882354,FABP4;PPARG;CD36
negative regulation of microtubule polymerization or depolymerization (GO:0031111),3/32,0.003836930926271927,0.022567456051865078,0,0,10.489655172413793,58.354816804882354,CDH5;CIB1;FKBP4
positive regulation of receptor signaling pathway via STAT (GO:1904894),3/32,0.003836930926271927,0.022567456051865078,0,0,10.489655172413793,58.354816804882354,GHR;LEP;KIT
regulation of cell-matrix adhesion (GO:0001952),4/65,0.003939689946421906,0.0231160120952707,0,0,6.672638161230354,36.944083778601154,PLAU;CIB1;CD36;UTRN
generation of neurons (GO:0048699),7/202,0.004065161610425635,0.023673020025073654,0,0,3.685031547858773,20.28721074055825,YAP1;NRP1;MEF2C;FZD4;MAP1B;MET;RUNX2
embryonic organ development (GO:0048568),4/66,0.004161915616409177,0.023673020025073654,0,0,6.564682407715331,35.986143586617594,KIT;KDR;TEAD1;TGFBR2
positive regulation of cell death (GO:0010942),4/66,0.004161915616409177,0.023673020025073654,0,0,6.564682407715331,35.986143586617594,EGR1;LRP1;CD36;FOS
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,CD36;TLR4
endothelium development (GO:0003158),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,KDR;PECAM1
response to laminar fluid shear stress (GO:0034616),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,ABCA1;KLF4
leptin-mediated signaling pathway (GO:0033210),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,LEP;LEPR
negative regulation of cholesterol storage (GO:0010887),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,ABCA1;PPARG
negative regulation of lymphocyte apoptotic process (GO:0070229),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,BCL6;IRS2
positive regulation of mesenchymal cell proliferation (GO:0002053),2/10,0.004164723228388281,0.023673020025073654,0,0,25.247448979591837,138.38393038592545,STAT1;TGFBR2
actin filament bundle assembly (GO:0051017),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,EPS8;NEDD9;EZR
actin filament bundle organization (GO:0061572),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,EPS8;NEDD9;EZR
regulation of cholesterol efflux (GO:0010874),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,LRP1;CAV1;PPARG
vasculogenesis (GO:0001570),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,CAV1;KDR;TGFBR2
positive regulation of cholesterol transport (GO:0032376),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,LRP1;CAV1;PPARG
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),3/33,0.004190173154335419,0.023673020025073654,0,0,10.13948717948718,55.51382635460182,GHR;LEP;KIT
regulation of intracellular signal transduction (GO:1902531),11/437,0.0043194437119239365,0.024346864441052746,0,0,2.675504004418669,14.567125770110623,AKAP12;VWF;PRKAR2B;ITSN1;BCL3;EZR;A2M;SGK1;RHOQ;EGFR;ARHGEF6
vascular endothelial growth factor receptor signaling pathway (GO:0048010),4/67,0.0043924578010948335,0.024701234978443235,0,0,6.460153820978563,35.06485150831621,NRP1;MAPKAPK2;KDR;PIK3R1
epithelial tube morphogenesis (GO:0060562),3/34,0.00456253296297078,0.025539696011112296,0,0,9.811910669975186,52.88499493646925,MEF2C;PKD2;MET
response to steroid hormone (GO:0048545),3/34,0.00456253296297078,0.025539696011112296,0,0,9.811910669975186,52.88499493646925,YAP1;CAV1;NR3C1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),4/68,0.00463145775055902,0.02580686412496845,0,0,6.358891752577319,34.178303068266494,GHR;SOCS3;KIT;FGFR3
positive regulation of protein localization to nucleus (GO:1900182),4/68,0.00463145775055902,0.02580686412496845,0,0,6.358891752577319,34.178303068266494,CCT3;YAP1;PLK1;PIK3R1
regulation of cell differentiation (GO:0045595),6/156,0.0046504455318357,0.025853504269451898,0,0,4.094166666666666,21.988918606303887,RPS6KA3;BCL6;MDK;BMPR1B;KLF4;RUNX2
regulation of interleukin-6 production (GO:0032675),5/110,0.004782723468932765,0.026528318102166933,0,0,4.859856896126326,25.964976770871843,LEP;MAPKAPK2;SIRPA;LPL;TLR4
cellular response to amyloid-beta (GO:1904646),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,LRP1;CD36;TLR4
cellular response to hydrogen peroxide (GO:0070301),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,ANXA1;SIRPA;AQP1
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,KIT;PIK3R1;FGFR3
response to estrogen (GO:0043627),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,KRT19;CAV1;ESR1
muscle cell differentiation (GO:0042692),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,MEF2C;DMD;SYNE1
peptidyl-tyrosine dephosphorylation (GO:0035335),3/35,0.004954301407202251,0.027004858002945366,0,0,9.504807692307692,50.44675835420841,PTPRB;DUSP1;TNS2
cellular response to increased oxygen levels (GO:0036295),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,CAV1;FOXO1
cellular response to interleukin-2 (GO:0071352),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,STAT5A;STAT5B
cellular response to UV-A (GO:0071492),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,MME;TIMP1
regulation of mesenchymal cell proliferation (GO:0010464),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,STAT1;TGFBR2
regulation of mitochondrial depolarization (GO:0051900),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,KDR;DCN
hepatocyte growth factor receptor signaling pathway (GO:0048012),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,NRP1;HGF
insulin-like growth factor receptor signaling pathway (GO:0048009),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,GHR;PIK3R1
interleukin-2-mediated signaling pathway (GO:0038110),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,STAT5A;STAT5B
metanephric mesenchyme development (GO:0072075),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,STAT1;PKD2
positive regulation of chondrocyte differentiation (GO:0032332),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,ZBTB16;BMPR1B
positive regulation of leukocyte apoptotic process (GO:2000108),2/11,0.005057172586999214,0.027004858002945366,0,0,22.441043083900226,118.64462177173134,MEF2C;ANXA1
endoderm formation (GO:0001706),3/36,0.005365755179904156,0.028527541185734976,0,0,9.216317016317017,48.18030776390706,MMP14;DUSP1;LAMA3
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/36,0.005365755179904156,0.028527541185734976,0,0,9.216317016317017,48.18030776390706,TCF7L2;GNG2;FZD4
myeloid leukocyte differentiation (GO:0002573),4/71,0.005400589910765379,0.02865018830656579,0,0,6.073242037236498,31.70989730555222,KIT;PPARG;PRTN3;TGFBR2
positive regulation of kinase activity (GO:0033674),5/114,0.005558388333535983,0.029423207809043735,0,0,4.680562817892285,24.30357474030599,KIT;KDR;FGFR3;MET;EGFR
negative regulation of epithelial cell proliferation (GO:0050680),4/72,0.005674797410983124,0.029909375964813655,0,0,5.983626440266828,30.945643015408038,MAGED1;CAV2;STAT1;CAV1
positive regulation of protein secretion (GO:0050714),4/72,0.005674797410983124,0.029909375964813655,0,0,5.983626440266828,30.945643015408038,TCF7L2;IRS2;EZR;TLR4
regulation of erythrocyte differentiation (GO:0045646),3/37,0.005797156931964179,0.030357155116844677,0,0,8.944796380090498,46.0691689486937,STAT5B;ZFP36;STAT1
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),3/37,0.005797156931964179,0.030357155116844677,0,0,8.944796380090498,46.0691689486937,JUN;MEF2C;PPARG
skeletal muscle tissue development (GO:0007519),3/37,0.005797156931964179,0.030357155116844677,0,0,8.944796380090498,46.0691689486937,MEF2C;CAV2;CAV1
regulation of Rho protein signal transduction (GO:0035023),4/73,0.005958141545822115,0.030649694072125522,0,0,5.896608396832511,30.208305167716556,EPS8;ABCA1;NRP1;MET
response to molecule of bacterial origin (GO:0002237),4/73,0.005958141545822115,0.030649694072125522,0,0,5.896608396832511,30.208305167716556,RPS6KA3;MAPKAPK2;TLR4;S100A8
negative regulation of cell adhesion (GO:0007162),4/73,0.005958141545822115,0.030649694072125522,0,0,5.896608396832511,30.208305167716556,MUC1;MDK;DUSP1;FZD4
regulation of protein-containing complex assembly (GO:0043254),5/116,0.005977762825391626,0.030649694072125522,0,0,4.595761564673482,23.5289613411956,ABCA1;CDH5;GSN;CD36;CRYAB
regulation of actin nucleation (GO:0051125),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,ARF1;GSN
regulation of B cell apoptotic process (GO:0002902),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,BCL6;IRS2
cellular response to growth hormone stimulus (GO:0071378),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,GHR;PIK3R1
cellular response to thyroid hormone stimulus (GO:0097067),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,THRB;LMO2
macrophage chemotaxis (GO:0048246),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,SAA1;CCL2
melanocyte differentiation (GO:0030318),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,MEF2C;KIT
negative regulation of cardiac muscle hypertrophy (GO:0010614),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,RGS2;FOXO1
negative regulation of complement activation (GO:0045916),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,SERPING1;A2M
negative regulation of gene silencing by miRNA (GO:0060965),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,PPARG;ESR1
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),2/12,0.0060292416675762316,0.030649694072125522,0,0,20.195918367346938,103.22404575742381,AGR2;PIK3R1
actin-myosin filament sliding (GO:0033275),3/38,0.006248755581808887,0.03138264312593877,0,0,8.688791208791208,44.098855799515434,TPM3;DMD;VIM
regulation of cell communication (GO:0010646),3/38,0.006248755581808887,0.03138264312593877,0,0,8.688791208791208,44.098855799515434,GRK3;ANXA1;ANK2
muscle filament sliding (GO:0030049),3/38,0.006248755581808887,0.03138264312593877,0,0,8.688791208791208,44.098855799515434,TPM3;DMD;VIM
negative regulation of endothelial cell migration (GO:0010596),3/38,0.006248755581808887,0.03138264312593877,0,0,8.688791208791208,44.098855799515434,MEF2C;PPARG;DCN
positive regulation of potassium ion transport (GO:0043268),3/38,0.006248755581808887,0.03138264312593877,0,0,8.688791208791208,44.098855799515434,GNG2;FHL1;ANK2
regulation of cytokine-mediated signaling pathway (GO:0001959),4/74,0.006250752326932362,0.03138264312593877,0,0,5.812076583210604,29.496599316268345,SOCS3;STAT1;LIFR;FADD
negative regulation of response to external stimulus (GO:0032102),5/118,0.006418936489991192,0.03209468244995596,0,0,4.51396212572791,22.788750569713784,CDH5;SAA1;SIRPA;PPARG;KLF4
positive regulation of protein-containing complex assembly (GO:0031334),5/118,0.006418936489991192,0.03209468244995596,0,0,4.51396212572791,22.788750569713784,ABCA1;CDH5;CD36;ESR1;TLR4
integrin-mediated signaling pathway (GO:0007229),4/75,0.006552757758754076,0.03262978556761999,0,0,5.7299259474372,28.809318682593226,NRP1;DST;LAMA3;NEDD9
positive regulation of lymphocyte proliferation (GO:0050671),4/75,0.006552757758754076,0.03262978556761999,0,0,5.7299259474372,28.809318682593226,MEF2C;ANXA1;LEP;IRS2
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),5/119,0.006647876667002586,0.033035876906431214,0,0,4.4741387146623035,22.43090551872311,GSN;PPARG;FADD;CTSD;S100A8
phosphorylation (GO:0016310),10/400,0.00669875273703545,0.033060839255467135,0,0,2.647572285870158,13.25330717694071,GRK3;CCL11;PLK1;MAPKAPK2;MAP3K20;CCL2;SGK1;BMPR1B;CDC25B;TGFBR2
regulation of ion transmembrane transporter activity (GO:0032412),3/39,0.006720786624828021,0.033060839255467135,0,0,8.447008547008547,42.25658323218377,FHL1;ANK2;UTRN
regulation of nitric-oxide synthase activity (GO:0050999),3/39,0.006720786624828021,0.033060839255467135,0,0,8.447008547008547,42.25658323218377,CAV1;LEP;EGFR
regulation of protein tyrosine kinase activity (GO:0061097),3/39,0.006720786624828021,0.033060839255467135,0,0,8.447008547008547,42.25658323218377,EFNA1;CAV1;NEDD9
regulation of receptor-mediated endocytosis (GO:0048259),3/39,0.006720786624828021,0.033060839255467135,0,0,8.447008547008547,42.25658323218377,C3;ARF1;TF
cellular response to interleukin-15 (GO:0071350),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,STAT5A;STAT5B
entry into host (GO:0044409),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,CXCR4;MET
relaxation of cardiac muscle (GO:0055119),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,RGS2;GSN
response to nitric oxide (GO:0071731),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,FOXO1;AQP1
response to thyroid hormone (GO:0097066),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,THRB;LMO2
icosanoid secretion (GO:0032309),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,ANXA1;LEP
interleukin-15-mediated signaling pathway (GO:0035723),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,STAT5A;STAT5B
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,HGF;MET
negative regulation of macrophage derived foam cell differentiation (GO:0010745),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,ABCA1;PPARG
positive regulation of calcium ion import (GO:0090280),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,CXCL12;CCL2
positive regulation of lipid transport (GO:0032370),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,LRP1;SPP1
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),2/13,0.007079282767531098,0.034000105599483674,0,0,18.35899814471243,90.88773824524405,CD36;TLR4
cellular response to interferon-gamma (GO:0071346),5/121,0.00712281743767494,0.0341418513006663,0,0,4.396551724137931,21.73853863265966,CCL11;STAT1;SIRPA;CCL2;TLR4
sulfur compound catabolic process (GO:0044273),3/40,0.007213472433387994,0.034306260498632356,0,0,8.218295218295218,40.531028052911616,VCAN;BGN;DCN
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),3/40,0.007213472433387994,0.034306260498632356,0,0,8.218295218295218,40.531028052911616,PER1;STAT1;ESR1
positive regulation of cation channel activity (GO:2001259),3/40,0.007213472433387994,0.034306260498632356,0,0,8.218295218295218,40.531028052911616,CCL2;ANK2;PKD2
positive regulation of ossification (GO:0045778),3/40,0.007213472433387994,0.034306260498632356,0,0,8.218295218295218,40.531028052911616,MEF2C;ZBTB16;BMPR1B
negative regulation of protein serine/threonine kinase activity (GO:0071901),4/78,0.007516391220102064,0.035677217584694984,0,0,5.496795764837002,26.883009455266375,RGS2;DUSP1;PRKAR2B;PLK1
regulation of filopodium assembly (GO:0051489),3/41,0.007727022558473128,0.03660564188693009,0,0,8.00161943319838,38.91212871973292,NRP1;PIK3R1;RHOQ
positive regulation of programmed cell death (GO:0043068),8/286,0.007815295608175262,0.03695193166195488,0,0,2.957061719045816,14.346694993768809,JUN;BCL6;ITSN1;MAP3K20;FADD;CTSD;FOXO1;ARHGEF6
cellular response to oxidative stress (GO:0034599),5/125,0.008142893292216506,0.03739233981452069,0,0,4.249136442141624,20.440937073647422,JUN;FOS;PKD2;FOXO1;EGFR
aorta development (GO:0035904),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,LRP1;PKD2
bone morphogenesis (GO:0060349),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,BMPR1B;FGFR3
cGMP-mediated signaling (GO:0019934),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,CD36;AQP1
regulation of response to interferon-gamma (GO:0060330),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,SOCS3;STAT1
regulation of trophoblast cell migration (GO:1901163),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,CALR;TIMP1
relaxation of muscle (GO:0090075),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,RGS2;GSN
renal absorption (GO:0070293),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,GSN;SGK1
response to chemokine (GO:1990868),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,CXCL12;DUSP1
intestinal absorption (GO:0050892),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,LEP;CD36
smooth muscle contraction (GO:0006939),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,ACTA2;MYLK
vascular endothelial growth factor signaling pathway (GO:0038084),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,NRP1;KDR
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,KLF4;MEOX2
negative regulation of smooth muscle cell migration (GO:0014912),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,MEF2C;LRP1
pancreas development (GO:0031016),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,TCF7L2;MET
positive regulation of glycogen biosynthetic process (GO:0045725),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,IRS2;SORBS1
positive regulation of lymphocyte migration (GO:2000403),2/14,0.008205672711332105,0.03739233981452069,0,0,16.828231292517007,80.82480968270536,CXCL10;CXCL12
regulation of NIK/NF-kappaB signaling (GO:1901222),4/80,0.008208040352122907,0.03739233981452069,0,0,5.351600651112317,25.701817100665263,BCL3;EZR;TLR4;EGFR
skin development (GO:0043588),4/80,0.008208040352122907,0.03739233981452069,0,0,5.351600651112317,25.701817100665263,ANXA1;COL1A2;TXNIP;MET
regulation of chemokine production (GO:0032642),3/42,0.008261634012407445,0.03739233981452069,0,0,7.796055226824458,37.390916875401935,EGR1;LPL;TLR4
monocyte chemotaxis (GO:0002548),3/42,0.008261634012407445,0.03739233981452069,0,0,7.796055226824458,37.390916875401935,CCL11;ANXA1;CCL2
nucleic acid-templated transcription (GO:0097659),3/42,0.008261634012407445,0.03739233981452069,0,0,7.796055226824458,37.390916875401935,THRB;BCL3;DTX1
positive regulation of epithelial to mesenchymal transition (GO:0010718),3/42,0.008261634012407445,0.03739233981452069,0,0,7.796055226824458,37.390916875401935,TCF7L2;MDK;TGFBR2
negative regulation of protein modification process (GO:0031400),4/81,0.008568985471380847,0.03871146497738843,0,0,5.281831570491364,25.13943688943252,PPP1R15A;SIRPA;CIB1;DMD
regulation of cell-substrate adhesion (GO:0010810),3/43,0.00881749156317996,0.03954068500247367,0,0,7.600769230769231,35.959374924879896,FZD4;AGR2;FBLN2
heart looping (GO:0001947),3/43,0.00881749156317996,0.03954068500247367,0,0,7.600769230769231,35.959374924879896,MEF2C;PKD2;TGFBR2
negative regulation of proteolysis (GO:0045861),3/43,0.00881749156317996,0.03954068500247367,0,0,7.600769230769231,35.959374924879896,EFNA1;DNAJC1;TIMP1
positive regulation of phospholipase C activity (GO:0010863),3/43,0.00881749156317996,0.03954068500247367,0,0,7.600769230769231,35.959374924879896,KIT;ESR1;EGFR
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/83,0.00932168246677275,0.041123139178387086,0,0,5.147592326764975,24.067115678930318,EPS8;NRP1;PIK3R1;RHOQ
regulation of endothelial cell apoptotic process (GO:2000351),3/44,0.009394768013373897,0.041123139178387086,0,0,7.415009380863039,34.610315129706294,CDH5;KDR;CCL2
response to amyloid-beta (GO:1904645),3/44,0.009394768013373897,0.041123139178387086,0,0,7.415009380863039,34.610315129706294,LRP1;CD36;TLR4
regulation of phospholipase C activity (GO:1900274),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,KIT;ESR1
endoderm development (GO:0007492),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,DUSP1;LAMC1
regulation of sequestering of triglyceride (GO:0010889),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,LPL;PPARG
regulation of triglyceride biosynthetic process (GO:0010866),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,C3;SREBF1
response to muscle stretch (GO:0035994),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,GSN;DMD
macrophage migration (GO:1905517),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,SAA1;CCL2
myoblast differentiation (GO:0045445),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,TCF7L2;EPAS1
peptidyl-tyrosine autophosphorylation (GO:0038083),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,KDR;EGFR
placenta development (GO:0001890),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,LEP;PPARG
positive regulation of endothelial cell chemotaxis (GO:2001028),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,KDR;MET
positive regulation of glycogen metabolic process (GO:0070875),2/15,0.009406812534850763,0.041123139178387086,0,0,15.532967032967033,72.48181203601595,IRS2;SORBS1
regulation of response to external stimulus (GO:0032101),5/130,0.009555233429848252,0.0416971207915421,0,0,4.078134715025906,18.96604356965297,ANXA1;BCL6;CAV1;CXCR4;CD36
lymphocyte differentiation (GO:0030098),4/84,0.009713653925796772,0.04231260699340812,0,0,5.082989690721649,23.555706523889203,KLF6;LEP;KIT;LEPR
zymogen activation (GO:0031638),3/45,0.00999362447732192,0.04345442071835513,0,0,7.238095238095238,33.337276529522526,MMP14;PLAU;FADD
regulation of neuron death (GO:1901214),4/86,0.010529374819127283,0.04562104570209063,0,0,4.958511440784511,22.579009894079444,EGR1;MEF2C;SNCG;FOS
response to interleukin-1 (GO:0070555),4/86,0.010529374819127283,0.04562104570209063,0,0,4.958511440784511,22.579009894079444,ANXA1;CCL11;SIRPA;CCL2
regulation of establishment of cell polarity (GO:2000114),2/16,0.010681127169161182,0.04587044913034829,0,0,14.422740524781341,65.46881305511042,CDH5;GSN
eosinophil chemotaxis (GO:0048245),2/16,0.010681127169161182,0.04587044913034829,0,0,14.422740524781341,65.46881305511042,CCL11;CCL2
eosinophil migration (GO:0072677),2/16,0.010681127169161182,0.04587044913034829,0,0,14.422740524781341,65.46881305511042,CCL11;CCL2
positive regulation of small molecule metabolic process (GO:0062013),2/16,0.010681127169161182,0.04587044913034829,0,0,14.422740524781341,65.46881305511042,IRS2;PPARG
protein localization to endoplasmic reticulum (GO:0070972),2/16,0.010681127169161182,0.04587044913034829,0,0,14.422740524781341,65.46881305511042,PPP1R15A;ANK2
regulation of DNA binding (GO:0051101),3/47,0.011256665078498882,0.04791954452123212,0,0,6.908391608391608,30.99653605846247,JUN;BCL3;PPARG
determination of heart left/right asymmetry (GO:0061371),3/47,0.011256665078498882,0.04791954452123212,0,0,6.908391608391608,30.99653605846247,MEF2C;PKD2;TGFBR2
embryonic heart tube morphogenesis (GO:0003143),3/47,0.011256665078498882,0.04791954452123212,0,0,6.908391608391608,30.99653605846247,MEF2C;PKD2;TGFBR2
epidermal growth factor receptor signaling pathway (GO:0007173),3/47,0.011256665078498882,0.04791954452123212,0,0,6.908391608391608,30.99653605846247,EFEMP1;PIK3R1;EGFR
positive regulation of neuron death (GO:1901216),3/47,0.011256665078498882,0.04791954452123212,0,0,6.908391608391608,30.99653605846247,EGR1;FOS;TLR4
regulation of endothelial cell migration (GO:0010594),4/89,0.011833928730337043,0.04997594467700393,0,0,4.782777440873256,21.220153090166587,NRP1;KDR;CALR;DCN
collagen fibril organization (GO:0030199),4/89,0.011833928730337043,0.04997594467700393,0,0,4.782777440873256,21.220153090166587,COL17A1;COL1A2;DST;LAMA3
positive regulation of inflammatory response (GO:0050729),4/89,0.011833928730337043,0.04997594467700393,0,0,4.782777440873256,21.220153090166587,MDK;LPL;TLR4;S100A8
cellular response to ionizing radiation (GO:0071479),3/48,0.011921115421544603,0.04997594467700393,0,0,6.754529914529915,29.918812314050808,YAP1;MAP3K20;CRYAB
positive regulation of endocytosis (GO:0045807),3/48,0.011921115421544603,0.04997594467700393,0,0,6.754529914529915,29.918812314050808,C3;TF;LRP1
aorta morphogenesis (GO:0035909),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,LRP1;MYLK
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,ANK2;DMD
regulation of NLRP3 inflammasome complex assembly (GO:1900225),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,CD36;TLR4
negative regulation of chemokine production (GO:0032682),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,SIRPA;KLF4
negative regulation of phagocytosis (GO:0050765),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,SIRPA;PRTN3
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,MEF2C;PPARG
positive regulation of positive chemotaxis (GO:0050927),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,CXCL12;KDR
positive regulation of smooth muscle cell migration (GO:0014911),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,NRP1;MDK
positive regulation of transcription of Notch receptor target (GO:0007221),2/17,0.01202706512555413,0.04997594467700393,0,0,13.460544217687074,59.50362444997404,MAML2;STAT1
positive regulation of apoptotic process (GO:0043065),8/310,0.012306818253936971,0.05105128185406563,0,0,2.718717323109097,11.955836304173728,JUN;BCL6;ITSN1;MAP3K20;FADD;CTSD;FOXO1;ARHGEF6
protein dephosphorylation (GO:0006470),5/139,0.012506476368048854,0.05168299268713804,0,0,3.8024901399737066,16.66064347558677,PPP1R15A;PTPRB;PPP2R1B;DUSP1;TNS2
cellular response to mechanical stimulus (GO:0071260),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,FADD;TLR4;AQP1
regulation of smooth muscle cell proliferation (GO:0048660),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,TCF7L2;STAT1;PPARG
regulation of stress-activated MAPK cascade (GO:0032872),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,PER1;EGFR;FOXO1
response to glucose (GO:0009749),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,TCF7L2;LPL;IRS2
response to hydrogen peroxide (GO:0042542),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,ANXA1;SIRPA;AQP1
positive regulation of reactive oxygen species metabolic process (GO:2000379),3/49,0.012607678708895275,0.05168299268713804,0,0,6.607357859531772,28.896944138515423,CD36;TLR4;TGFBR2
positive regulation of cellular catabolic process (GO:0031331),5/141,0.013237384283290868,0.053662203441235685,0,0,3.7461901859189273,16.20118731905114,IRS2;EZR;FOXO1;DCN;SH3D19
cellular response to fibroblast growth factor stimulus (GO:0044344),4/92,0.013237969058823202,0.053662203441235685,0,0,4.619025304592315,19.975742309575832,NR4A1;ZFP36;CCL2;FGFR3
regulation of lipid metabolic process (GO:0019216),4/92,0.013237969058823202,0.053662203441235685,0,0,4.619025304592315,19.975742309575832,SREBF1;CAV1;IRS2;PPARG
T cell activation (GO:0042110),4/92,0.013237969058823202,0.053662203441235685,0,0,4.619025304592315,19.975742309575832,MDK;LEP;KIT;LEPR
negative regulation of mitotic cell cycle phase transition (GO:1901991),4/92,0.013237969058823202,0.053662203441235685,0,0,4.619025304592315,19.975742309575832,FHL1;CCL2;PKD2;KLF4
negative regulation of ERK1 and ERK2 cascade (GO:0070373),3/50,0.013316461594383946,0.053662203441235685,0,0,6.466448445171849,27.927001997452024,SIRPA;EZR;TLR4
neuron migration (GO:0001764),3/50,0.013316461594383946,0.053662203441235685,0,0,6.466448445171849,27.927001997452024,NRP1;MEF2C;MAP1B
positive regulation of ion transport (GO:0043270),3/50,0.013316461594383946,0.053662203441235685,0,0,6.466448445171849,27.927001997452024,FHL1;ANK2;MYLK
3'-UTR-mediated mRNA stabilization (GO:0070935),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,ZFP36;MAPKAPK2
regulation of fatty acid metabolic process (GO:0019217),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,CAV1;PPARG
dendritic cell migration (GO:0036336),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,EPS8;CXCR4
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,ESR1;EGFR
T cell migration (GO:0072678),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,CXCL10;S1PR1
positive chemotaxis (GO:0050918),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,NRP1;MET
positive regulation of glial cell differentiation (GO:0045687),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,MDK;CXCR4
positive regulation of macrophage derived foam cell differentiation (GO:0010744),2/18,0.013443098192670951,0.053662203441235685,0,0,12.618622448979592,54.37729659500092,LPL;CD36
cholesterol transport (GO:0030301),3/51,0.014047560603519462,0.05570978838692165,0,0,6.331410256410257,27.00540545253821,ABCA1;CAV1;CD36
inositol lipid-mediated signaling (GO:0048017),3/51,0.014047560603519462,0.05570978838692165,0,0,6.331410256410257,27.00540545253821,IRS2;PIK3R1;EZR
mesenchymal cell differentiation (GO:0048762),3/51,0.014047560603519462,0.05570978838692165,0,0,6.331410256410257,27.00540545253821,MEF2C;HGF;S100A4
negative regulation of transport (GO:0051051),3/51,0.014047560603519462,0.05570978838692165,0,0,6.331410256410257,27.00540545253821,SIRPA;PRTN3;CRYAB
negative regulation of intracellular signal transduction (GO:1902532),6/198,0.014161021462121892,0.05606843456953953,0,0,3.1917317708333335,13.588038561418122,PER1;DUSP1;STAT1;CAV1;CIB1;ESR1
regulation of release of sequestered calcium ion into cytosol (GO:0051279),3/52,0.014801062374415972,0.05825160407780144,0,0,6.201883830455259,26.128885859948436,CXCL10;ANK2;DMD
positive regulation of developmental growth (GO:0048639),3/52,0.014801062374415972,0.05825160407780144,0,0,6.201883830455259,26.128885859948436,GHR;LEP;AGR2
actin filament capping (GO:0051693),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,EPS8;GSN
atrioventricular valve morphogenesis (GO:0003181),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,EFNA1;TGFBR2
barbed-end actin filament capping (GO:0051016),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,EPS8;GSN
regulation of oligodendrocyte differentiation (GO:0048713),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,MDK;CXCR4
positive regulation of focal adhesion assembly (GO:0051894),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,NRP1;KDR
positive regulation of mitochondrial fission (GO:0090141),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,KDR;DCN
positive regulation of monocyte chemotaxis (GO:0090026),2/19,0.014927721127124474,0.05825160407780144,0,0,11.875750300120048,49.9320115437787,CXCL10;CXCL12
bicellular tight junction assembly (GO:0070830),3/53,0.01557704391187205,0.060494538123335065,0,0,6.077538461538461,25.294453697927946,CDH5;PARD6B;PECAM1
positive regulation of B cell activation (GO:0050871),3/53,0.01557704391187205,0.060494538123335065,0,0,6.077538461538461,25.294453697927946,MEF2C;MMP14;IRS2
positive regulation of chemokine production (GO:0032722),3/53,0.01557704391187205,0.060494538123335065,0,0,6.077538461538461,25.294453697927946,EGR1;LPL;TLR4
positive regulation of cytosolic calcium ion concentration (GO:0007204),5/147,0.01560187677267122,0.060494538123335065,0,0,3.586805808946946,14.922417999343145,CAV1;SAA1;CXCR4;CD36;ESR1
regulation of MAP kinase activity (GO:0043405),4/97,0.01580564630690436,0.06118719993213373,0,0,4.36958208624321,18.122352491235524,RGS2;DUSP1;KIT;EGFR
cytoplasmic microtubule organization (GO:0031122),3/54,0.016375572804880743,0.06240663148144036,0,0,5.9580693815987935,24.49936989066364,DST;CIB1;EZR
regulation of potassium ion transmembrane transport (GO:1901379),3/54,0.016375572804880743,0.06240663148144036,0,0,5.9580693815987935,24.49936989066364,GNG2;CAV1;FHL1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),5/149,0.016448765348731027,0.06240663148144036,0,0,3.536629245826137,14.526721813041766,CCND1;PRKAR2B;PLK1;FHL1;CDC25B
regulation of protein kinase A signaling (GO:0010738),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,AKAP12;PRKAR2B
energy reserve metabolic process (GO:0006112),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,LEP;LEPR
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,EGR1;EPAS1
regulation of T cell migration (GO:2000404),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,CXCL10;CXCL12
hepaticobiliary system development (GO:0061008),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,PKD2;MET
lipopolysaccharide-mediated signaling pathway (GO:0031663),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,CCL2;TLR4
maintenance of protein location in nucleus (GO:0051457),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,BCL3;SYNE1
negative regulation of lipid storage (GO:0010888),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,ABCA1;PPARG
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,CCND1;CDC25B
positive regulation of interferon-alpha production (GO:0032727),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,STAT1;TLR4
positive regulation of lymphocyte differentiation (GO:0045621),2/20,0.016479451352183223,0.06240663148144036,0,0,11.215419501133788,46.046486660840145,MMP14;MDK
response to UV (GO:0009411),4/99,0.016914279206624038,0.0639538351989589,0,0,4.2771568095496475,17.449076475128724,CCND1;BCL3;EGFR;AQP1
triglyceride metabolic process (GO:0006641),3/55,0.017196707468804112,0.06492090338998141,0,0,5.84319526627219,23.74112055013548,FABP4;CAV1;LPL
negative regulation of signal transduction (GO:0009968),7/267,0.01729098106230055,0.06517575679056012,0,0,2.7546113572291584,11.17702906391585,MMP14;RGS2;LRP1;CALR;TNS2;EGFR;DCN
mitotic cell cycle phase transition (GO:0044772),6/209,0.01801056078729678,0.06646421992421288,0,0,3.0170874384236455,12.119027719286208,EPS8;CCND2;CCND1;PRKAR2B;PLK1;CDC25B
glycosaminoglycan catabolic process (GO:0006027),3/56,0.01804049737404705,0.06646421992421288,0,0,5.732656023222061,23.017394687188755,VCAN;BGN;DCN
tight junction assembly (GO:0120192),3/56,0.01804049737404705,0.06646421992421288,0,0,5.732656023222061,23.017394687188755,CDH5;PARD6B;PECAM1
epithelial cell differentiation (GO:0030855),4/101,0.01807041000752177,0.06646421992421288,0,0,4.188542884472314,16.81063093752566,MAF;ANXA1;KDR;PPARG
purinergic nucleotide receptor signaling pathway (GO:0035590),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,C3;TXNIP
autonomic nervous system development (GO:0048483),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,NRP1;SOX10
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,ANK2;DMD
cellular response to estradiol stimulus (GO:0071392),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,ESR1;EGFR
cellular response to inorganic substance (GO:0071241),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,FOXO1;AQP1
response to progesterone (GO:0032570),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,YAP1;CAV1
sensory perception of pain (GO:0019233),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,MME;CCL2
sterol transport (GO:0015918),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,CAV1;CD36
myotube differentiation (GO:0014902),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,MEF2C;ADAM12
negative regulation of peptidyl-serine phosphorylation (GO:0033137),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,CAV1;DMD
positive regulation of lipid storage (GO:0010884),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,C3;LPL
positive regulation of phosphatase activity (GO:0010922),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,PPP1R15A;MEF2C
protein localization to chromatin (GO:0071168),2/21,0.018096828669303136,0.06646421992421288,0,0,10.624597207303974,42.626081270062826,PLK1;ESR1
positive regulation of vasculature development (GO:1904018),4/102,0.018666457931082864,0.06845304979244997,0,0,4.145592257521566,16.503714953773493,CDH5;ADAM12;KDR;AQP1
positive regulation of protein kinase activity (GO:0045860),5/154,0.018698397614017946,0.06846706494756948,0,0,3.417081058524881,13.597650277018793,EFNA1;EGR1;NEDD9;CIB1;TGFBR2
regulation of bone mineralization (GO:0030500),3/57,0.01890698326246999,0.06891991653310542,0,0,5.626210826210826,22.326064494152536,MEF2C;S1PR1;BMPR1B
positive regulation of cell junction assembly (GO:1901890),3/57,0.01890698326246999,0.06891991653310542,0,0,5.626210826210826,22.326064494152536,NRP1;CAV1;KDR
positive regulation of proteolysis (GO:0045862),3/57,0.01890698326246999,0.06891991653310542,0,0,5.626210826210826,22.326064494152536,PLK1;FADD;SH3D19
positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/155,0.019171417088592317,0.06977937311019775,0,0,3.3941278065630396,13.42151770947499,CAV1;CIB1;CD36;TLR4;S100A8
peptidyl-serine phosphorylation (GO:0018105),5/156,0.01965224476067903,0.07109696253012547,0,0,3.3714785711834745,13.248439842388004,RPS6KA3;MAPKAPK2;PLK1;SGK1;TGFBR2
regulation of membrane protein ectodomain proteolysis (GO:0051043),2/22,0.01977841494840752,0.07109696253012547,0,0,10.092857142857143,39.595934708889004,TIMP1;SH3D19
regulation of response to cytokine stimulus (GO:0060759),2/22,0.01977841494840752,0.07109696253012547,0,0,10.092857142857143,39.595934708889004,LIFR;KLF4
negative regulation of interleukin-2 production (GO:0032703),2/22,0.01977841494840752,0.07109696253012547,0,0,10.092857142857143,39.595934708889004,ZFP36;EZR
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),2/22,0.01977841494840752,0.07109696253012547,0,0,10.092857142857143,39.595934708889004,ANK2;PKD2
regulation of calcium ion transport (GO:0051924),3/58,0.019796197369784423,0.07109696253012547,0,0,5.5236363636363635,21.665167856214616,ANK2;PKD2;MYLK
regulation of phagocytosis (GO:0050764),3/58,0.019796197369784423,0.07109696253012547,0,0,5.5236363636363635,21.665167856214616,SIRPA;PRTN3;CALR
negative regulation of neuron projection development (GO:0010977),3/58,0.019796197369784423,0.07109696253012547,0,0,5.5236363636363635,21.665167856214616,EFNA1;CIB1;FKBP4
positive regulation of protein binding (GO:0032092),3/58,0.019796197369784423,0.07109696253012547,0,0,5.5236363636363635,21.665167856214616,TCF7L2;LRP1;CAV1
positive regulation of apoptotic signaling pathway (GO:2001235),3/59,0.02070816364581049,0.0742627076252556,0,0,5.424725274725275,21.032892807745707,CAV1;FADD;S100A8
protein autophosphorylation (GO:0046777),5/159,0.021142029329160792,0.07570711973015666,0,0,3.305295740528901,12.746847600305095,MAPKAPK2;KIT;KDR;FGFR3;EGFR
artery development (GO:0060840),2/23,0.0215227938545348,0.07650803362889377,0,0,9.61175898931001,36.89610872992742,NRP1;PKD2
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),2/23,0.0215227938545348,0.07650803362889377,0,0,9.61175898931001,36.89610872992742,ANK2;DMD
triglyceride catabolic process (GO:0019433),2/23,0.0215227938545348,0.07650803362889377,0,0,9.61175898931001,36.89610872992742,FABP4;LPL
positive regulation of cell cycle G2/M phase transition (GO:1902751),2/23,0.0215227938545348,0.07650803362889377,0,0,9.61175898931001,36.89610872992742,CCND1;CDC25B
positive regulation of epithelial cell apoptotic process (GO:1904037),2/23,0.0215227938545348,0.07650803362889377,0,0,9.61175898931001,36.89610872992742,GSN;CCL2
apical junction assembly (GO:0043297),3/60,0.021642897959238256,0.07682282293111538,0,0,5.329284750337382,20.427563690905835,CDH5;PARD6B;PECAM1
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),4/108,0.022498395646189637,0.07974322183183663,0,0,3.9052339413164154,14.817673182578273,CAV1;PPARG;BMPR1B;TGFBR2
positive regulation of DNA biosynthetic process (GO:2000573),3/61,0.022600408305363247,0.07987227028092818,0,0,5.237135278514589,19.84762879967108,CCT3;HGF;KLF4
positive regulation of interleukin-8 production (GO:0032757),3/61,0.022600408305363247,0.07987227028092818,0,0,5.237135278514589,19.84762879967108,LEP;FADD;TLR4
axon extension (GO:0048675),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,NRP1;MAP1B
regulation of keratinocyte proliferation (GO:0010837),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,ZFP36;MDK
dendritic cell differentiation (GO:0097028),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,PRTN3;TGFBR2
regulation of ruffle assembly (GO:1900027),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,EPS8;CAV1
negative regulation of neuron differentiation (GO:0045665),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,DTX1;CALR
negative regulation of ossification (GO:0030279),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,MEF2C;MDK
negative regulation of stress fiber assembly (GO:0051497),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,PIK3R1;MET
protein kinase B signaling (GO:0043491),2/24,0.023328570549778514,0.08149938204980012,0,0,9.174397031539888,34.478085571504906,KDR;CCL2
cellular protein metabolic process (GO:0044267),9/417,0.023447671457603982,0.08179810888146948,0,0,2.2635387488328664,8.495024905138129,C3;TF;VCAN;GOLM1;SPP1;UBE2L6;TIMP1;LAMC1;PRSS23
regulation of neurogenesis (GO:0050767),3/62,0.023580695019013095,0.08202713195899555,0,0,5.148109517601043,19.291649327691985,YAP1;CCL11;MME
stress-activated MAPK cascade (GO:0051403),3/62,0.023580695019013095,0.08202713195899555,0,0,5.148109517601043,19.291649327691985,ZFP36;MAP3K20;ARHGEF6
cellular response to DNA damage stimulus (GO:0006974),8/350,0.02362831355427721,0.08207552568425822,0,0,2.395814096645122,8.973065438163092,YAP1;PPP1R15A;CCND1;BCL6;MAPKAPK2;BCL3;CIB1;FOXO1
response to endoplasmic reticulum stress (GO:0034976),4/110,0.023874427316359477,0.0826944957543888,0,0,3.831161252674577,14.309185681702607,PPP1R15A;JUN;AGR2;PIK3R1
response to tumor necrosis factor (GO:0034612),4/110,0.023874427316359477,0.0826944957543888,0,0,3.831161252674577,14.309185681702607,ZFP36;CCL11;CCL2;CIB1
proteolysis (GO:0006508),7/287,0.024511464199738837,0.08478041949767623,0,0,2.555235602094241,9.47638340713323,MMP14;TINAGL1;MME;PLAU;HGF;PRTN3;CTSD
negative regulation of peptidase activity (GO:0010466),3/63,0.024583750965535087,0.08490983489514602,0,0,5.062051282051282,18.75828946928507,LRP1;SERPING1;TIMP1
regulation of cardiac muscle cell action potential (GO:0098901),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,CAV1;ANK2
regulation of interferon-alpha production (GO:0032647),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,STAT1;TLR4
regulation of microtubule depolymerization (GO:0031114),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,MAP1B;CIB1
regulation of mitochondrial fission (GO:0090140),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,KDR;DCN
energy derivation by oxidation of organic compounds (GO:0015980),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,LEP;LEPR
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,DMD;PKD2
positive regulation of lipid metabolic process (GO:0045834),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,PPARG;SORBS1
positive regulation of T cell migration (GO:2000406),2/25,0.02519437140945269,0.08604248861433002,0,0,8.775066548358474,32.30220166920191,CXCL10;CXCL12
regulation of cytoskeleton organization (GO:0051493),4/112,0.02530047105927401,0.08616314269836674,0,0,3.759831996945399,13.824647578586625,LRP1;EZR;S100A8;RHOQ
Fc receptor signaling pathway (GO:0038093),4/112,0.02530047105927401,0.08616314269836674,0,0,3.759831996945399,13.824647578586625,JUN;KIT;PIK3R1;FOS
regulation of extrinsic apoptotic signaling pathway (GO:2001236),3/64,0.02560956173282167,0.08673057415774794,0,0,4.978814627994955,18.246307531510734,TCF7L2;CAV1;FADD
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),3/64,0.02560956173282167,0.08673057415774794,0,0,4.978814627994955,18.246307531510734,TCF7L2;CCND1;RUNX2
lipid homeostasis (GO:0055088),3/64,0.02560956173282167,0.08673057415774794,0,0,4.978814627994955,18.246307531510734,ABCA1;IRS2;PPARG
plasma membrane organization (GO:0007009),3/64,0.02560956173282167,0.08673057415774794,0,0,4.978814627994955,18.246307531510734,CXCR4;ANK2;SPTBN1
peptidyl-serine modification (GO:0018209),5/169,0.026633135523253353,0.09007178472100266,0,0,3.1021736383166942,11.247238081625579,RPS6KA3;MAPKAPK2;PLK1;SGK1;TGFBR2
activation of protein kinase activity (GO:0032147),4/114,0.02677686292729476,0.09043226245209811,0,0,3.6910965323336455,13.362570739635308,GHR;PRKAR2B;LEP;TGFBR2
regulation of glycogen biosynthetic process (GO:0005979),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,IRS2;SORBS1
regulation of mitotic metaphase/anaphase transition (GO:0030071),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,DUSP1;PLK1
regulation of potassium ion transmembrane transporter activity (GO:1901016),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,FHL1;ANK2
regulation of regulatory T cell differentiation (GO:0045589),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,BCL6;MDK
glial cell development (GO:0021782),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,MDK;SOX10
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,MUC1;CXCL12
positive regulation of interleukin-2 production (GO:0032743),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,ANXA1;SPTBN1
positive regulation of ion transmembrane transporter activity (GO:0032414),2/26,0.027118843760692908,0.09058214616911829,0,0,8.409013605442176,30.335739008548607,DMD;ANK2
cellular response to nutrient levels (GO:0031669),3/66,0.027729354930768665,0.0922417749404668,0,0,4.82026862026862,17.281934022354477,SREBF1;LPL;FOXO1
ERBB signaling pathway (GO:0038127),3/66,0.027729354930768665,0.0922417749404668,0,0,4.82026862026862,17.281934022354477,EFEMP1;PIK3R1;EGFR
positive regulation of T cell proliferation (GO:0042102),3/66,0.027729354930768665,0.0922417749404668,0,0,4.82026862026862,17.281934022354477,ANXA1;LEP;FADD
regulation of cardiac muscle cell contraction (GO:0086004),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,CAV1;ANK2
negative regulation of actin filament bundle assembly (GO:0032232),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,PIK3R1;MET
negative regulation of endothelial cell apoptotic process (GO:2000352),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,CDH5;KDR
positive regulation of BMP signaling pathway (GO:0030513),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,CDH5;BMPR1B
positive regulation of calcium ion transmembrane transport (GO:1904427),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,CXCL10;ANK2
positive regulation of erythrocyte differentiation (GO:0045648),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,STAT5B;STAT1
positive regulation of gene silencing by miRNA (GO:2000637),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,ZFP36;EGFR
positive regulation of striated muscle cell differentiation (GO:0051155),2/27,0.029100655575342308,0.09575688692697097,0,0,8.072244897959184,28.55148642584497,MEF2C;MMP14
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),4/118,0.02988185308782108,0.09806241545666353,0,0,3.5608609151745343,12.50041614067433,ABCA1;CXCL10;GNG2;S1PR1
regulation of protein binding (GO:0043393),4/118,0.02988185308782108,0.09806241545666353,0,0,3.5608609151745343,12.50041614067433,TCF7L2;LRP1;CAV1;PLK1
canonical Wnt signaling pathway (GO:0060070),3/68,0.02993982120662665,0.09812041001095007,0,0,4.671479289940828,16.390192807184754,TCF7L2;FZD4;CAV1
protein transport (GO:0015031),8/369,0.03099626697407099,0.10096169887988746,0,0,2.2675025513923313,7.877051041399943,ABCA1;TF;ARF1;LRP1;TXNIP;PPARG;CD36;SPTBN1
regulation of calcineurin-NFAT signaling cascade (GO:0070884),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,RCAN1;CIB1
regulation of microtubule polymerization or depolymerization (GO:0031110),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,MAP1B;FKBP4
regulation of protein transport (GO:0051223),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,DNAJC1;SAA1
regulation of reactive oxygen species biosynthetic process (GO:1903426),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,CD36;TLR4
response to ketone (GO:1901654),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,YAP1;CAV1
leukocyte cell-cell adhesion (GO:0007159),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,PECAM1;EZR
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),2/28,0.031138495219217858,0.10096169887988746,0,0,7.76138147566719,26.926641757721413,KIT;FGFR3
carbohydrate homeostasis (GO:0033500),3/70,0.032240602824136856,0.10439610089996443,0,0,4.531572904707233,15.563817031954146,TCF7L2;LEPR;PPARG
regulation of calcium ion transmembrane transporter activity (GO:1901019),2/29,0.03323107118118974,0.10689254732654824,0,0,7.473544973544974,25.441964661375263,DMD;ANK2
establishment of endothelial barrier (GO:0061028),2/29,0.03323107118118974,0.10689254732654824,0,0,7.473544973544974,25.441964661375263,PECAM1;EZR
limb development (GO:0060173),2/29,0.03323107118118974,0.10689254732654824,0,0,7.473544973544974,25.441964661375263,MAP3K20;BMPR1B
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),2/29,0.03323107118118974,0.10689254732654824,0,0,7.473544973544974,25.441964661375263,CD36;TLR4
negative regulation of transferase activity (GO:0051348),2/29,0.03323107118118974,0.10689254732654824,0,0,7.473544973544974,25.441964661375263,ZFP36;IRS2
cholesterol homeostasis (GO:0042632),3/71,0.03342472296780239,0.10709105319289319,0,0,4.464705882352941,15.173121871466257,ABCA1;CAV1;LPL
negative regulation of neuron apoptotic process (GO:0043524),3/71,0.03342472296780239,0.10709105319289319,0,0,4.464705882352941,15.173121871466257,MEF2C;MDK;CCL2
phosphatidylinositol-mediated signaling (GO:0048015),3/71,0.03342472296780239,0.10709105319289319,0,0,4.464705882352941,15.173121871466257,IRS2;PIK3R1;EZR
membrane organization (GO:0061024),6/242,0.03370885772060116,0.10785948561059634,0,0,2.59083686440678,8.782923072536585,TF;FZD4;ITSN1;ANK2;SPTBN1;EGFR
regulation of anatomical structure morphogenesis (GO:0022603),4/123,0.034050873274918236,0.10881086144937782,0,0,3.41037858442346,11.526737212915167,MEF2C;BCL6;LEP;SH3D19
extrinsic apoptotic signaling pathway (GO:0097191),3/72,0.034631243394974115,0.11023147407419864,0,0,4.399777034559643,14.796445838164997,CIB1;FADD;FGFR3
sterol homeostasis (GO:0055092),3/72,0.034631243394974115,0.11023147407419864,0,0,4.399777034559643,14.796445838164997,ABCA1;CAV1;LPL
negative regulation of supramolecular fiber organization (GO:1902904),3/72,0.034631243394974115,0.11023147407419864,0,0,4.399777034559643,14.796445838164997,CDH5;CIB1;CRYAB
cardiac muscle cell action potential (GO:0086001),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,DMD;ANK2
regulation of striated muscle contraction (GO:0006942),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,DMD;ANK2
Golgi to plasma membrane protein transport (GO:0043001),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,KRT18;SPTBN1
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,FADD;TLR4
morphogenesis of an epithelium (GO:0002009),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,LAMA3;SOX10
negative regulation of Notch signaling pathway (GO:0045746),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,MMP14;EGFR
plasma membrane invagination (GO:0099024),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,GSN;CD36
positive regulation of B cell proliferation (GO:0030890),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,MEF2C;IRS2
positive regulation of lipid kinase activity (GO:0090218),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,KIT;FGFR3
positive regulation of phosphate metabolic process (GO:0045937),2/30,0.03537711180032136,0.11115260288230003,0,0,7.206268221574344,24.081116091085146,NRP1;EGFR
regulation of protein secretion (GO:0050708),4/125,0.0358085756649081,0.11223563667615696,0,0,3.353667887875948,11.166264847963616,SNAP25;DNAJC1;SAA1;EZR
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/73,0.03586009253965097,0.11223563667615696,0,0,4.336703296703297,14.43311334128344,TAP1;CD36;CALR
regulation of actin filament-based process (GO:0032970),3/73,0.03586009253965097,0.11223563667615696,0,0,4.336703296703297,14.43311334128344,LRP1;EZR;RHOQ
circulatory system development (GO:0072359),4/126,0.036706794514484824,0.11473818311010339,0,0,3.3260098022646614,10.991775257569902,CDH5;MEF2C;PKD2;TGFBR2
regulation of stress fiber assembly (GO:0051492),3/74,0.03711119333308614,0.11585353303341636,0,0,4.275406283856988,14.082489901925209,NRP1;PIK3R1;MET
regulation of potassium ion transport (GO:0043266),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,FHL1;ANK2
renal water homeostasis (GO:0003091),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,PRKAR2B;AQP1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,FADD;TLR4
negative regulation of interleukin-6 production (GO:0032715),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,SIRPA;TLR4
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,SOCS3;CAV1
peptide cross-linking (GO:0018149),2/31,0.037575365000100946,0.11640714220769185,0,0,6.9574243490499645,22.830138383092528,ANXA1;F13A1
actomyosin structure organization (GO:0031032),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,KRT19;EPB41L2;SORBS1
regulation of BMP signaling pathway (GO:0030510),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,CDH5;PPARG;BMPR1B
regulation of cell division (GO:0051302),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,PLK1;TXNIP;CIB1
cell morphogenesis involved in neuron differentiation (GO:0048667),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,MEF2C;PARD6B;MAP1B
regulation of epithelial to mesenchymal transition (GO:0010717),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,EFNA1;MDK;TGFBR2
positive regulation of interleukin-6 production (GO:0032755),3/76,0.03967981514445567,0.12106478929161793,0,0,4.157850368809273,13.417019973680777,LEP;LPL;TLR4
regulation of cellular biosynthetic process (GO:0031326),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,C3;SIRPA
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,YAP1;ESR1
regulation of NMDA receptor activity (GO:2000310),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,MEF2C;CCL2
endodermal cell differentiation (GO:0035987),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,MMP14;LAMA3
ERBB2 signaling pathway (GO:0038128),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,PIK3R1;EGFR
hematopoietic progenitor cell differentiation (GO:0002244),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,KIT;KDR
skeletal muscle organ development (GO:0060538),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,MEF2C;CAV1
modulation by host of symbiont process (GO:0051851),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,JUN;AQP1
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/32,0.03982459803802298,0.12106478929161793,0,0,6.725170068027211,21.677042398344934,PER1;CALR
regulation of canonical Wnt signaling pathway (GO:0060828),6/253,0.040449008109673765,0.12280964432301199,0,0,2.474063765182186,7.93608689125438,TCF7L2;ZEB2;FZD4;MDK;CAV1;EGFR
cellular response to UV (GO:0034644),3/77,0.04099715599836838,0.12416427220898882,0,0,4.101455301455301,13.101084180795667,MME;TIMP1;AQP1
positive regulation of tumor necrosis factor production (GO:0032760),3/77,0.04099715599836838,0.12416427220898882,0,0,4.101455301455301,13.101084180795667,LPL;FADD;TLR4
negative regulation of gene expression (GO:0010629),7/322,0.041684709983172745,0.1259683579799065,0,0,2.2672484002326936,7.204455866897756,YAP1;MEF2C;ZFP36;KDR;CALR;KLF4;ESR1
negative regulation of Wnt signaling pathway (GO:0030178),5/191,0.04169630247712716,0.1259683579799065,0,0,2.732185637082846,8.681090427061559,TCF7L2;LRP1;FZD4;MDK;CAV1
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,TAP1;CALR
apoptotic cell clearance (GO:0043277),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,ANXA1;LRP1
regulation of sprouting angiogenesis (GO:1903670),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,E2F2;KLF4
muscle cell development (GO:0055001),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,DMD;ANK2
negative regulation of JNK cascade (GO:0046329),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,PER1;SIRPA
negative regulation of smooth muscle cell proliferation (GO:0048662),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,MEF2C;PPARG
neuron projection extension (GO:1990138),2/33,0.042123597241946545,0.12616354155490755,0,0,6.507899934167216,20.611476994235183,NRP1;MAP1B
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/78,0.042336388479290825,0.12664509330107268,0,0,4.046564102564102,12.795673995872372,TAP1;CD36;CALR
regulation of cell motility (GO:2000145),4/133,0.04335656491883551,0.1293003108945967,0,0,3.1444098137936547,9.868092348698358,PARD6B;AMOTL2;SGK1;EGFR
regulation of cellular response to heat (GO:1900034),3/79,0.04369741040585582,0.1293003108945967,0,0,3.9931174089068824,12.500320027917539,MAPKAPK2;FKBP4;CRYAB
regulation of neuron differentiation (GO:0045664),3/79,0.04369741040585582,0.1293003108945967,0,0,3.9931174089068824,12.500320027917539,MEF2C;DTX1;CALR
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),3/79,0.04369741040585582,0.1293003108945967,0,0,3.9931174089068824,12.500320027917539,CAV1;PLK1;ELOB
cellular response to tumor necrosis factor (GO:0071356),5/194,0.0440790836972897,0.1293003108945967,0,0,2.6884063930696054,8.39258616120776,ZFP36;CCL11;STAT1;CCL2;CIB1
negative regulation of macromolecule metabolic process (GO:0010605),5/194,0.0440790836972897,0.1293003108945967,0,0,2.6884063930696054,8.39258616120776,YAP1;MEF2C;KDR;KLF4;ESR1
cardiac muscle contraction (GO:0060048),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,GSN;DMD
striated muscle tissue development (GO:0014706),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,MEF2C;CAV1
positive regulation of calcium ion transport into cytosol (GO:0010524),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,CXCL10;CAV1
positive regulation of interleukin-12 production (GO:0032735),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,MDK;TLR4
positive regulation of protein dephosphorylation (GO:0035307),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,PPP1R15A;CDH5
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,CXCL10;PKD2
protein destabilization (GO:0031648),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,GSN;PLK1
protein localization to chromosome (GO:0034502),2/34,0.044471167749982124,0.1293003108945967,0,0,6.3042091836734695,19.624462385524268,PLK1;ESR1
regulation of organelle organization (GO:0033043),3/80,0.04508011501370713,0.1293003108945967,0,0,3.941058941058941,12.21457930253793,ZEB2;EZR;S100A8
negative regulation of cell cycle (GO:0045786),3/80,0.04508011501370713,0.1293003108945967,0,0,3.941058941058941,12.21457930253793,NR4A1;DUSP1;PLK1
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),3/81,0.04648439109138168,0.1293003108945967,0,0,3.8903353057199213,11.93803346808487,PPARG;FADD;S100A8
positive regulation of cellular amide metabolic process (GO:0034250),3/81,0.04648439109138168,0.1293003108945967,0,0,3.8903353057199213,11.93803346808487,EFNA1;BCL3;VIM
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/81,0.04648439109138168,0.1293003108945967,0,0,3.8903353057199213,11.93803346808487,LPL;FADD;TLR4
acylglycerol catabolic process (GO:0046464),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,FABP4;LPL
bicarbonate transport (GO:0015701),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,CA12;AQP1
cellular response to virus (GO:0098586),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,CXCL10;ARF1
regulation of lipid biosynthetic process (GO:0046890),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,C3;SORBS1
semaphorin-plexin signaling pathway (GO:0071526),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,NRP1;MET
positive regulation of lipid biosynthetic process (GO:0046889),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,SREBF1;SORBS1
positive regulation of lymphocyte activation (GO:0051251),2/35,0.04686613328502421,0.1293003108945967,0,0,6.112863327149041,18.70817350974744,CCL2;SIRPA
cell-cell junction organization (GO:0045216),3/82,0.04791012314996256,0.1293003108945967,0,0,3.840895813047712,11.670287141219873,CDH5;PARD6B;PRTN3
regulation of G protein-coupled receptor signaling pathway (GO:0008277),3/82,0.04791012314996256,0.1293003108945967,0,0,3.840895813047712,11.670287141219873,RGS4;C3;RGS2
activation of protein kinase C activity (GO:1990051),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LEP
alpha-beta T cell differentiation (GO:0046632),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,ANXA1
reelin-mediated signaling pathway (GO:0038026),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,STAT5A
carbon dioxide transport (GO:0015670),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,AQP1
caveolin-mediated endocytosis (GO:0072584),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CAV1
regulation of dendritic cell cytokine production (GO:0002730),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KIT
regulation of endothelial tube morphogenesis (GO:1901509),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CXCL10
cellular response to antibiotic (GO:0071236),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MEF2C
cellular response to erythropoietin (GO:0036018),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KIT
cellular response to heparin (GO:0071504),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,EGR1
cellular response to nutrient (GO:0031670),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LPL
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MET
cellular response to salt stress (GO:0071472),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,AQP1
cellular response to testosterone stimulus (GO:0071394),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,SPP1
regulation of hormone metabolic process (GO:0032350),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TCF7L2
regulation of inflammatory response to wounding (GO:0106014),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MDK
regulation of inward rectifier potassium channel activity (GO:1901979),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CAV1
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LIFR
regulation of natural killer cell mediated immunity (GO:0002715),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LEP
regulation of plasma membrane organization (GO:1903729),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,GSN
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LRP1
regulation of protein kinase C activity (GO:1900019),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,EGFR
regulation of retinal ganglion cell axon guidance (GO:0090259),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,NRP1
regulation of skeletal muscle tissue development (GO:0048641),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MEF2C
regulation of sterol transport (GO:0032371),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LRP1
regulation of triglyceride metabolic process (GO:0090207),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,C3
regulation of type B pancreatic cell apoptotic process (GO:2000674),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TCF7L2
heart field specification (GO:0003128),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MEF2C
response to salt stress (GO:0009651),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,AQP1
immature B cell differentiation (GO:0002327),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KIT
SA node cell to atrial cardiac muscle cell signaling (GO:0086018),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,ANK2
secondary heart field specification (GO:0003139),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MEF2C
lipid transport across blood-brain barrier (GO:1990379),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CD36
lymph node development (GO:0048535),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,FADD
T cell extravasation (GO:0072683),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CCL2
mature conventional dendritic cell differentiation (GO:0097029),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PRTN3
membrane depolarization during SA node cell action potential (GO:0086046),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,ANK2
tonic smooth muscle contraction (GO:0014820),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MYLK
mesonephric duct development (GO:0072177),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PKD2
metanephric distal tubule development (GO:0072235),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PKD2
metanephric mesenchymal cell differentiation (GO:0072162),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,STAT1
tricuspid valve development (GO:0003175),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TGFBR2
tricuspid valve morphogenesis (GO:0003186),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TGFBR2
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KDR
ventricular cardiac muscle cell differentiation (GO:0055012),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MEF2C
negative regulation of gene silencing by RNA (GO:0060967),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PPARG
negative regulation of PERK-mediated unfolded protein response (GO:1903898),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PPP1R15A
negative regulation of pinocytosis (GO:0048550),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CAV1
negative regulation of posttranscriptional gene silencing (GO:0060149),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PPARG
negative regulation of regulatory T cell differentiation (GO:0045590),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MDK
negative regulation of response to food (GO:0032096),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LEP
nephric duct development (GO:0072176),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PKD2
p38MAPK cascade (GO:0038066),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,ZFP36
peptidyl-cysteine S-nitrosylation (GO:0018119),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,S100A8
positive regulation of axon extension involved in axon guidance (GO:0048842),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,NRP1
positive regulation of cardiac muscle contraction (GO:0060452),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,RGS2
"positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)",1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TGFBR2
positive regulation of dopamine receptor signaling pathway (GO:0060161),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CAV2
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KDR
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TGFBR2
positive regulation of leukocyte mediated immunity (GO:0002705),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KIT
positive regulation of low-density lipoprotein receptor activity (GO:1905599),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PPARG
positive regulation of neutrophil extravasation (GO:2000391),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,MDK
positive regulation of oxidative stress-induced neuron death (GO:1903223),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,TLR4
positive regulation of prostaglandin biosynthetic process (GO:0031394),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,ANXA1
positive regulation of protein catabolic process in the vacuole (GO:1904352),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LRP1
positive regulation of protein kinase C activity (GO:1900020),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,EGFR
positive regulation of protein localization to cell cortex (GO:1904778),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,EPB41L2
positive regulation of smooth muscle cell differentiation (GO:0051152),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,KIT
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,PPARG
prostaglandin transport (GO:0015732),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,LEP
protein localization to membrane raft (GO:1903044),1/5,0.0485340797362059,0.1293003108945967,0,0,25.124365482233504,76.0134927256932,CAV1
regulation of cardiac muscle contraction (GO:0055117),2/36,0.04930733587510383,0.13064566143185835,0,0,5.932773109243698,17.855762859273696,RGS2;ANK2
cyclic-nucleotide-mediated signaling (GO:0019935),2/36,0.04930733587510383,0.13064566143185835,0,0,5.932773109243698,17.855762859273696,CD36;AQP1
negative regulation of fat cell differentiation (GO:0045599),2/36,0.04930733587510383,0.13064566143185835,0,0,5.932773109243698,17.855762859273696,YAP1;FOXO1
positive regulation of bone mineralization (GO:0030501),2/36,0.04930733587510383,0.13064566143185835,0,0,5.932773109243698,17.855762859273696,MEF2C;BMPR1B
positive regulation of cytokine-mediated signaling pathway (GO:0001961),2/36,0.04930733587510383,0.13064566143185835,0,0,5.932773109243698,17.855762859273696,CXCR4;FADD
positive regulation of response to external stimulus (GO:0032103),4/139,0.04956083080995593,0.13117459024156813,0,0,3.003741886216113,9.024906076839908,MDK;LPL;TLR4;S100A8
protein localization to cell periphery (GO:1990778),4/140,0.05064002059220429,0.13388539646255965,0,0,2.981503941782899,8.8938652996632,CAV1;ANK2;EZR;SPTBN1
regulation of small GTPase mediated signal transduction (GO:0051056),4/141,0.0517320695329892,0.13561021805347284,0,0,2.959590638874257,8.765352676826284,ITSN1;A2M;RHOQ;ARHGEF6
regulation of actin cytoskeleton reorganization (GO:2000249),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,NRP1;MDK
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,CALR;ESR1
regulation of transport (GO:0051049),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,NRP1;LEPR
lysosome localization (GO:0032418),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,KLC2;KIT
neural crest cell migration (GO:0001755),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,NRP1;SOX10
"phagocytosis, engulfment (GO:0006911)",2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,GSN;CD36
positive regulation of myeloid cell differentiation (GO:0045639),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,STAT5B;STAT1
positive regulation of signaling receptor activity (GO:2000273),2/37,0.051793635642599485,0.13561021805347284,0,0,5.762973760932945,17.061214671092433,NRP1;CCL2
B cell activation (GO:0042113),3/85,0.05231483860519873,0.13668093562624345,0,0,3.699812382739212,10.916204780603257,MEF2C;KLF6;KIT
positive regulation of protein catabolic process (GO:0045732),3/85,0.05231483860519873,0.13668093562624345,0,0,3.699812382739212,10.916204780603257,EZR;FOXO1;SH3D19
regulation of interferon-gamma production (GO:0032649),3/86,0.05382515838616386,0.14014168781674896,0,0,3.655050973123262,10.680111185558149,SIRPA;FADD;TLR4
transport across blood-brain barrier (GO:0150104),3/86,0.05382515838616386,0.14014168781674896,0,0,3.655050973123262,10.680111185558149,LRP1;LEPR;CD36
negative regulation of phosphorylation (GO:0042326),3/86,0.05382515838616386,0.14014168781674896,0,0,3.655050973123262,10.680111185558149,SIRPA;CIB1;IRS2
negative regulation of DNA-binding transcription factor activity (GO:0043433),4/143,0.05395466746061663,0.14014168781674896,0,0,2.916709931024253,8.515658621434108,TCF7L2;PKD2;KLF4;ESR1
synaptic vesicle endocytosis (GO:0048488),2/38,0.05432391052176327,0.14014168781674896,0,0,5.602607709750567,16.31922423702565,ITSN1;SNCG
negative regulation of innate immune response (GO:0045824),2/38,0.05432391052176327,0.14014168781674896,0,0,5.602607709750567,16.31922423702565,SERPING1;A2M
positive regulation of insulin secretion (GO:0032024),2/38,0.05432391052176327,0.14014168781674896,0,0,5.602607709750567,16.31922423702565,TCF7L2;IRS2
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),3/87,0.05535629690745097,0.14014168781674896,0,0,3.6113553113553114,10.451135371765963,MUC1;EPAS1;ELOB
regulation of cellular component biogenesis (GO:0044087),2/39,0.05689705606135651,0.14014168781674896,0,0,5.450910093767237,15.625097439536829,CD36;EZR
regulation of heart rate by cardiac conduction (GO:0086091),2/39,0.05689705606135651,0.14014168781674896,0,0,5.450910093767237,15.625097439536829,CAV1;ANK2
odontogenesis (GO:0042476),2/39,0.05689705606135651,0.14014168781674896,0,0,5.450910093767237,15.625097439536829,COL1A2;AQP1
activation of Janus kinase activity (GO:0042976),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,GHR
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,FOXO1
cardiac ventricle formation (GO:0003211),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MEF2C
regulation of digestive system process (GO:0044058),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,SGK1
cellular hyperosmotic response (GO:0071474),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,AQP1
cellular response to bacterial lipopeptide (GO:0071221),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CD36
cellular response to cold (GO:0070417),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,FOXO1
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,ZFP36
regulation of focal adhesion disassembly (GO:0120182),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PIK3R1
cellular response to iron ion (GO:0071281),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,TF
regulation of hepatocyte proliferation (GO:2000345),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MDK
regulation of hormone biosynthetic process (GO:0046885),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,EGR1
cellular water homeostasis (GO:0009992),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,AQP1
cholesterol import (GO:0070508),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CD36
chondrocyte development (GO:0002063),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,BMPR1B
regulation of long-chain fatty acid import across plasma membrane (GO:0010746),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,IRS2
contact inhibition (GO:0060242),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,YAP1
regulation of macrophage apoptotic process (GO:2000109),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MEF2C
regulation of mitotic sister chromatid segregation (GO:0033047),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,DUSP1
regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,DUSP1
determination of liver left/right asymmetry (GO:0071910),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PKD2
regulation of neutrophil extravasation (GO:2000389),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MDK
regulation of nitric oxide mediated signal transduction (GO:0010749),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,EGFR
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,DMD
regulation of protein depolymerization (GO:1901879),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MAP1B
regulation of protein targeting (GO:1903533),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,SREBF1
regulation of saliva secretion (GO:0046877),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,AQP1
glomerulus vasculature development (GO:0072012),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PECAM1
regulation of type B pancreatic cell proliferation (GO:0061469),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,NR4A1
response to catecholamine (GO:0071869),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,GNG2
response to granulocyte macrophage colony-stimulating factor (GO:0097012),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,ZFP36
response to heparin (GO:0071503),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,EGR1
hepatocyte differentiation (GO:0070365),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,ANXA1
response to testosterone (GO:0033574),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,SPP1
retinal ganglion cell axon guidance (GO:0031290),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,NRP1
ISG15-protein conjugation (GO:0032020),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,UBE2L6
leukocyte chemotaxis involved in inflammatory response (GO:0002232),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MDK
sterol import (GO:0035376),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CD36
maintenance of DNA repeat elements (GO:0043570),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,TCF7L2
T-tubule organization (GO:0033292),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,ANK2
megakaryocyte development (GO:0035855),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,KIT
mesenchymal cell differentiation involved in kidney development (GO:0072161),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,STAT1
mesodermal cell fate commitment (GO:0001710),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,KLF4
negative regulation of actin filament depolymerization (GO:0030835),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,GSN
negative regulation of cardiac muscle cell apoptotic process (GO:0010667),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MDK
negative regulation of cellular extravasation (GO:0002692),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CXCL12
negative regulation of erythrocyte differentiation (GO:0045647),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,ZFP36
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PER1
negative regulation of meiotic cell cycle (GO:0051447),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,DUSP1
negative regulation of monocyte chemotaxis (GO:0090027),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,DUSP1
negative regulation of sequestering of triglyceride (GO:0010891),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PPARG
nephron tubule development (GO:0072080),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,MEF2C
peptide antigen assembly with MHC protein complex (GO:0002501),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CALR
peroxisome proliferator activated receptor signaling pathway (GO:0035357),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PPARG
positive regulation of cholesterol storage (GO:0010886),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,LPL
positive regulation of endothelial cell development (GO:1901552),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CDH5
positive regulation of establishment of endothelial barrier (GO:1903142),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CDH5
positive regulation of focal adhesion disassembly (GO:0120183),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PIK3R1
positive regulation of gap junction assembly (GO:1903598),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CAV1
positive regulation of hemoglobin biosynthetic process (GO:0046985),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,KLF4
positive regulation of receptor binding (GO:1900122),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,NRP1
positive regulation of tau-protein kinase activity (GO:1902949),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,EGR1
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,CAV1
protein localization to nuclear envelope (GO:0090435),1/6,0.05795592592668016,0.14014168781674896,0,0,20.098477157360406,57.241919181742155,PLK1
regulation of cation channel activity (GO:2001257),3/89,0.058480472824523295,0.14112978327821035,0,0,3.5270125223613595,10.013408560165383,MEF2C;ANK2;DMD
second-messenger-mediated signaling (GO:0019932),3/89,0.058480472824523295,0.14112978327821035,0,0,3.5270125223613595,10.013408560165383,RCAN1;CXCR4;CD36
regulation of microtubule polymerization (GO:0031113),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,CDH5;MET
digestive tract development (GO:0048565),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,KIT;AGR2
regulation of sodium ion transmembrane transporter activity (GO:2000649),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,DMD;UTRN
stem cell differentiation (GO:0048863),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,MEF2C;KIT
positive regulation of catalytic activity (GO:0043085),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,CAV1;CIB1
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,CAV1;S100A8
positive regulation of wound healing (GO:0090303),2/40,0.05951198515243541,0.14262961008482306,0,0,5.307196562835661,14.974666704757507,ANXA1;MYLK
positive regulation of autophagy (GO:0010508),3/90,0.0600732231799833,0.14383313514578105,0,0,3.486295313881521,9.804128564744659,KDR;DCN;FOXO1
positive regulation of hydrolase activity (GO:0051345),4/149,0.06092875322559685,0.14573822603568598,0,0,2.795165303945965,7.82101249487622,CCL11;CAV2;CCL2;PRTN3
acylglycerol metabolic process (GO:0006639),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,CAV1;LPL
regulation of cell development (GO:0060284),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,YAP1;FOXO1
cortical cytoskeleton organization (GO:0030865),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,EZR;RHOQ
regulation of protein dephosphorylation (GO:0035304),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,PPP1R15A;CDH5
keratinocyte differentiation (GO:0030216),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,ANXA1;TXNIP
visual system development (GO:0150063),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,C3;BMPR1B
positive regulation of biomineral tissue development (GO:0070169),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,MEF2C;BMPR1B
positive regulation of cation transmembrane transport (GO:1904064),2/41,0.06216762783487358,0.1463096445686052,0,0,5.170852956567242,14.364220331003802,GNG2;ANK2
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),3/92,0.06331930722375989,0.1463096445686052,0,0,3.4076058772687987,9.40350986126655,CDH5;ZEB2;BMPR1B
actin filament organization (GO:0007015),4/152,0.06458666014977964,0.1463096445686052,0,0,2.7380886040679857,7.501671103152908,EPS8;GSN;TPM3;NEDD9
negative regulation of protein phosphorylation (GO:0001933),4/152,0.06458666014977964,0.1463096445686052,0,0,2.7380886040679857,7.501671103152908,CAV1;SIRPA;CIB1;DMD
negative regulation of protein catabolic process (GO:0042177),2/42,0.06486293104564635,0.1463096445686052,0,0,5.041326530612245,13.79044280007415,TIMP1;EGFR
phosphatidylinositol phosphate biosynthetic process (GO:0046854),2/42,0.06486293104564635,0.1463096445686052,0,0,5.041326530612245,13.79044280007415,SOCS3;PIK3R1
positive regulation of protein tyrosine kinase activity (GO:0061098),2/42,0.06486293104564635,0.1463096445686052,0,0,5.041326530612245,13.79044280007415,EFNA1;NEDD9
positive regulation of epithelial cell migration (GO:0010634),3/94,0.06664514552633603,0.1463096445686052,0,0,3.3323753169907016,9.025315568749445,NRP1;KDR;CALR
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,GNG2
ammonium transport (GO:0015696),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,AQP1
angiotensin-activated signaling pathway (GO:0038166),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CAV1
regulation by virus of viral protein levels in host cell (GO:0046719),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,STAT1
axon ensheathment in central nervous system (GO:0032291),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,SOX10
bleb assembly (GO:0032060),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MYLK
cellular hypotonic response (GO:0071476),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MYLK
regulation of entry of bacterium into host cell (GO:2000535),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CAV1
regulation of glial cell apoptotic process (GO:0034350),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CCL2
cellular response to laminar fluid shear stress (GO:0071499),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,KLF4
regulation of glucocorticoid receptor signaling pathway (GO:2000322),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PER1
cellular response to monoamine stimulus (GO:0071868),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,GNG2
regulation of hemoglobin biosynthetic process (GO:0046984),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,KLF4
cellular response to prostaglandin E stimulus (GO:0071380),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,GNG2
regulation of I-kappaB phosphorylation (GO:1903719),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,SIRPA
regulation of ketone biosynthetic process (GO:0010566),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EGR1
"complement activation, alternative pathway (GO:0006957)",1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,C3
regulation of lysosomal protein catabolic process (GO:1905165),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,LRP1
death-inducing signaling complex assembly (GO:0071550),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,FADD
dendrite arborization (GO:0140059),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,NRP1
regulation of morphogenesis of an epithelium (GO:1905330),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CXCL10
detection of molecule of bacterial origin (GO:0032490),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TLR4
regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CCL2
regulation of natural killer cell proliferation (GO:0032817),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,LEP
regulation of prostaglandin biosynthetic process (GO:0031392),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANXA1
endothelial cell morphogenesis (GO:0001886),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MET
epithelial cell differentiation involved in kidney development (GO:0035850),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MEF2C
establishment of centrosome localization (GO:0051660),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EZR
regulation of skeletal muscle contraction (GO:0014819),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,DMD
regulation of T cell tolerance induction (GO:0002664),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TGFBR2
regulation of T-helper 1 cell differentiation (GO:0045625),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANXA1
gas homeostasis (GO:0033483),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CAV1
gland morphogenesis (GO:0022612),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EZR
glial cell migration (GO:0008347),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CCL2
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PPARG
regulation of vascular associated smooth muscle cell differentiation (GO:1905063),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,KIT
glycerol transport (GO:0015793),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,AQP1
hyperosmotic response (GO:0006972),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,AQP1
hypotonic response (GO:0006971),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MYLK
SA node cell action potential (GO:0086015),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANK2
skin morphogenesis (GO:0043589),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,COL1A2
smooth muscle cell migration (GO:0014909),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PARVA
long-term synaptic depression (GO:0060292),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ARF1
"substrate-dependent cell migration, cell extension (GO:0006930)",1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,NRP1
macropinocytosis (GO:0044351),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MAPKAPK2
synaptic vesicle docking (GO:0016081),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,SNAP25
membrane biogenesis (GO:0044091),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,SPTBN1
TRAIL-activated apoptotic signaling pathway (GO:0036462),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,FADD
metanephric nephron tubule development (GO:0072234),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PKD2
vascular wound healing (GO:0061042),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,KDR
mitral valve development (GO:0003174),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EFNA1
white fat cell differentiation (GO:0050872),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PPARG
negative regulation of cardiocyte differentiation (GO:1905208),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EGFR
negative regulation of dendritic cell apoptotic process (GO:2000669),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CXCL12
negative regulation of dendritic spine development (GO:0061000),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EFNA1
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PPARG
negative regulation of intracellular transport (GO:0032387),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CRYAB
negative regulation of membrane protein ectodomain proteolysis (GO:0051045),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TIMP1
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TLR4
negative regulation of response to interferon-gamma (GO:0060331),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,PPARG
negative regulation of retinoic acid receptor signaling pathway (GO:0048387),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CALR
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,FOXO1
negative regulation of T cell apoptotic process (GO:0070233),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,FADD
negative regulation of type 2 immune response (GO:0002829),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANXA1
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ZFP36
nucleobase catabolic process (GO:0046113),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,DPYSL2
peptide transport (GO:0015833),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TAP1
platelet dense granule organization (GO:0060155),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ABCA1
positive regulation of amyloid-beta clearance (GO:1900223),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,LRP1
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EFNA1
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TGFBR2
positive regulation of cardiac muscle cell differentiation (GO:2000727),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MEF2C
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CAV1
positive regulation of histone H4 acetylation (GO:0090240),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,MUC1
positive regulation of hormone metabolic process (GO:0032352),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,EGR1
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,YAP1
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,AGR2
positive regulation of multicellular organism growth (GO:0040018),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,GHR
positive regulation of oxidative stress-induced cell death (GO:1903209),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,TLR4
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ESR1
positive regulation of striated muscle contraction (GO:0045989),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,RGS2
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,FADD
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANXA1
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,KIT
positive regulation of vesicle fusion (GO:0031340),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,ANXA1
protein localization to basolateral plasma membrane (GO:1903361),1/7,0.06728494121441418,0.1463096445686052,0,0,16.74788494077834,45.199507131472544,CAV1
cellular glucose homeostasis (GO:0001678),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,PIK3R1;FOXO1
cellular response to retinoic acid (GO:0071300),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,FZD4;AQP1
spermatid development (GO:0007286),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,RFX2;CIB1
negative regulation of type I interferon production (GO:0032480),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,SIRPA;UBE2L6
positive regulation of peptide hormone secretion (GO:0090277),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,TCF7L2;IRS2
positive regulation of T cell differentiation (GO:0045582),2/43,0.06759685837358557,0.1463096445686052,0,0,4.918118466898955,13.250364137460942,BCL6;MDK
cellular response to interleukin-1 (GO:0071347),4/155,0.0683572354468304,0.14782403935438013,0,0,2.683279852529528,7.199260942017054,EGR1;CCL11;SIRPA;CCL2
"transcription, DNA-templated (GO:0006351)",5/221,0.06914956998079827,0.14940479405789156,0,0,2.3491172519669927,6.275627836154048,MAF;THRB;BCL3;DTX1;ELOB
cardiac ventricle morphogenesis (GO:0003208),2/44,0.07036838987261805,0.1513666336924249,0,0,4.800777453838679,12.741316767024726,MEF2C;TGFBR2
mRNA stabilization (GO:0048255),2/44,0.07036838987261805,0.1513666336924249,0,0,4.800777453838679,12.741316767024726,ZFP36;MAPKAPK2
neurogenesis (GO:0022008),2/44,0.07036838987261805,0.1513666336924249,0,0,4.800777453838679,12.741316767024726,ANXA1;CXCR4
positive regulation of potassium ion transmembrane transport (GO:1901381),2/44,0.07036838987261805,0.1513666336924249,0,0,4.800777453838679,12.741316767024726,GNG2;ANK2
positive regulation of receptor-mediated endocytosis (GO:0048260),2/44,0.07036838987261805,0.1513666336924249,0,0,4.800777453838679,12.741316767024726,C3;TF
glycosaminoglycan biosynthetic process (GO:0006024),3/97,0.07178065819391924,0.15310694790503374,0,0,3.225531914893617,8.496503359863171,VCAN;BGN;DCN
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),5/224,0.07233723530600643,0.15310694790503374,0,0,2.3165826767927697,6.084310436006017,PER1;STAT1;S100A4;FADD;ESR1
regulation of insulin receptor signaling pathway (GO:0046626),2/45,0.07317652182093962,0.15310694790503374,0,0,4.688894162316089,12.260898613128823,SORBS1;TNS2
positive regulation of Notch signaling pathway (GO:0045747),2/45,0.07317652182093962,0.15310694790503374,0,0,4.688894162316089,12.260898613128823,YAP1;MAML2
positive regulation of RNA metabolic process (GO:0051254),2/45,0.07317652182093962,0.15310694790503374,0,0,4.688894162316089,12.260898613128823,PIK3R1;EGFR
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),3/98,0.07353097344146252,0.15310694790503374,0,0,3.191417004048583,8.329753337150311,ARF1;KLC2;CTSD
regulation of neuron apoptotic process (GO:0043523),3/98,0.07353097344146252,0.15310694790503374,0,0,3.191417004048583,8.329753337150311,MEF2C;MDK;CCL2
regulation of peptidyl-serine phosphorylation (GO:0033135),3/98,0.07353097344146252,0.15310694790503374,0,0,3.191417004048583,8.329753337150311,CAV1;DMD;EGFR
negative regulation of neuron death (GO:1901215),3/98,0.07353097344146252,0.15310694790503374,0,0,3.191417004048583,8.329753337150311,MEF2C;MDK;CCL2
regulation of B cell proliferation (GO:0030888),2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,MEF2C;IRS2
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,MEF2C;CCL2
vesicle organization (GO:0016050),2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,CAV2;CAV1
negative regulation of tumor necrosis factor production (GO:0032720),2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,SIRPA;TLR4
positive regulation of nucleocytoplasmic transport (GO:0046824),2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,TCF7L2;PIK3R1
positive regulation of smooth muscle cell proliferation (GO:0048661),2/46,0.07602026649927245,0.15310694790503374,0,0,4.582096474953618,11.806941421762529,JUN;STAT1
alpha-beta T cell activation (GO:0046631),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANXA1
pyrimidine nucleobase catabolic process (GO:0006208),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,DPYSL2
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,TAP1
atrial cardiac muscle cell to AV node cell signaling (GO:0086026),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANK2
axon extension involved in axon guidance (GO:0048846),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,NRP1
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CAV1
cardiac atrium development (GO:0003230),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANK2
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,SIRPA
cell-cell adhesion mediated by cadherin (GO:0044331),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CDH5
regulation of dendritic cell chemotaxis (GO:2000508),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CALR
regulation of dopamine receptor signaling pathway (GO:0060159),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CAV2
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,TGFBR2
regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,SREBF1
cellular response to interleukin-21 (GO:0098757),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,STAT1
cellular response to UV-B (GO:0071493),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,MME
commissural neuron axon guidance (GO:0071679),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,NRP1
coronary vasculature morphogenesis (GO:0060977),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,NRP1
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,PLK1
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,TLR4
regulation of nitric oxide metabolic process (GO:0080164),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,SIRPA
regulation of oxidative stress-induced neuron death (GO:1903203),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,TLR4
regulation of pattern recognition receptor signaling pathway (GO:0062207),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CD36
regulation of positive chemotaxis (GO:0050926),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,KDR
regulation of protein localization to early endosome (GO:1902965),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,EZR
entry of bacterium into host cell (GO:0035635),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,MET
regulation of response to wounding (GO:1903034),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,PLAU
regulation of T-helper 2 cell differentiation (GO:0045628),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANXA1
fusion of virus membrane with host plasma membrane (GO:0019064),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CXCR4
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CAV1
integrin activation (GO:0033622),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CXCL12
interleukin-21-mediated signaling pathway (GO:0038114),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,STAT1
skeletal muscle tissue regeneration (GO:0043403),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANXA1
kidney mesenchyme development (GO:0072074),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,PKD2
lens fiber cell differentiation (GO:0070306),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,MAF
leukocyte aggregation (GO:0070486),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,S100A8
spleen development (GO:0048536),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,FADD
SREBP signaling pathway (GO:0032933),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,SREBF1
lipid import into cell (GO:0140354),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CD36
mast cell activation involved in immune response (GO:0002279),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,KIT
mast cell degranulation (GO:0043303),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,KIT
membrane fusion involved in viral entry into host cell (GO:0039663),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CXCR4
tyrosine phosphorylation of STAT protein (GO:0007260),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,LEP
vascular associated smooth muscle contraction (GO:0014829),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ACTA2
water homeostasis (GO:0030104),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,AQP1
myoblast migration (GO:0051451),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ANXA1
negative regulation of appetite (GO:0032099),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,LEP
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,PRKAR2B
negative regulation of glial cell apoptotic process (GO:0034351),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CCL2
negative regulation of glucose import (GO:0046325),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,LEP
negative regulation of muscle hypertrophy (GO:0014741),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,RGS2
negative regulation of striated muscle cell apoptotic process (GO:0010664),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,MDK
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,NRP1
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,PTPRB
positive regulation of adaptive immune response (GO:0002821),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,FADD
positive regulation of aspartic-type peptidase activity (GO:1905247),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,EFNA1
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,KDR
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,GSN
positive regulation of dendritic cell chemotaxis (GO:2000510),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,CALR
positive regulation of dendritic cell cytokine production (GO:0002732),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,KIT
positive regulation of early endosome to late endosome transport (GO:2000643),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,EZR
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,YAP1
positive regulation of melanin biosynthetic process (GO:0048023),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ZEB2
positive regulation of membrane invagination (GO:1905155),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,C3
positive regulation of myotube differentiation (GO:0010831),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,MMP14
positive regulation of neuron projection arborization (GO:0150012),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,FZD4
positive regulation of protein localization to early endosome (GO:1902966),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,EZR
positive regulation of protein localization to endosome (GO:1905668),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,EZR
positive regulation of secondary metabolite biosynthetic process (GO:1900378),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ZEB2
postsynapse organization (GO:0099173),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,ARF1
progesterone receptor signaling pathway (GO:0050847),1/8,0.07652203515417907,0.15310694790503374,0,0,14.354604786076868,36.89386843909958,YAP1
cilium organization (GO:0044782),5/228,0.07671104752211841,0.15335911388863574,0,0,2.2745649294825623,5.840422081270483,ABLIM1;GSN;RFX2;PARVA;PKD2
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),3/100,0.07708830635407195,0.1538606770263649,0,0,3.125297383029342,8.009523629556108,ARF1;KLC2;CTSD
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),3/100,0.07708830635407195,0.1538606770263649,0,0,3.125297383029342,8.009523629556108,ZEB2;CAV1;TGFBR2
cellular response to chemical stress (GO:0062197),3/101,0.07889497825568491,0.15683119800509746,0,0,3.0932496075353217,7.855733319132799,CAV1;PKD2;FOXO1
regulation of protein localization to nucleus (GO:1900180),2/47,0.07889865197381699,0.15683119800509746,0,0,4.4800453514739225,11.377483465836477,YAP1;PLK1
epithelial to mesenchymal transition (GO:0001837),2/47,0.07889865197381699,0.15683119800509746,0,0,4.4800453514739225,11.377483465836477,HGF;S100A4
regulation of T cell activation (GO:0050863),2/47,0.07889865197381699,0.15683119800509746,0,0,4.4800453514739225,11.377483465836477,CCL2;SIRPA
negative regulation of cold-induced thermogenesis (GO:0120163),2/47,0.07889865197381699,0.15683119800509746,0,0,4.4800453514739225,11.377483465836477,LAMA4;TLR4
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),4/165,0.08172469478347204,0.16182705754664772,0,0,2.5153358519562015,6.299404745880737,ABCA1;AKAP12;CXCL10;S1PR1
negative regulation of canonical Wnt signaling pathway (GO:0090090),4/165,0.08172469478347204,0.16182705754664772,0,0,2.5153358519562015,6.299404745880737,TCF7L2;FZD4;MDK;CAV1
cellular response to interleukin-12 (GO:0071349),2/48,0.08181072190551267,0.16182705754664772,0,0,4.382431233362911,10.970745946307456,ARF1;SIRPA
myelination (GO:0042552),2/48,0.08181072190551267,0.16182705754664772,0,0,4.382431233362911,10.970745946307456,CXCR4;SOX10
negative regulation of MAP kinase activity (GO:0043407),2/48,0.08181072190551267,0.16182705754664772,0,0,4.382431233362911,10.970745946307456,RGS2;DUSP1
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/48,0.08181072190551267,0.16182705754664772,0,0,4.382431233362911,10.970745946307456,SIRPA;TLR4
antigen processing and presentation of exogenous peptide antigen (GO:0002478),3/103,0.08256345325766513,0.1623360656275555,0,0,3.031076923076923,7.560076145928414,ARF1;KLC2;CTSD
negative regulation of cell population proliferation (GO:0008285),7/379,0.08349765707414546,0.1623360656275555,0,0,1.914231830208861,4.752916475997807,MAGED1;PPARG;CIB1;BMPR1B;PKD2;KLF4;TNS2
regulation of insulin secretion (GO:0050796),3/104,0.08442489877948275,0.1623360656275555,0,0,3.000913937547601,7.417937890699555,SNAP25;TCF7L2;IRS2
regulation of cellular localization (GO:0060341),2/49,0.08475553532049038,0.1623360656275555,0,0,4.288970907511941,10.585112525518486,PARD6B;GSN
regulation of interferon-beta production (GO:0032648),2/49,0.08475553532049038,0.1623360656275555,0,0,4.288970907511941,10.585112525518486,SIRPA;TLR4
mitotic cytokinesis (GO:0000281),2/49,0.08475553532049038,0.1623360656275555,0,0,4.288970907511941,10.585112525518486,PLK1;SPTBN1
negative regulation of cell projection organization (GO:0031345),2/49,0.08475553532049038,0.1623360656275555,0,0,4.288970907511941,10.585112525518486,CIB1;FKBP4
positive regulation of actin filament polymerization (GO:0030838),2/49,0.08475553532049038,0.1623360656275555,0,0,4.288970907511941,10.585112525518486,CCL11;GSN
regulation of actin filament organization (GO:0110053),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CXCL12
astral microtubule organization (GO:0030953),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,EZR
ATF6-mediated unfolded protein response (GO:0036500),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CALR
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,EFNA1
bone cell development (GO:0098751),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,KIT
regulation of cell adhesion molecule production (GO:0060353),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CAV1
regulation of complement-dependent cytotoxicity (GO:1903659),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CFH
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CAV1
regulation of gap junction assembly (GO:1903596),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CAV1
cellular response to muramyl dipeptide (GO:0071225),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,VIM
cellular response to sterol depletion (GO:0071501),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,SREBF1
regulation of histone H4 acetylation (GO:0090239),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,MUC1
regulation of interleukin-23 production (GO:0032667),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,TLR4
chylomicron remodeling (GO:0034371),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,LPL
regulation of leukocyte mediated cytotoxicity (GO:0001910),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,LEP
regulation of lipid transport (GO:0032368),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,LRP1
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,KIT
regulation of pinocytosis (GO:0048548),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CAV1
epithelial cell apoptotic process (GO:1904019),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,GSN
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,MEF2C
regulation of sterol biosynthetic process (GO:0106118),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,SREBF1
regulation of vesicle fusion (GO:0031338),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,ANXA1
response to UV-C (GO:0010225),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,BCL3
response to vitamin (GO:0033273),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,SPP1
response to vitamin D (GO:0033280),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,SPP1
intestinal cholesterol absorption (GO:0030299),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CD36
intestinal epithelial cell differentiation (GO:0060575),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,YAP1
skeletal muscle fiber development (GO:0048741),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CAV2
lipoprotein metabolic process (GO:0042157),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,CTSD
sympathetic ganglion development (GO:0061549),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,NRP1
synapse pruning (GO:0098883),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,C3
T-helper 1 type immune response (GO:0042088),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,TLR4
mast cell mediated immunity (GO:0002448),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,KIT
very-low-density lipoprotein particle remodeling (GO:0034372),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,LPL
mitral valve morphogenesis (GO:0003183),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,EFNA1
muscle cell fate commitment (GO:0042693),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,MEF2C
negative regulation of exocytosis (GO:0045920),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,ANXA1
negative regulation of lipase activity (GO:0060192),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,RGS2
one-carbon compound transport (GO:0019755),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,AQP1
peptidyl-cysteine modification (GO:0018198),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,S100A8
plasminogen activation (GO:0031639),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,PLAU
positive regulation of B cell differentiation (GO:0045579),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,MMP14
positive regulation of fatty acid beta-oxidation (GO:0032000),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,IRS2
"positive regulation of phagocytosis, engulfment (GO:0060100)",1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,C3
positive regulation of sequestering of triglyceride (GO:0010890),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,LPL
positive regulation of smooth muscle cell apoptotic process (GO:0034393),1/9,0.08566810855499336,0.1623360656275555,0,0,12.559644670050762,30.86249647975658,PPARG
regulation of JNK cascade (GO:0046328),3/105,0.08630424160765618,0.16328735688783433,0,0,2.971342383107089,7.279421974495557,PER1;SIRPA;EGFR
positive regulation of cellular metabolic process (GO:0031325),3/105,0.08630424160765618,0.16328735688783433,0,0,2.971342383107089,7.279421974495557,PPARG;KLF4;TGFBR2
protein localization to nucleus (GO:0034504),3/106,0.0882012986116829,0.16674702027907443,0,0,2.9423450336071695,7.144406817089898,PLK1;BCL3;CALR
response to calcium ion (GO:0051592),3/107,0.09011588508667766,0.17023442993487983,0,0,2.9139053254437868,7.01277596622521,MEF2C;CAV1;PKD2
regulation of interleukin-12 production (GO:0032655),2/51,0.09073970425461392,0.17069133109819712,0,0,4.113494377342774,9.871400352988514,MDK;TLR4
sensory perception (GO:0007600),2/51,0.09073970425461392,0.17069133109819712,0,0,4.113494377342774,9.871400352988514,MME;CCL2
cilium assembly (GO:0060271),6/314,0.09261913644020173,0.17069133109819712,0,0,1.9778814935064934,4.705893336580833,ABLIM1;GSN;PRKAR2B;PLK1;RFX2;PARVA
ameboidal-type cell migration (GO:0001667),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,AMOTL2;SOX10
regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,CAV1;S100A8
signal transduction in response to DNA damage (GO:0042770),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,BCL3;MAP3K20
myeloid cell differentiation (GO:0030099),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,ZBTB16;KIT
negative regulation of BMP signaling pathway (GO:0030514),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,PPARG;BMPR1B
negative regulation of cellular biosynthetic process (GO:0031327),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,CAV1;SIRPA
negative regulation of protein metabolic process (GO:0051248),2/52,0.09377725278603731,0.17069133109819712,0,0,4.031020408163266,9.540751964438103,CRYAB;EGFR
adrenal gland development (GO:0030325),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MDK
regulation of actin filament-based movement (GO:1903115),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANK2
arachidonate transport (GO:1903963),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANXA1
arachidonic acid secretion (GO:0050482),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANXA1
regulation of axon guidance (GO:1902667),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,NRP1
B cell homeostasis (GO:0001782),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MEF2C
regulation of cell-cell adhesion involved in gastrulation (GO:0070587),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,KLF4
cell differentiation involved in metanephros development (GO:0072202),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,STAT1
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,PIK3R1
regulation of hair cycle (GO:0042634),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,PER1
cellular response to prostaglandin stimulus (GO:0071379),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,GNG2
chloride ion homeostasis (GO:0055064),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CA12
regulation of leukocyte tethering or rolling (GO:1903236),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CXCL12
defense response to tumor cell (GO:0002357),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,KLF4
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MUC1
"regulation of phagocytosis, engulfment (GO:0060099)",1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,C3
regulation of podosome assembly (GO:0071801),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,GSN
regulation of protein neddylation (GO:2000434),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,EPAS1
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ESR1
regulation of tau-protein kinase activity (GO:1902947),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,EGR1
regulation of type B pancreatic cell development (GO:2000074),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,FOXO1
granulocyte migration (GO:0097530),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANXA1
retinoic acid receptor signaling pathway (GO:0048384),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,PPARG
I-kappaB phosphorylation (GO:0007252),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,TLR4
sarcoplasmic reticulum calcium ion transport (GO:0070296),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANK2
secretory granule organization (GO:0033363),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ABCA1
sequestering of actin monomers (GO:0042989),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,GSN
smooth muscle tissue development (GO:0048745),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MYLK
long-chain fatty acid import into cell (GO:0044539),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CD36
toxin transport (GO:1901998),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,ANTXR2
monovalent inorganic anion homeostasis (GO:0055083),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CA12
myelin maintenance (GO:0043217),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CXCR4
myeloid dendritic cell differentiation (GO:0043011),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,TGFBR2
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MUC1
negative regulation of cellular protein catabolic process (GO:1903363),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,EFNA1
negative regulation of heterotypic cell-cell adhesion (GO:0034115),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,KLF4
negative regulation of interferon-beta production (GO:0032688),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,SIRPA
negative regulation of protein autophosphorylation (GO:0031953),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CAV1
negative regulation of transcription by competitive promoter binding (GO:0010944),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MUC1
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,JUN
negative regulation of transmembrane transport (GO:0034763),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,IRS2
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,SOCS3
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,DCN
neuron remodeling (GO:0016322),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,C3
pinocytosis (GO:0006907),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MAPKAPK2
positive regulation of behavior (GO:0048520),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MEF2C
positive regulation of cell activation (GO:0050867),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,TLR4
positive regulation of establishment of protein localization to telomere (GO:1904851),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,CCT3
positive regulation of lipase activity (GO:0060193),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,FGFR3
positive regulation of skeletal muscle tissue development (GO:0048643),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,MEF2C
positive regulation of vasculogenesis (GO:2001214),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,KDR
protein localization to endosome (GO:0036010),1/10,0.09472405357539049,0.17069133109819712,0,0,11.163564579808234,26.310147374168167,NRP1
neuron differentiation (GO:0030182),4/174,0.09477399574733573,0.17069133109819712,0,0,2.3810794420861128,5.610442755314999,MEF2C;FZD4;MET;RUNX2
epidermal cell differentiation (GO:0009913),2/53,0.09684393045207626,0.17403318867218134,0,0,3.951780712284914,9.226042862678687,ANXA1;TXNIP
positive regulation of macroautophagy (GO:0016239),2/53,0.09684393045207626,0.17403318867218134,0,0,3.951780712284914,9.226042862678687,KDR;DCN
positive regulation of NIK/NF-kappaB signaling (GO:1901224),2/53,0.09684393045207626,0.17403318867218134,0,0,3.951780712284914,9.226042862678687,TLR4;EGFR
defense response to bacterium (GO:0042742),4/176,0.09780034659422997,0.17562230380306046,0,0,2.3531527211699834,5.4706733531902065,TF;TLR4;S100A8;AQP1
regulation of protein serine/threonine kinase activity (GO:0071900),3/111,0.09794578087283178,0.1756244303573972,0,0,2.8054131054131055,6.5179318783586355,CCND2;CCND1;CIB1
Fc-epsilon receptor signaling pathway (GO:0038095),3/111,0.09794578087283178,0.1756244303573972,0,0,2.8054131054131055,6.5179318783586355,JUN;PIK3R1;FOS
regulation of cyclin-dependent protein kinase activity (GO:1904029),2/54,0.09993887001581798,0.17805852278145223,0,0,3.8755886970172684,8.926242631510387,CCND2;CCND1
regulation of focal adhesion assembly (GO:0051893),2/54,0.09993887001581798,0.17805852278145223,0,0,3.8755886970172684,8.926242631510387,NRP1;KDR
regulation of megakaryocyte differentiation (GO:0045652),2/54,0.09993887001581798,0.17805852278145223,0,0,3.8755886970172684,8.926242631510387,MEF2C;CIB1
regulation of translation (GO:0006417),4/178,0.100871563808662,0.17805852278145223,0,0,2.3258679938381324,5.335325376451908,RPS6KA3;BCL3;CALR;VIM
sulfur compound biosynthetic process (GO:0044272),3/113,0.10196100060169108,0.17805852278145223,0,0,2.754125874125874,6.288123487024435,VCAN;BGN;DCN
regulation of immune response (GO:0050776),4/179,0.10242382439042166,0.17805852278145223,0,0,2.312459499263623,5.269253309496851,COL17A1;C3;COL1A2;BCL6
actin filament depolymerization (GO:0030042),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,GSN
angiogenesis involved in wound healing (GO:0060055),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,KDR
regulation of cardiac muscle cell apoptotic process (GO:0010665),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MDK
regulation of cardiac muscle cell differentiation (GO:2000725),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MEF2C
"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,TGFBR2
regulation of coagulation (GO:0050818),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV1
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,GSN
cell-cell junction maintenance (GO:0045217),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,PRTN3
regulation of dendritic cell apoptotic process (GO:2000668),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CXCL12
regulation of establishment of protein localization to telomere (GO:0070203),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CCT3
central nervous system myelination (GO:0022010),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,SOX10
regulation of lipid kinase activity (GO:0043550),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,PIK3R1
regulation of melanin biosynthetic process (GO:0048021),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ZEB2
desensitization of G protein-coupled receptor signaling pathway (GO:0002029),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,GRK3
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MUC1
embryonic eye morphogenesis (GO:0048048),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,EFEMP1
regulation of protein localization to Cajal body (GO:1904869),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CCT3
enteric nervous system development (GO:0048484),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,SOX10
establishment of epithelial cell apical/basal polarity (GO:0045198),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,EZR
response to prostaglandin E (GO:0034695),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,GNG2
response to sterol (GO:0036314),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,TGFBR2
induction of positive chemotaxis (GO:0050930),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CXCL12
interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,STAT1
intestinal lipid absorption (GO:0098856),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CD36
somite development (GO:0061053),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MEOX2
lipoprotein catabolic process (GO:0042159),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CTSD
T cell chemotaxis (GO:0010818),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CXCL10
T cell homeostasis (GO:0043029),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,FADD
mesonephros development (GO:0001823),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ZBTB16
miRNA mediated inhibition of translation (GO:0035278),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ZFP36
vasoconstriction (GO:0042310),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ACTA2
monocyte differentiation (GO:0030224),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,PPARG
myotube cell development (GO:0014904),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV2
negative regulation of interleukin-17 production (GO:0032700),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,TLR4
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,LRP1
negative regulation of potassium ion transmembrane transport (GO:1901380),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV1
negative regulation of response to cytokine stimulus (GO:0060761),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,KLF4
negative regulation of sprouting angiogenesis (GO:1903671),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,E2F2
negative regulation of T-helper cell differentiation (GO:0045623),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ANXA1
"negative regulation of translation, ncRNA-mediated (GO:0040033)",1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ZFP36
negative regulation of voltage-gated potassium channel activity (GO:1903817),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV1
PERK-mediated unfolded protein response (GO:0036499),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CCL2
positive regulation by host of viral process (GO:0044794),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV2
positive regulation of actin nucleation (GO:0051127),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,GSN
positive regulation of bone resorption (GO:0045780),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,SPP1
positive regulation of cellular extravasation (GO:0002693),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MDK
positive regulation of cytoplasmic transport (GO:1903651),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,EZR
positive regulation of keratinocyte proliferation (GO:0010838),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,MDK
positive regulation of macrophage differentiation (GO:0045651),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,FADD
positive regulation of posttranscriptional gene silencing (GO:0060148),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,ZFP36
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,EGFR
positive regulation of protein localization to Cajal body (GO:1904871),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CCT3
positive regulation of triglyceride biosynthetic process (GO:0010867),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,SREBF1
positive regulation of viral release from host cell (GO:1902188),1/11,0.10369075371831592,0.17805852278145223,0,0,10.046700507614213,22.769262652105503,CAV2
positive regulation of cellular component organization (GO:0051130),3/114,0.10399300568417985,0.17845170460956866,0,0,2.7291753291753293,6.177301777896561,PPP1R15A;CDH5;LRP1
calcium ion transport (GO:0006816),3/115,0.10604101519431147,0.1818379380268651,0,0,2.70467032967033,6.069089064270181,CAV1;ANK2;PKD2
Rho protein signal transduction (GO:0007266),2/56,0.10621013664473684,0.1818717881363813,0,0,3.7316704459561603,8.36765795898803,EPS8;COL1A2
negative regulation of metabolic process (GO:0009892),2/56,0.10621013664473684,0.1818717881363813,0,0,3.7316704459561603,8.36765795898803,LAMA4;TLR4
regulation of mitotic nuclear division (GO:0007088),2/57,0.10938479931304602,0.1851066854382132,0,0,3.6636363636363636,8.107199889755803,DUSP1;CAV2
renal system development (GO:0072001),2/57,0.10938479931304602,0.1851066854382132,0,0,3.6636363636363636,8.107199889755803,MME;STAT1
positive regulation of interferon-gamma production (GO:0032729),2/57,0.10938479931304602,0.1851066854382132,0,0,3.6636363636363636,8.107199889755803,FADD;TLR4
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),4/185,0.11196599303322378,0.1851066854382132,0,0,2.2351198951984963,4.89392931313617,F8;PROS1;ANK2;SPTBN1
regulation of cellular response to stress (GO:0080135),3/118,0.11227911165079854,0.1851066854382132,0,0,2.6337123745819397,5.759316465557757,MAPKAPK2;FKBP4;CRYAB
actin crosslink formation (GO:0051764),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,EPS8
pyrimidine nucleobase metabolic process (GO:0006206),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,DPYSL2
angiotensin maturation (GO:0002003),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MME
regulation of alcohol biosynthetic process (GO:1902930),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,SREBF1
regulation of angiotensin levels in blood (GO:0002002),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MME
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CAV1
regulation of feeding behavior (GO:0060259),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,LEPR
regulation of leukocyte cell-cell adhesion (GO:1903037),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MDK
regulation of natural killer cell activation (GO:0032814),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,LEP
digestive system development (GO:0055123),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,KIT
epithelial cell-cell adhesion (GO:0090136),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,KIT
regulation of sequestering of calcium ion (GO:0051282),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ANK2
ethanol oxidation (GO:0006069),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ALDH2
exit from mitosis (GO:0010458),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,EPS8
ganglion development (GO:0061548),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,NRP1
gas transport (GO:0015669),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,AQP1
regulation of vascular associated smooth muscle cell migration (GO:1904752),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MEF2C
regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CAV1
replicative senescence (GO:0090399),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MME
inorganic ion transmembrane transport (GO:0098660),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,PKD2
sensory perception of taste (GO:0050909),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CD36
smooth muscle cell differentiation (GO:0051145),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MEF2C
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,SNAP25
megakaryocyte differentiation (GO:0030219),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,KIT
toll-like receptor 3 signaling pathway (GO:0034138),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,FADD
urogenital system development (GO:0001655),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ANXA1
mitotic G1/S transition checkpoint signaling (GO:0044819),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CCND1
mitotic nuclear membrane disassembly (GO:0007077),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,PLK1
modulation by host of viral process (GO:0044788),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CAV2
morphogenesis of a polarized epithelium (GO:0001738),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,LAMA3
negative regulation of amyloid fibril formation (GO:1905907),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CRYAB
negative regulation of calcineurin-mediated signaling (GO:0106057),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,RCAN1
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,RCAN1
negative regulation of cell division (GO:0051782),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,TXNIP
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,DCN
negative regulation of cilium assembly (GO:1902018),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,YAP1
negative regulation of glucose transmembrane transport (GO:0010829),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,LEP
negative regulation of leukocyte apoptotic process (GO:2000107),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CXCL12
negative regulation of leukocyte chemotaxis (GO:0002689),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,DUSP1
negative regulation of microtubule polymerization (GO:0031115),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CDH5
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ESR1
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,PKD2
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,PKD2
neurotransmitter uptake (GO:0001504),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,SNAP25
phospholipid efflux (GO:0033700),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ABCA1
phospholipid homeostasis (GO:0055091),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,ABCA1
polyol transport (GO:0015791),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,AQP1
positive regulation of cardiocyte differentiation (GO:1905209),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,MEF2C
positive regulation of fatty acid oxidation (GO:0046321),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,IRS2
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,CCT3
positive regulation of sodium ion transmembrane transport (GO:1902307),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,DMD
positive regulation of ubiquitin protein ligase activity (GO:1904668),1/12,0.11256908393690102,0.1851066854382132,0,0,9.13290263036456,19.947977849834988,PLK1
eye development (GO:0001654),2/58,0.1125843947162192,0.1851066854382132,0,0,3.5980320699708455,7.85828972612605,EFEMP1;BMPR1B
positive regulation of mitochondrion organization (GO:0010822),2/58,0.1125843947162192,0.1851066854382132,0,0,3.5980320699708455,7.85828972612605,KDR;DCN
mitotic DNA damage checkpoint signaling (GO:0044773),2/59,0.11580812452808689,0.19027853119155977,0,0,3.5347296813462226,7.6202429080226235,CCND1;PLK1
regulation of GTPase activity (GO:0043087),4/189,0.11853968166913981,0.1946352831182437,0,0,2.186347171914182,4.662401759323885,CCL11;CAV2;CCL2;PRTN3
regulation of mRNA catabolic process (GO:0061013),3/122,0.1208086907885828,0.19479985656472334,0,0,2.544667097608274,5.378273643629554,ZFP36;MAPKAPK2;VIM
purine ribonucleoside triphosphate metabolic process (GO:0009205),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,RHOQ
atrial cardiac muscle cell action potential (GO:0086014),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,ANK2
regulation of cell communication by electrical coupling (GO:0010649),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CAV1
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,MDK
regulation of membrane repolarization (GO:0060306),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CAV1
cytoplasmic sequestering of protein (GO:0051220),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,PKD2
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,DUSP1
high-density lipoprotein particle assembly (GO:0034380),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,ABCA1
response to iron ion (GO:0010039),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,TF
response to muramyl dipeptide (GO:0032495),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,VIM
response to UV-B (GO:0010224),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,MME
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,NRP1
intracellular sterol transport (GO:0032366),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,ABCA1
spinal cord development (GO:0021510),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,PKD2
triglyceride-rich lipoprotein particle remodeling (GO:0034370),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,LPL
negative regulation by host of viral transcription (GO:0043922),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,JUN
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,PPP1R15A
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,MUC1
negative regulation of mononuclear cell migration (GO:0071676),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,DUSP1
negative regulation of potassium ion transport (GO:0043267),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CAV1
pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,TGFBR2
positive regulation of calcineurin-mediated signaling (GO:0106058),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CIB1
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CIB1
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,TGFBR2
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,IRS2
positive regulation of ERAD pathway (GO:1904294),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,CAV1
positive regulation of insulin receptor signaling pathway (GO:0046628),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,SORBS1
positive regulation of neuron migration (GO:2001224),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,MDK
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,ZFP36
positive regulation of ruffle assembly (GO:1900029),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,EPS8
positive regulation of transporter activity (GO:0032411),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,SGK1
positive regulation of vascular endothelial cell proliferation (GO:1905564),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,MDK
protein heterotetramerization (GO:0051290),1/13,0.12135991064011717,0.19479985656472334,0,0,8.37140439932318,17.655247344501635,PKD2
B cell differentiation (GO:0030183),2/61,0.1223248600244283,0.19621939009188596,0,0,3.414562435143549,7.174251720956937,KLF6;KIT
fatty acid metabolic process (GO:0006631),3/124,0.1251608046607575,0.20050431536114768,0,0,2.502352193261284,5.200278052240274,LPL;PPARG;CD36
non-canonical Wnt signaling pathway (GO:0035567),3/124,0.1251608046607575,0.20050431536114768,0,0,2.502352193261284,5.200278052240274,TCF7L2;GNG2;FZD4
response to retinoic acid (GO:0032526),2/62,0.12561633441268988,0.20083767189422186,0,0,3.3574829931972787,6.965175632228617,FZD4;AQP1
I-kappaB kinase/NF-kappaB signaling (GO:0007249),2/62,0.12561633441268988,0.20083767189422186,0,0,3.3574829931972787,6.965175632228617,BCL3;TLR4
positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/62,0.12561633441268988,0.20083767189422186,0,0,3.3574829931972787,6.965175632228617,FADD;CTSD
regulation of phosphorylation (GO:0042325),3/125,0.1273579917662965,0.2010832150076849,0,0,2.48171500630517,5.1142024513851005,CDH5;NRP1;EGFR
protein localization to membrane (GO:0072657),4/195,0.128706078126084,0.2010832150076849,0,0,2.117018405570249,4.340361813151137,CAV1;ANK2;EZR;SPTBN1
negative regulation of endopeptidase activity (GO:0010951),2/63,0.12892888030731356,0.2010832150076849,0,0,3.3022750083640013,6.764691670684913,SERPING1;TIMP1
positive regulation of DNA metabolic process (GO:0051054),2/63,0.12892888030731356,0.2010832150076849,0,0,3.3022750083640013,6.764691670684913,HGF;EGFR
negative regulation of growth (GO:0045926),3/126,0.12956899770134903,0.2010832150076849,0,0,2.461413383364603,5.030000985710454,BCL6;FHL1;FGFR3
phosphatidylinositol biosynthetic process (GO:0006661),3/126,0.12956899770134903,0.2010832150076849,0,0,2.461413383364603,5.030000985710454,SOCS3;ARF1;PIK3R1
activation of cysteine-type endopeptidase activity (GO:0097202),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,FADD
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TAP1
antiviral innate immune response (GO:0140374),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,CXCL10
atrial septum development (GO:0003283),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ANK2
atrioventricular valve development (GO:0003171),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TGFBR2
regulation of cAMP-dependent protein kinase activity (GO:2000479),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,PRKAR2B
carbohydrate transport (GO:0008643),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,AQP1
cardiac left ventricle morphogenesis (GO:0003214),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TGFBR2
cell junction maintenance (GO:0034331),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,PRTN3
cellular copper ion homeostasis (GO:0006878),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ARF1
regulation of fatty acid beta-oxidation (GO:0031998),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,IRS2
regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TIMP1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,MUC1
regulation of IRE1-mediated unfolded protein response (GO:1903894),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,AGR2
regulation of lipase activity (GO:0060191),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,LPL
cytoplasmic sequestering of transcription factor (GO:0042994),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,PKD2
endothelial cell differentiation (GO:0045446),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,KDR
regulation of retinoic acid receptor signaling pathway (GO:0048385),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,CALR
regulation of vasculogenesis (GO:2001212),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,KDR
response to X-ray (GO:0010165),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ANXA1
immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,KIT
secondary palate development (GO:0062009),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TGFBR2
steroid catabolic process (GO:0006706),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,SPP1
substrate-dependent cell migration (GO:0006929),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,NRP1
T cell differentiation in thymus (GO:0033077),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,FADD
thymus development (GO:0048538),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,FADD
microvillus organization (GO:0032528),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,EZR
myeloid dendritic cell activation (GO:0001773),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TGFBR2
negative regulation of cartilage development (GO:0061037),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,EFEMP1
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,PPARG
negative regulation of T cell differentiation (GO:0045581),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,MDK
negative regulation of viral transcription (GO:0032897),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ZFP36
nuclear membrane disassembly (GO:0051081),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,PLK1
ovarian follicle development (GO:0001541),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,KIT
peptidyl-serine dephosphorylation (GO:0070262),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,DUSP1
polarized epithelial cell differentiation (GO:0030859),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,EZR
positive regulation of alpha-beta T cell differentiation (GO:0046638),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,TGFBR2
positive regulation of cardiac muscle cell proliferation (GO:0060045),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,MEF2C
positive regulation of cellular response to insulin stimulus (GO:1900078),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,SORBS1
positive regulation of glucose metabolic process (GO:0010907),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,IRS2
positive regulation of macrophage chemotaxis (GO:0010759),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,MDK
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ANK2
positive regulation of regulatory T cell differentiation (GO:0045591),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,BCL6
positive regulation of sodium ion transmembrane transporter activity (GO:2000651),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,DMD
positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,ANXA1
positive regulation of transmembrane transport (GO:0034764),1/14,0.13006409184275305,0.2010832150076849,0,0,7.727059742288168,15.761099618273683,C3
protein secretion (GO:0009306),2/64,0.13226176364444261,0.20422155641992248,0,0,3.248847926267281,6.572329238772686,ABCA1;ANXA1
diterpenoid metabolic process (GO:0016101),2/64,0.13226176364444261,0.20422155641992248,0,0,3.248847926267281,6.572329238772686,LRP1;LPL
BMP signaling pathway (GO:0030509),2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,BMPR1B;RUNX2
cellular response to type I interferon (GO:0071357),2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,EGR1;STAT1
chemical homeostasis (GO:0048878),2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,IRS2;PPARG
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,ANXA1;CCL2
type I interferon signaling pathway (GO:0060337),2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,EGR1;STAT1
mitotic G1 DNA damage checkpoint signaling (GO:0031571),2/65,0.13561426276275013,0.2081947176131951,0,0,3.197116942014901,6.387650145486205,MUC1;CCND1
regulation of primary metabolic process (GO:0080090),3/130,0.1385471814751852,0.2081947176131951,0,0,2.383403997577226,4.710903707313486,SREBF1;IRS2;PPARG
G2/M transition of mitotic cell cycle (GO:0000086),3/130,0.1385471814751852,0.2081947176131951,0,0,2.383403997577226,4.710903707313486,PRKAR2B;PLK1;CDC25B
positive regulation of canonical Wnt signaling pathway (GO:0090263),3/130,0.1385471814751852,0.2081947176131951,0,0,2.383403997577226,4.710903707313486,ZEB2;CAV1;EGFR
acute-phase response (GO:0006953),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,SAA1
regulation of amyloid fibril formation (GO:1905906),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CRYAB
regulation of endothelial cell chemotaxis (GO:2001026),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,MET
regulation of establishment of protein localization (GO:0070201),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CTSD
cellular response to exogenous dsRNA (GO:0071360),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CAV1
regulation of extracellular matrix disassembly (GO:0010715),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,LRP1
regulation of extracellular matrix organization (GO:1903053),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,LRP1
regulation of lymphocyte activation (GO:0051249),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,LEP
contractile actin filament bundle assembly (GO:0030038),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,SORBS1
regulation of macrophage differentiation (GO:0045649),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,FADD
detection of mechanical stimulus involved in sensory perception (GO:0050974),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,KIT
regulation of neuron projection arborization (GO:0150011),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,FZD4
"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,ZFP36
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,ZFP36
embryonic cranial skeleton morphogenesis (GO:0048701),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,TGFBR2
establishment of apical/basal cell polarity (GO:0035089),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,EZR
regulation of secretion (GO:0051046),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,SGK1
fibrinolysis (GO:0042730),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,PLAU
regulation of T cell chemotaxis (GO:0010819),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CXCL10
GTP metabolic process (GO:0046039),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,RHOQ
histone H3 deacetylation (GO:0070932),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,PER1
integrated stress response signaling (GO:0140467),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CCL2
interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,STAT1
intracellular cholesterol transport (GO:0032367),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,ABCA1
stress fiber assembly (GO:0043149),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,SORBS1
microvillus assembly (GO:0030033),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,EZR
myoblast fusion (GO:0007520),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,ADAM12
negative regulation of chondrocyte differentiation (GO:0032331),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,EFEMP1
positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,SH3D19
"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,ZFP36
positive regulation of protein export from nucleus (GO:0046827),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,TCF7L2
positive regulation of secretion (GO:0051047),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,AQP1
positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,KLF4
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CCT3
protein kinase A signaling (GO:0010737),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,EZR
protein localization to cell-cell junction (GO:0150105),1/15,0.13868247719449792,0.2081947176131951,0,0,7.174764321972444,14.174236923314213,CDH5
cell-cell junction assembly (GO:0007043),2/66,0.13898566811264107,0.20852131968840482,0,0,3.147002551020408,6.210245924321761,CDH5;PARD6B
cell cycle G2/M phase transition (GO:0044839),3/131,0.1408242591687122,0.2110197360466549,0,0,2.3646634615384614,4.635313945246757,PRKAR2B;PLK1;CDC25B
cellular response to hypoxia (GO:0071456),3/131,0.1408242591687122,0.2110197360466549,0,0,2.3646634615384614,4.635313945246757,EPAS1;ELOB;AQP1
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),2/67,0.1423752821610712,0.21308163003208871,0,0,3.098430141287284,6.039735405617296,AGR2;EGFR
regulation of gene silencing by miRNA (GO:0060964),2/67,0.1423752821610712,0.21308163003208871,0,0,3.098430141287284,6.039735405617296,ZFP36;PPARG
defense response to virus (GO:0051607),3/133,0.14541604046523057,0.21594622656560689,0,0,2.3280473372781065,4.48883937380504,CXCL10;STAT1;FADD
regulation of myeloid cell differentiation (GO:0045637),2/68,0.1457824192048369,0.21594622656560689,0,0,3.0513296227581943,5.875762522036254,MEF2C;ZBTB16
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),2/68,0.1457824192048369,0.21594622656560689,0,0,3.0513296227581943,5.875762522036254,CAV1;TGFBR2
3'-UTR-mediated mRNA destabilization (GO:0061158),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,ZFP36
regulation of amyloid-beta clearance (GO:1900221),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,LRP1
regulation of ERBB signaling pathway (GO:1901184),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,EGFR
regulation of hormone secretion (GO:0046883),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,ANXA1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CXCL12
dendritic cell chemotaxis (GO:0002407),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CXCR4
regulation of mitotic sister chromatid separation (GO:0010965),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,PLK1
digestive tract morphogenesis (GO:0048546),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,AGR2
regulation of neurotransmitter transport (GO:0051588),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,MEF2C
filopodium assembly (GO:0046847),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,EZR
response to organophosphorus (GO:0046683),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,STAT1
retrograde axonal transport (GO:0008090),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,DST
sympathetic nervous system development (GO:0048485),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,NRP1
mesenchyme development (GO:0060485),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,PKD2
necroptotic process (GO:0070266),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,TLR4
negative regulation of anoikis (GO:2000811),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CAV1
negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CAV1
negative regulation of release of cytochrome c from mitochondria (GO:0090201),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,HGF
neural tube development (GO:0021915),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,PKD2
neuron projection organization (GO:0106027),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,ARF1
oligodendrocyte development (GO:0014003),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,SOX10
oogenesis (GO:0048477),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,MDK
platelet-derived growth factor receptor signaling pathway (GO:0048008),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,NRP1
positive regulation by host of viral transcription (GO:0043923),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,JUN
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,TGFBR2
positive regulation of collagen biosynthetic process (GO:0032967),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,VIM
positive regulation of endothelial cell apoptotic process (GO:2000353),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CCL2
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,MDK
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,KIT
positive regulation of vasoconstriction (GO:0045907),1/16,0.1472159080488326,0.21594622656560689,0,0,6.696108291032149,12.82877260042208,CAV1
cellular response to calcium ion (GO:0071277),2/69,0.14920640519815692,0.2183399018374472,0,0,3.0056350898568382,5.717994319469603,MEF2C;PKD2
cellular response to decreased oxygen levels (GO:0036294),2/69,0.14920640519815692,0.2183399018374472,0,0,3.0056350898568382,5.717994319469603,EPAS1;AQP1
positive regulation of MAP kinase activity (GO:0043406),2/69,0.14920640519815692,0.2183399018374472,0,0,3.0056350898568382,5.717994319469603,KIT;EGFR
positive regulation of protein polymerization (GO:0032273),2/69,0.14920640519815692,0.2183399018374472,0,0,3.0056350898568382,5.717994319469603,CCL11;MET
protein localization to plasma membrane (GO:0072659),3/136,0.1523947530501871,0.22273782933805858,0,0,2.275187969924812,4.280268047423883,ANK2;EZR;SPTBN1
organic substance transport (GO:0071702),3/136,0.1523947530501871,0.22273782933805858,0,0,2.275187969924812,4.280268047423883,ABCA1;TAP1;TXNIP
kidney development (GO:0001822),2/70,0.15264657758572944,0.22283837914943116,0,0,2.961284513805522,5.566119151638943,MME;ZBTB16
negative regulation of viral process (GO:0048525),2/70,0.15264657758572944,0.22283837914943116,0,0,2.961284513805522,5.566119151638943,ZFP36;STAT1
activation of protein kinase A activity (GO:0034199),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,PRKAR2B
pyrimidine-containing compound catabolic process (GO:0072529),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,DPYSL2
amyloid-beta metabolic process (GO:0050435),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,MME
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ARF1
regulation of cell killing (GO:0031341),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,CFH
regulation of cholesterol biosynthetic process (GO:0045540),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,SREBF1
regulation of establishment of endothelial barrier (GO:1903140),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,CDH5
cellular response to fatty acid (GO:0071398),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,LPL
regulation of leukocyte migration (GO:0002685),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ANXA1
copper ion homeostasis (GO:0055070),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ARF1
regulation of metal ion transport (GO:0010959),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ANK2
epithelial cell morphogenesis (GO:0003382),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,MET
regulation of stem cell proliferation (GO:0072091),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,YAP1
regulation of steroid biosynthetic process (GO:0050810),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,EGR1
gliogenesis (GO:0042063),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ANXA1
response to purine-containing compound (GO:0014074),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,STAT1
reverse cholesterol transport (GO:0043691),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ABCA1
synaptic vesicle membrane organization (GO:0048499),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,SNAP25
membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,ANK2
mesonephric tubule development (GO:0072164),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,PKD2
vasculature development (GO:0001944),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,CDH5
muscle tissue morphogenesis (GO:0060415),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,MYLK
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,MUC1
negative regulation of viral entry into host cell (GO:0046597),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,GSN
positive regulation of cardiac muscle tissue growth (GO:0055023),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,MEF2C
positive regulation of collagen metabolic process (GO:0010714),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,VIM
positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,TLR4
positive regulation of DNA replication (GO:0045740),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,EGFR
positive regulation of macrophage activation (GO:0043032),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,TLR4
protein heterooligomerization (GO:0051291),1/17,0.15566521760209712,0.22323015598416165,0,0,6.277284263959391,11.676047647649668,PKD2
regulation of endopeptidase activity (GO:0052548),2/71,0.1561022852070619,0.223330825193417,0,0,2.9182194616977224,5.419845037847333,SERPING1;TIMP1
cellular response to BMP stimulus (GO:0071773),2/71,0.1561022852070619,0.223330825193417,0,0,2.9182194616977224,5.419845037847333,BMPR1B;RUNX2
regulation of hematopoietic stem cell differentiation (GO:1902036),2/71,0.1561022852070619,0.223330825193417,0,0,2.9182194616977224,5.419845037847333,YAP1;LMO2
positive regulation of cellular protein localization (GO:1903829),2/71,0.1561022852070619,0.223330825193417,0,0,2.9182194616977224,5.419845037847333,YAP1;PLK1
cytoskeleton-dependent cytokinesis (GO:0061640),2/72,0.1595728880321379,0.22816205658147726,0,0,2.8763848396501457,5.2788981714619965,PLK1;SPTBN1
neuron projection morphogenesis (GO:0048812),3/140,0.16186119657228895,0.23007836822906155,0,0,2.2083099382369453,4.021368000574755,PARD6B;MAP1B;SGK1
defense response to Gram-negative bacterium (GO:0050829),2/73,0.16305775708765646,0.23007836822906155,0,0,2.835728657660247,5.143021556990856,TLR4;AQP1
positive regulation of GTPase activity (GO:0043547),4/214,0.16312822706010444,0.23007836822906155,0,0,1.9236131566028474,3.487931382429924,CCL11;CAV2;CCL2;PRTN3
regulation of adaptive immune response (GO:0002819),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,FADD
regulation of B cell differentiation (GO:0045577),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,MMP14
regulation of brown fat cell differentiation (GO:0090335),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,LEP
regulation of cellular protein catabolic process (GO:1903362),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,EZR
regulation of early endosome to late endosome transport (GO:2000641),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,EZR
regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CDH5
cellular response to dsRNA (GO:0071359),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CAV1
regulation of membrane depolarization (GO:0003254),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,FHL1
embryonic digit morphogenesis (GO:0042733),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,MAP3K20
regulation of protein sumoylation (GO:0033233),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,EGR1
fluid transport (GO:0042044),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,AQP1
regulation of telomerase RNA localization to Cajal body (GO:1904872),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CCT3
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,ANK2
intermediate filament organization (GO:0045109),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,VIM
intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,ESR1
maintenance of gastrointestinal epithelium (GO:0030277),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,TLR4
ventricular cardiac muscle cell action potential (GO:0086005),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,ANK2
water transport (GO:0006833),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,AQP1
negative regulation of cation transmembrane transport (GO:1904063),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CAV1
negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,MET
neuron maturation (GO:0042551),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,C3
nitric oxide mediated signal transduction (GO:0007263),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CD36
positive regulation of amyloid-beta formation (GO:1902004),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,EFNA1
positive regulation of cell adhesion mediated by integrin (GO:0033630),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CIB1
positive regulation of fatty acid metabolic process (GO:0045923),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,PPARG
positive regulation of myoblast differentiation (GO:0045663),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,MEF2C
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,PPP1R15A
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,PIK3R1
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,CCL2
programmed necrotic cell death (GO:0097300),1/18,0.16403123090170466,0.23007836822906155,0,0,5.907733651836369,10.679400888402991,TLR4
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",2/74,0.16655627424084804,0.23322824952000606,0,0,2.796201814058957,5.011973768857596,MUC1;BCL3
mitotic nuclear division (GO:0140014),2/74,0.16655627424084804,0.23322824952000606,0,0,2.796201814058957,5.011973768857596,EPS8;PLK1
Ras protein signal transduction (GO:0007265),3/142,0.1666600222442754,0.23322824952000606,0,0,2.1763143331488655,3.8995185782758317,EPS8;JUN;COL1A2
protein localization to organelle (GO:0033365),3/142,0.1666600222442754,0.23322824952000606,0,0,2.1763143331488655,3.8995185782758317,PPP1R15A;ANK2;CALR
monocarboxylic acid metabolic process (GO:0032787),3/143,0.16907513777178257,0.234668038387633,0,0,2.1606593406593406,3.8403819710773486,LPL;PPARG;CD36
regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/75,0.17006783218574845,0.234668038387633,0,0,2.7577578976796198,4.885527813801126,YAP1;LMO2
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),2/75,0.17006783218574845,0.234668038387633,0,0,2.7577578976796198,4.885527813801126,EPAS1;ELOB
negative regulation of cell migration (GO:0030336),3/144,0.17150045691314347,0.234668038387633,0,0,2.145226404800873,3.78239744181505,LRP1;CALR;TIMP1
Rac protein signal transduction (GO:0016601),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,EPS8
regulation of autophagy of mitochondrion (GO:1903146),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,SREBF1
branching involved in ureteric bud morphogenesis (GO:0001658),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PKD2
cardiac muscle cell contraction (GO:0086003),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,GSN
regulation of collagen biosynthetic process (GO:0032965),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,VIM
regulation of epithelial cell differentiation (GO:0030856),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,CAV1
cellular response to copper ion (GO:0071280),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,AQP1
cellular response to glucagon stimulus (GO:0071377),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PRKAR2B
regulation of glucose transmembrane transport (GO:0010827),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,C3
regulation of leukocyte chemotaxis (GO:0002688),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MDK
regulation of lymphocyte proliferation (GO:0050670),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,LEP
regulation of mitotic spindle assembly (GO:1901673),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PLK1
detection of mechanical stimulus (GO:0050982),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PKD2
DNA alkylation (GO:0006305),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,FOS
DNA methylation or demethylation (GO:0044728),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,FOS
endocardial cushion morphogenesis (GO:0003203),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,TGFBR2
establishment of skin barrier (GO:0061436),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MET
ethanol metabolic process (GO:0006067),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,ALDH2
excitatory postsynaptic potential (GO:0060079),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MEF2C
fatty acid transmembrane transport (GO:1902001),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,CD36
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,DCN
regulation of water loss via skin (GO:0033561),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MET
response to cholesterol (GO:0070723),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,TGFBR2
heart trabecula morphogenesis (GO:0061384),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,S1PR1
long-term memory (GO:0007616),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,SGK1
striated muscle cell differentiation (GO:0051146),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MEF2C
maintenance of protein localization in organelle (GO:0072595),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,BCL3
ureteric bud development (GO:0001657),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PKD2
ureteric bud morphogenesis (GO:0060675),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PKD2
negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,SIRPA
negative regulation of immune system process (GO:0002683),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,FADD
negative regulation of nervous system development (GO:0051961),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,CCL11
negative regulation of RNA metabolic process (GO:0051253),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,ESR1
negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,EZR
neural crest cell differentiation (GO:0014033),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MEF2C
nuclear membrane organization (GO:0071763),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,PLK1
positive regulation of actin cytoskeleton reorganization (GO:2000251),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,NRP1
positive regulation of cellular protein catabolic process (GO:1903364),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,EZR
positive regulation of establishment of protein localization (GO:1904951),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,CCT3
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,C3
positive regulation of leukocyte activation (GO:0002696),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,TLR4
positive regulation of macrophage migration (GO:1905523),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MDK
positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,MDK
positive regulation of triglyceride metabolic process (GO:0090208),1/19,0.17231476494336256,0.234668038387633,0,0,5.579244218838127,9.810724057952932,SREBF1
regulation of RNA splicing (GO:0043484),2/76,0.17359183405203202,0.2360112316676147,0,0,2.720353006067292,4.763470096264379,PIK3R1;QKI
regulation of T cell proliferation (GO:0042129),2/76,0.17359183405203202,0.2360112316676147,0,0,2.720353006067292,4.763470096264379,ANXA1;LEP
RNA transport (GO:0050658),2/76,0.17359183405203202,0.2360112316676147,0,0,2.720353006067292,4.763470096264379,ZFP36;TGFBR2
regulation of mRNA stability (GO:0043488),3/146,0.17638091466856445,0.23966937902787636,0,0,2.1150080688542228,3.669770243344017,ZFP36;MAPKAPK2;VIM
regulation of organelle assembly (GO:1902115),2/77,0.1771276934917909,0.24041579356327247,0,0,2.6839455782312927,4.64559946298882,GSN;EZR
positive regulation of type I interferon production (GO:0032481),2/77,0.1771276934917909,0.24041579356327247,0,0,2.6839455782312927,4.64559946298882,STAT1;TLR4
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,TLR4
cellular response to interferon-beta (GO:0035458),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,STAT1
regulation of granulocyte chemotaxis (GO:0071622),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,MDK
cortical actin cytoskeleton organization (GO:0030866),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,RHOQ
regulation of nuclear division (GO:0051783),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,CAV2
establishment of epithelial cell polarity (GO:0090162),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,EZR
regulation of smooth muscle contraction (GO:0006940),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,CAV1
eye morphogenesis (GO:0048592),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,EFEMP1
insulin secretion (GO:0030073),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,ANXA1
toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,TLR4
mesoderm development (GO:0007498),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,MEST
modulation by symbiont of entry into host (GO:0052372),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,CAV1
myeloid cell development (GO:0061515),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,KIT
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,PLK1
negative regulation of dephosphorylation (GO:0035305),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,PPP1R15A
negative regulation of osteoclast differentiation (GO:0045671),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,TLR4
negative regulation of viral life cycle (GO:1903901),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,GSN
oligodendrocyte differentiation (GO:0048709),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,SOX10
positive regulation of activated T cell proliferation (GO:0042104),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,FADD
positive regulation of heart contraction (GO:0045823),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,RGS2
positive regulation of hormone secretion (GO:0046887),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,SPP1
positive regulation of nitrogen compound metabolic process (GO:0051173),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,KLF4
positive regulation of protein processing (GO:0010954),1/20,0.18051662874040858,0.2419141392310924,0,0,5.285332620892333,9.048132049958218,GSN
negative regulation of apoptotic signaling pathway (GO:2001234),2/78,0.18067483439031992,0.24199297125436137,0,0,2.648496240601504,4.531726332759098,TCF7L2;HGF
innate immune response (GO:0045087),5/302,0.1808704103503033,0.24212174227761876,0,0,1.7013834371347325,2.9093222395769134,C3;CXCL10;SAA1;PPARG;TLR4
positive regulation of intracellular protein transport (GO:0090316),3/148,0.18129981822856048,0.24256321834425534,0,0,2.0856233421750665,3.561417017639496,TCF7L2;CIB1;PIK3R1
axon development (GO:0061564),2/79,0.18423269079888285,0.24608151513729004,0,0,2.613967664988073,4.421671893993019,PARD6B;MAP1B
regulation of ion transport (GO:0043269),2/79,0.18423269079888285,0.24608151513729004,0,0,2.613967664988073,4.421671893993019,PER1;TF
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),2/79,0.18423269079888285,0.24608151513729004,0,0,2.613967664988073,4.421671893993019,PLK1;ELOB
lipid biosynthetic process (GO:0008610),2/80,0.18780070677341396,0.2480197695152502,0,0,2.5803244374672945,4.315267368616446,SREBF1;LPL
negative regulation of cellular response to growth factor stimulus (GO:0090288),2/80,0.18780070677341396,0.2480197695152502,0,0,2.5803244374672945,4.315267368616446,PPARG;BMPR1B
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/80,0.18780070677341396,0.2480197695152502,0,0,2.5803244374672945,4.315267368616446,TCF7L2;FADD
androgen metabolic process (GO:0008209),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,SPP1
regulation of anoikis (GO:2000209),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,CAV1
beta-catenin destruction complex disassembly (GO:1904886),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,CAV1
regulation of cardiac muscle cell proliferation (GO:0060043),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,MEF2C
calcium-mediated signaling using intracellular calcium source (GO:0035584),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,KDR
regulation of cholesterol metabolic process (GO:0090181),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,SREBF1
regulation of dendritic spine development (GO:0060998),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,MEF2C
cellular response to steroid hormone stimulus (GO:0071383),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,NR3C1
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,CD36
regulation of lipoprotein lipase activity (GO:0051004),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,LPL
epithelial cell development (GO:0002064),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,ACTA2
focal adhesion assembly (GO:0048041),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,SORBS1
regulation of ubiquitin protein ligase activity (GO:1904666),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,PLK1
response to glucagon (GO:0033762),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,PRKAR2B
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,BCL3
spindle assembly checkpoint signaling (GO:0071173),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,PLK1
mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,PLK1
mitotic spindle checkpoint signaling (GO:0071174),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,PLK1
negative regulation of microtubule depolymerization (GO:0007026),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,CIB1
negative regulation of protein localization to cell periphery (GO:1904376),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,RHOQ
negative regulation of protein localization to plasma membrane (GO:1903077),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,RHOQ
negative regulation of response to wounding (GO:1903035),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,MDK
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,ZFP36
positive regulation of immune system process (GO:0002684),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,ANXA1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,RUNX2
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.1886376234670404,0.2480197695152502,0,0,5.020812182741117,8.374350413278753,JUN
dephosphorylation (GO:0016311),3/153,0.19375501680445675,0.25447328258837765,0,0,2.0155897435897434,3.307906710580835,PTPRB;PPP2R1B;DUSP1
positive regulation of Wnt signaling pathway (GO:0030177),3/153,0.19375501680445675,0.25447328258837765,0,0,2.0155897435897434,3.307906710580835,ZEB2;CAV1;EGFR
ephrin receptor signaling pathway (GO:0048013),2/82,0.19496504257308805,0.2554198671433834,0,0,2.515561224489796,4.112779104006726,EFNA1;ITSN1
positive regulation of cytoskeleton organization (GO:0051495),2/82,0.19496504257308805,0.2554198671433834,0,0,2.515561224489796,4.112779104006726,NRP1;CCL11
positive regulation of protein ubiquitination (GO:0031398),2/82,0.19496504257308805,0.2554198671433834,0,0,2.515561224489796,4.112779104006726,CAV1;PLK1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,ANK2
cellular response to nerve growth factor stimulus (GO:1990090),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,CIB1
regulation of macrophage chemotaxis (GO:0010758),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,MDK
regulation of platelet activation (GO:0010543),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,TLR4
female gonad development (GO:0008585),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,KIT
regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,DMD
limb morphogenesis (GO:0035108),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,BMPR1B
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,PLK1
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,PLK1
negative regulation of protein dephosphorylation (GO:0035308),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,PPP1R15A
peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,DUSP1
positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,EFNA1
positive regulation of axon extension (GO:0045773),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,NRP1
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,JUN
positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,MDK
positive regulation of lipid catabolic process (GO:0050996),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,IRS2
positive regulation of neural precursor cell proliferation (GO:2000179),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,MDK
positive regulation of neutrophil migration (GO:1902624),1/22,0.19667854246153751,0.2554198671433834,0,0,4.781484167270969,7.77557614353097,MDK
regulation of defense response (GO:0031347),2/83,0.1985602991999591,0.25758888042189687,0,0,2.484378936759889,4.016402140314714,ANXA1;BCL6
peptide metabolic process (GO:0006518),2/83,0.1985602991999591,0.25758888042189687,0,0,2.484378936759889,4.016402140314714,MME;DMD
regulation of cytokinesis (GO:0032465),2/84,0.2021635886549317,0.26198421414303286,0,0,2.4539571926331507,3.923087535089334,PLK1;CDC25B
vascular transport (GO:0010232),2/84,0.2021635886549317,0.26198421414303286,0,0,2.4539571926331507,3.923087535089334,LRP1;LEPR
regulation of calcium ion transmembrane transport (GO:1903169),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,ANK2
regulation of mononuclear cell migration (GO:0071675),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,MDK
regulation of neural precursor cell proliferation (GO:2000177),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,MDK
DNA methylation (GO:0006306),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,FOS
regulation of peptidase activity (GO:0052547),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,CAV1
regulation of protein export from nucleus (GO:0046825),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,TCF7L2
ERK1 and ERK2 cascade (GO:0070371),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,KDR
regulation of supramolecular fiber organization (GO:1902903),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,MAP1B
response to copper ion (GO:0046688),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,AQP1
membrane protein ectodomain proteolysis (GO:0006509),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,PRTN3
negative regulation of phosphoprotein phosphatase activity (GO:0032515),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,PPP1R15A
positive regulation of histone acetylation (GO:0035066),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,MUC1
positive regulation of morphogenesis of an epithelium (GO:1905332),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,MDK
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/23,0.20464017128814416,0.2632323386617174,0,0,4.56391324411629,7.240657964857908,ESR1
regulation of cell cycle G2/M phase transition (GO:1902749),2/85,0.20577440286180937,0.2645515686211752,0,0,2.4242685025817554,3.832707512898453,PRKAR2B;PLK1
regulation of Ras protein signal transduction (GO:0046578),2/86,0.20939224289493977,0.26891883515252024,0,0,2.3952866861030127,3.745140978393362,EPS8;IRS2
positive regulation of proteasomal protein catabolic process (GO:1901800),2/86,0.20939224289493977,0.26891883515252024,0,0,2.3952866861030127,3.745140978393362,PLK1;ELOB
regulation of axon extension involved in axon guidance (GO:0048841),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,NRP1
regulation of cardiac muscle hypertrophy (GO:0010611),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,RGS2
regulation of cell size (GO:0008361),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,EZR
cardiac muscle cell development (GO:0055013),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,SORBS2
cardiac muscle cell differentiation (GO:0055007),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,MEF2C
cellular response to catecholamine stimulus (GO:0071870),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,GNG2
cholesterol efflux (GO:0033344),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,ABCA1
defense response to fungus (GO:0050832),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,S100A8
dorsal/ventral pattern formation (GO:0009953),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,BMPR1B
endocrine system development (GO:0035270),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,MDK
establishment of mitotic spindle orientation (GO:0000132),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,PLK1
leukotriene metabolic process (GO:0006691),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,MAPKAPK2
lipid translocation (GO:0034204),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,ABCA1
lymphocyte activation involved in immune response (GO:0002285),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,MDK
mammary gland development (GO:0030879),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,CAV1
negative regulation of protein depolymerization (GO:1901880),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,CIB1
negative regulation of protein tyrosine kinase activity (GO:0061099),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,CAV1
negative regulation of synaptic transmission (GO:0050805),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,ARF1
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,ZEB2
positive regulation of lamellipodium assembly (GO:0010592),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,PIK3R1
positive regulation of p38MAPK cascade (GO:1900745),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,LEP
positive regulation of protein targeting to membrane (GO:0090314),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,CIB1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,MUC1
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/24,0.21252328787467278,0.2695282322785564,0,0,4.365261531670713,6.760496714480504,ZEB2
metal ion transport (GO:0030001),2/88,0.2166470500581033,0.2744721992151309,0,0,2.339345040341718,3.5779948966412287,CAV1;PKD2
negative regulation of binding (GO:0051100),2/88,0.2166470500581033,0.2744721992151309,0,0,2.339345040341718,3.5779948966412287,JUN;CAV1
post-Golgi vesicle-mediated transport (GO:0006892),2/89,0.22028306409152282,0.2761195539532633,0,0,2.312338728594886,3.4982029264778536,ARF1;SH3D19
acylglycerol homeostasis (GO:0055090),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,LPL
regulation of AMPA receptor activity (GO:2000311),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,MEF2C
regulation of cAMP-mediated signaling (GO:0043949),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,PRKAR2B
regulation of cholesterol transport (GO:0032374),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,LRP1
regulation of epidermal cell differentiation (GO:0045604),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,ZFP36
regulation of heterotypic cell-cell adhesion (GO:0034114),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,KLF4
"chemical synaptic transmission, postsynaptic (GO:0099565)",1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,MEF2C
regulation of myotube differentiation (GO:0010830),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,MMP14
divalent inorganic cation homeostasis (GO:0072507),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,CAV1
regulation of neutrophil chemotaxis (GO:0090022),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,MDK
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,EFNA1
regulation of spindle assembly (GO:0090169),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,PLK1
negative regulation of actin filament polymerization (GO:0030837),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,GSN
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,EZR
negative regulation of endocytosis (GO:0045806),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,CAV1
negative regulation of sequestering of calcium ion (GO:0051283),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,PKD2
peripheral nervous system development (GO:0007422),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,SOX10
positive regulation of ERBB signaling pathway (GO:1901186),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,AGR2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,PLK1
positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,0.2203286625590105,0.2761195539532633,0,0,4.1831641285956005,6.327600165017342,C3
heart development (GO:0007507),3/164,0.2218494278284681,0.2778823851658024,0,0,1.8768275203057811,2.8260450133337525,MEF2C;PKD2;TGFBR2
anterograde trans-synaptic signaling (GO:0098916),4/244,0.22315659246390288,0.2793759910794877,0,0,1.6805841924398626,2.520677216061983,RPS6KA3;SNAP25;PRKAR2B;SNCG
sodium ion transport (GO:0006814),2/90,0.22392419754529538,0.2800490092566997,0,0,2.285946196660482,3.4207989013747016,PKD2;SGK1
negative regulation of protein kinase activity (GO:0006469),2/90,0.22392419754529538,0.2800490092566997,0,0,2.285946196660482,3.4207989013747016,PTPRB;CAV1
regulation of neuron projection development (GO:0010975),3/165,0.2244443306225126,0.28055541327814076,0,0,1.865147198480532,2.786767857047943,MDK;CIB1;FKBP4
regulation of stem cell differentiation (GO:2000736),2/91,0.22756999547526713,0.2826050567965207,0,0,2.260146755331346,3.345689400553753,YAP1;LMO2
positive regulation of supramolecular fiber organization (GO:1902905),2/91,0.22756999547526713,0.2826050567965207,0,0,2.260146755331346,3.345689400553753,CCL11;MET
cellular protein localization (GO:0034613),5/329,0.22781620028549032,0.2826050567965207,0,0,1.55744258939423,2.303794175222033,ARF1;ITSN1;ANK2;DMD;EGFR
proteoglycan metabolic process (GO:0006029),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,BMPR1B
regulation of biomineral tissue development (GO:0070167),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,S1PR1
cellular response to drug (GO:0035690),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,MEF2C
clathrin-dependent endocytosis (GO:0072583),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,ITSN1
DNA geometric change (GO:0032392),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,ANXA1
regulation of synapse organization (GO:0050807),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,MEF2C
metanephros development (GO:0001656),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,PKD2
mononuclear cell differentiation (GO:1903131),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,PPARG
negative regulation of cell development (GO:0010721),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,CCL11
negative regulation of protein localization to membrane (GO:1905476),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,RHOQ
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,EFNA1
negative regulation of signaling receptor activity (GO:2000272),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,PPARG
positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,MET
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/26,0.22805705815407112,0.2826050567965207,0,0,4.015634517766498,5.935748014910027,FADD
retinoid metabolic process (GO:0001523),2/92,0.23122001139185985,0.28623321186536793,0,0,2.234920634920635,3.2727855758488826,LRP1;LPL
Wnt signaling pathway (GO:0016055),2/92,0.23122001139185985,0.28623321186536793,0,0,2.234920634920635,3.2727855758488826,TCF7L2;FZD4
visual perception (GO:0007601),2/93,0.23487380705231975,0.28783950606491226,0,0,2.210248934738731,3.2020028832166227,ABLIM1;EFEMP1
positive regulation of peptidyl-serine phosphorylation (GO:0033138),2/93,0.23487380705231975,0.28783950606491226,0,0,2.210248934738731,3.2020028832166227,CAV1;EGFR
protein peptidyl-prolyl isomerization (GO:0000413),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,FKBP4
acute inflammatory response (GO:0002526),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,SAA1
regulation of blood coagulation (GO:0030193),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CAV1
regulation of cell junction assembly (GO:1901888),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,MEF2C
camera-type eye development (GO:0043010),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,EFEMP1
cellular senescence (GO:0090398),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CALR
dendritic spine organization (GO:0097061),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,ARF1
entrainment of circadian clock by photoperiod (GO:0043153),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,PER1
regulation of toll-like receptor signaling pathway (GO:0034121),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CD36
regulation of vascular endothelial growth factor production (GO:0010574),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,C3
regulation of vasculature development (GO:1901342),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,LEP
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,PKD2
stress-activated protein kinase signaling cascade (GO:0031098),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,MAP3K20
mitotic chromosome condensation (GO:0007076),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,PLK1
negative regulation of catalytic activity (GO:0043086),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,TIMP1
negative regulation of cation channel activity (GO:2001258),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,PKD2
negative regulation of insulin receptor signaling pathway (GO:0046627),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,TNS2
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,YAP1
negative regulation of protein polymerization (GO:0032272),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CDH5
peptide hormone secretion (GO:0030072),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,ANXA1
positive regulation of mitotic cell cycle (GO:0045931),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CDC25B
positive regulation of muscle cell differentiation (GO:0051149),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,MEF2C
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CAV1
presynaptic endocytosis (GO:0140238),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,SNCG
protein export from nucleus (GO:0006611),1/27,0.23570923001783783,0.28783950606491226,0,0,3.8609918000780943,5.579736661899487,CALR
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/170,0.23750549278293537,0.28988765660473564,0,0,1.8088438507600184,2.6003297570279034,CDH5;PECAM1;TGFBR2
negative regulation of cellular protein metabolic process (GO:0032269),2/94,0.2385309524036545,0.29099342139423784,0,0,2.1861135758651287,3.1332608312751975,DNAJC1;CALR
ciliary basal body-plasma membrane docking (GO:0097711),2/95,0.24219102545322174,0.2937041299699026,0,0,2.162497256967303,3.0664827476720657,PRKAR2B;PLK1
sensory perception of light stimulus (GO:0050953),2/95,0.24219102545322174,0.2937041299699026,0,0,2.162497256967303,3.0664827476720657,ABLIM1;EFEMP1
amide transport (GO:0042886),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,TAP1
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,PPP2R1B
regulation of muscle contraction (GO:0006937),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,CAV1
regulation of neuron migration (GO:2001222),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,MDK
regulation of sodium ion transmembrane transport (GO:1902305),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,UTRN
response to interferon-beta (GO:0035456),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,STAT1
sarcomere organization (GO:0045214),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,KRT19
T cell activation involved in immune response (GO:0002286),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,MDK
ventricular septum morphogenesis (GO:0060412),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,TGFBR2
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,PKD2
negative regulation of cellular response to insulin stimulus (GO:1900077),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,TNS2
negative regulation of phosphatase activity (GO:0010923),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,PPP1R15A
photoperiodism (GO:0009648),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,PER1
positive regulation of defense response to virus by host (GO:0002230),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,STAT1
positive regulation of fibroblast proliferation (GO:0048146),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,AQP1
positive regulation of microtubule polymerization (GO:0031116),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,MET
positive regulation of protein import into nucleus (GO:0042307),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,PIK3R1
protein depolymerization (GO:0051261),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,GSN
protein localization to cell surface (GO:0034394),1/28,0.24328592613934025,0.2937041299699026,0,0,3.7178040985147582,5.255182554848429,ANK2
cellular transition metal ion homeostasis (GO:0046916),2/96,0.24585361218265625,0.2966568610826402,0,0,2.139383412939644,3.001595560816009,ARF1;TF
protein maturation (GO:0051604),2/97,0.24951830635914535,0.29949411741605647,0,0,2.1167561761546723,2.938529597067055,MMP14;MME
actin filament polymerization (GO:0030041),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,GSN
aggrephagy (GO:0035973),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,VIM
regulation of actin polymerization or depolymerization (GO:0008064),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,CXCL12
beta-catenin-TCF complex assembly (GO:1904837),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,TCF7L2
regulation of DNA biosynthetic process (GO:2000278),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,HGF
determination of bilateral symmetry (GO:0009855),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,PKD2
regulation of protein targeting to membrane (GO:0090313),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,CIB1
regulation of response to biotic stimulus (GO:0002831),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,CD36
establishment of mitotic spindle localization (GO:0040001),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,PLK1
regulation of T cell mediated cytotoxicity (GO:0001914),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,FADD
glial cell differentiation (GO:0010001),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,SOX10
regulation of ubiquitin-protein transferase activity (GO:0051438),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,PLK1
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,PPP1R15A
lipid catabolic process (GO:0016042),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,LPL
transition metal ion homeostasis (GO:0055076),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,TF
negative regulation of epithelial to mesenchymal transition (GO:0010719),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,EFNA1
negative regulation of interferon-gamma production (GO:0032689),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,TLR4
negative regulation of myeloid leukocyte differentiation (GO:0002762),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,TLR4
positive regulation of dephosphorylation (GO:0035306),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,CDH5
positive regulation of leukocyte migration (GO:0002687),1/29,0.25078788723258283,0.29949411741605647,0,0,3.584844089920232,4.958369101280273,MDK
regulation of nucleic acid-templated transcription (GO:1903506),6/430,0.2542322751887759,0.30345862259052414,0,0,1.4282134433962264,1.9559482519375138,MEF2C;EFEMP1;MAGED1;CALR;NR3C1;ESR1
organic anion transport (GO:0015711),2/99,0.25685243069014174,0.30596378920737893,0,0,2.0729013254786453,2.8175985033911357,CA12;AQP1
regulation of macrophage activation (GO:0043030),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,TLR4
regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,LEP
establishment of spindle orientation (GO:0051294),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,PLK1
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,FADD
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,FADD
regulation of vasoconstriction (GO:0019229),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,CAV1
response to alcohol (GO:0097305),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,TGFBR2
heterotypic cell-cell adhesion (GO:0034113),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,PARVA
ion homeostasis (GO:0050801),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,FHL1
synaptic vesicle cycle (GO:0099504),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,SNAP25
negative regulation of cytoskeleton organization (GO:0051494),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,FKBP4
positive regulation of endopeptidase activity (GO:0010950),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,EFNA1
positive regulation of protein import (GO:1904591),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,PIK3R1
positive regulation of small GTPase mediated signal transduction (GO:0051057),1/30,0.2582158467438044,0.30596378920737893,0,0,3.4610537370908454,4.686126340024527,IRS2
regulation of mitotic cell cycle (GO:0007346),3/178,0.2586610296826644,0.3063422214383696,0,0,1.7254505494505494,2.333217798855864,CAV2;PLK1;CDC25B
cell-matrix adhesion (GO:0007160),2/100,0.26052108658368917,0.3082453089559199,0,0,2.0516451478550604,2.75960936414797,COL17A1;SORBS1
positive regulation of translation (GO:0045727),2/100,0.26052108658368917,0.3082453089559199,0,0,2.0516451478550604,2.75960936414797,BCL3;VIM
positive regulation of cell cycle process (GO:0090068),2/101,0.264190301111838,0.312398184983201,0,0,2.030818387961245,2.7031931083070115,MAP3K20;CDC25B
proteoglycan biosynthetic process (GO:0030166),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,BMPR1B
cardiac muscle cell action potential involved in contraction (GO:0086002),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,ANK2
embryonic skeletal system morphogenesis (GO:0048704),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,TGFBR2
triglyceride homeostasis (GO:0070328),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,LPL
negative regulation of DNA binding (GO:0043392),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,JUN
negative regulation of osteoblast differentiation (GO:0045668),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,PPARG
negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,CXCL12
phospholipid translocation (GO:0045332),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,ABCA1
positive regulation of RNA splicing (GO:0033120),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,PIK3R1
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,PLK1
protein acetylation (GO:0006473),1/31,0.2655705309713454,0.312398184983201,0,0,3.3455160744500847,4.435735523700054,FOXO1
cell junction assembly (GO:0034329),2/102,0.26785970560933436,0.3146350135835645,0,0,2.010408163265306,2.6482944335340326,CDH5;PARD6B
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/102,0.26785970560933436,0.3146350135835645,0,0,2.010408163265306,2.6482944335340326,PLK1;ELOB
regulation of protein catabolic process (GO:0042176),2/102,0.26785970560933436,0.3146350135835645,0,0,2.010408163265306,2.6482944335340326,FOXO1;EGFR
activation of phospholipase C activity (GO:0007202),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,EGFR
aortic valve morphogenesis (GO:0003180),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,EFNA1
B cell proliferation (GO:0042100),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,MEF2C
regulation of cell morphogenesis (GO:0022604),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,SH3D19
regulation of chemotaxis (GO:0050920),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,CXCR4
cardiac muscle tissue morphogenesis (GO:0055008),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,S1PR1
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,EFNA1
DNA damage checkpoint signaling (GO:0000077),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,MAP3K20
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,EZR
gene silencing by miRNA (GO:0035195),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,ZFP36
membrane depolarization (GO:0051899),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,CAV1
negative regulation of developmental growth (GO:0048640),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,FGFR3
peptidyl-proline modification (GO:0018208),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,FKBP4
positive regulation of interleukin-10 production (GO:0032733),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,TLR4
positive regulation of lamellipodium organization (GO:1902745),1/32,0.27285265908571066,0.3181974257057976,0,0,3.2374324545603406,4.2048528330153285,PIK3R1
regulation of interleukin-17 production (GO:0032660),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,TLR4
regulation of neurotransmitter secretion (GO:0046928),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,MEF2C
signal transduction by p53 class mediator (GO:0072331),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,BCL3
lytic vacuole organization (GO:0080171),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,ABCA1
mitotic G2 DNA damage checkpoint signaling (GO:0007095),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,PLK1
positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,KIT
positive regulation of organelle organization (GO:0010638),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,ANXA1
positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.2800629433371513,0.32535938312307416,0,0,3.1361040609137056,3.9914479157798444,CCT3
protein processing (GO:0016485),2/106,0.2825320973506965,0.32791499382695233,0,0,1.9326923076923077,2.4428517913246384,MMP14;MME
regulation of cell cycle process (GO:0010564),2/106,0.2825320973506965,0.32791499382695233,0,0,1.9326923076923077,2.4428517913246384,CAV2;PLK1
regulation of activated T cell proliferation (GO:0046006),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,FADD
regulation of amyloid-beta formation (GO:1902003),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,EFNA1
B cell receptor signaling pathway (GO:0050853),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,MEF2C
regulation of glucose metabolic process (GO:0010906),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,IRS2
regulation of keratinocyte differentiation (GO:0045616),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,ZFP36
regulation of lamellipodium assembly (GO:0010591),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,PIK3R1
regulation of myoblast differentiation (GO:0045661),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,MEF2C
female gamete generation (GO:0007292),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,MDK
sister chromatid segregation (GO:0000819),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,PLK1
synaptic vesicle recycling (GO:0036465),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,SNCG
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,FADD
negative regulation of mitochondrion organization (GO:0010823),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,HGF
phosphatidylinositol 3-kinase signaling (GO:0014065),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,PIK3R1
positive regulation of DNA binding (GO:0043388),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,PPARG
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,AGR2
positive regulation of telomerase activity (GO:0051973),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,KLF4
protein insertion into membrane (GO:0051205),1/34,0.28720208890875654,0.3306558328571263,0,0,3.040916782033533,3.7937540211642773,EGFR
lipid transport (GO:0006869),2/109,0.29352136266913165,0.3371997100120408,0,0,1.8782185771504865,2.3023294533217498,ABCA1;CD36
regulation of mitotic spindle organization (GO:0060236),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,PLK1
regulation of muscle cell differentiation (GO:0051147),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,MEF2C
regulation of postsynaptic membrane potential (GO:0060078),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,MEF2C
regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,EZR
response to exogenous dsRNA (GO:0043330),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,CAV1
negative regulation of epithelial cell migration (GO:0010633),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,DCN
negative regulation of neurogenesis (GO:0050768),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,CCL11
negative regulation of organelle assembly (GO:1902116),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,YAP1
negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.2942707941583518,0.3371997100120408,0,0,2.9513287548521947,3.610227263492937,MET
regulation of Wnt signaling pathway (GO:0030111),2/111,0.3008355225828406,0.3413642823260924,0,0,1.843568620108594,2.214479140840955,LRP1;ESR1
aortic valve development (GO:0003176),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,EFNA1
axonal transport (GO:0098930),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,DST
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,CDH5
regulation of defense response to virus by host (GO:0050691),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,STAT1
regulation of mRNA processing (GO:0050684),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,QKI
regulation of osteoclast differentiation (GO:0045670),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TLR4
embryonic limb morphogenesis (GO:0030326),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,MAP3K20
regulation of protein import into nucleus (GO:0042306),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,PIK3R1
regulation of receptor internalization (GO:0002090),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,ARF1
establishment of protein localization to plasma membrane (GO:0061951),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,SPTBN1
regulation of sodium ion transport (GO:0002028),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,PER1
retina homeostasis (GO:0001895),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TF
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,BCL3
macrophage activation (GO:0042116),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TLR4
membrane assembly (GO:0071709),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,SPTBN1
transferrin transport (GO:0033572),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TF
transition metal ion transport (GO:0000041),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TF
negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TLR4
positive regulation of innate immune response (GO:0045089),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,FADD
positive regulation of interferon-beta production (GO:0032728),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,TLR4
positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,FADD
positive regulation of T cell mediated immunity (GO:0002711),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,FADD
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.30126975060319205,0.3413642823260924,0,0,2.8668600435097895,3.439513141639341,CCT3
regulation of macroautophagy (GO:0016241),2/112,0.30448807384619386,0.34469012543723015,0,0,1.8267161410018553,2.172190833436246,KDR;DCN
phosphatidylinositol metabolic process (GO:0046488),2/112,0.30448807384619386,0.34469012543723015,0,0,1.8267161410018553,2.172190833436246,ARF1;PIK3R1
positive regulation of cytokinesis (GO:0032467),1/37,0.30819964303812986,0.34872961468301406,0,0,2.7870840383530737,3.2804188561600878,CDC25B
connective tissue development (GO:0061448),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,ZBTB16
regulation of phosphoprotein phosphatase activity (GO:0043666),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,PPP1R15A
lymphocyte proliferation (GO:0046651),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,MEF2C
lysosome organization (GO:0007040),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,ABCA1
ventricular septum development (GO:0003281),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,TGFBR2
mRNA destabilization (GO:0061157),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,ZFP36
positive regulation of cell development (GO:0010720),1/38,0.3150611495175608,0.35525202181909,0,0,2.7116202496913155,3.131890295718747,MME
endomembrane system organization (GO:0010256),3/199,0.31513115693192373,0.35525202181909,0,0,1.5389324960753532,1.7771074700111746,CAV2;SPTBN1;SYNE1
positive regulation of protein metabolic process (GO:0051247),2/115,0.31542408657502663,0.35541770051373894,0,0,1.777948347480585,2.051463012390042,KLF4;FOXO1
regulation of cellular macromolecule biosynthetic process (GO:2000112),6/468,0.3188691153588695,0.359133346854231,0,0,1.3081709956709957,1.4952061643523646,MEF2C;EFEMP1;MAGED1;CALR;NR3C1;ESR1
regulation of intracellular transport (GO:0032386),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,CRYAB
DNA integrity checkpoint signaling (GO:0031570),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,MAP3K20
regulation of peptidyl-threonine phosphorylation (GO:0010799),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,PLK1
regulation of protein targeting to mitochondrion (GO:1903214),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,SREBF1
regulation of T cell differentiation (GO:0045580),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,MDK
regulation of viral entry into host cell (GO:0046596),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,GSN
membrane protein proteolysis (GO:0033619),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,PRTN3
negative regulation of secretion by cell (GO:1903531),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,ANXA1
protein acylation (GO:0043543),1/39,0.32185494148715865,0.36099345118435344,0,0,2.6401282393801764,2.992992802977873,FOXO1
positive regulation of cell projection organization (GO:0031346),2/117,0.32269390934390657,0.3617678035232102,0,0,1.7468500443655723,1.9757765841265966,FZD4;MDK
bone development (GO:0060348),1/40,0.32858168380858743,0.36752246213776313,0,0,2.57230248600807,2.8628950220174127,FGFR3
synaptic vesicle exocytosis (GO:0016079),1/40,0.32858168380858743,0.36752246213776313,0,0,2.57230248600807,2.8628950220174127,SNAP25
negative regulation of cell-substrate adhesion (GO:0010812),1/40,0.32858168380858743,0.36752246213776313,0,0,2.57230248600807,2.8628950220174127,FZD4
negative regulation of ERBB signaling pathway (GO:1901185),1/40,0.32858168380858743,0.36752246213776313,0,0,2.57230248600807,2.8628950220174127,EGFR
negative regulation of protein kinase B signaling (GO:0051898),1/40,0.32858168380858743,0.36752246213776313,0,0,2.57230248600807,2.8628950220174127,CIB1
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,HGF
regulation of viral transcription (GO:0046782),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,ZFP36
heart contraction (GO:0060047),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,DMD
hexose metabolic process (GO:0019318),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,IRS2
import into cell (GO:0098657),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,SNAP25
JNK cascade (GO:0007254),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,ARHGEF6
negative regulation of cell-cell adhesion (GO:0022408),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,KLF4
positive regulation of TOR signaling (GO:0032008),1/41,0.3352420349621892,0.373599247200426,0,0,2.5078680203045685,2.7408552681952725,LEP
potassium ion transport (GO:0006813),2/122,0.3407799726633541,0.37921286341605054,0,0,1.6736394557823129,1.8017034204344426,PKD2;AQP1
calcium ion transmembrane import into cytosol (GO:0097553),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,PKD2
regulation of DNA recombination (GO:0000018),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,PPP4C
regulation of double-strand break repair (GO:2000779),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,PPP4C
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,FADD
determination of left/right symmetry (GO:0007368),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,PKD2
regulation of nervous system development (GO:0051960),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,YAP1
histone H3 acetylation (GO:0043966),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,PER1
skeletal system morphogenesis (GO:0048705),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,FGFR3
translesion synthesis (GO:0019985),1/42,0.3418366468986575,0.37921286341605054,0,0,2.4465766992695306,2.626209979517433,UBE2L6
defense response to symbiont (GO:0140546),2/124,0.34797376771407956,0.38505293333343543,0,0,1.6460354633656742,1.737601423997908,STAT1;FADD
development of primary male sexual characteristics (GO:0046546),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,KIT
DNA synthesis involved in DNA repair (GO:0000731),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,UBE2L6
signal release from synapse (GO:0099643),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,SNAP25
male gonad development (GO:0008584),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,KIT
myofibril assembly (GO:0030239),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,KRT19
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,FADD
positive regulation of neuron differentiation (GO:0045666),1/43,0.3483661651472519,0.38505293333343543,0,0,2.3882040125694948,2.518363886481836,MEF2C
antibacterial humoral response (GO:0019731),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,TF
cation transmembrane transport (GO:0098655),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,PKD2
embryonic organ morphogenesis (GO:0048562),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,EFEMP1
metal ion homeostasis (GO:0055065),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,CAV1
mRNA catabolic process (GO:0006402),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,ZFP36
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,EGFR
neurotransmitter secretion (GO:0007269),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,SNAP25
positive regulation of cell division (GO:0051781),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,CDC25B
positive regulation of mRNA catabolic process (GO:0061014),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,ZFP36
positive regulation of stress fiber assembly (GO:0051496),1/44,0.3548312291114732,0.3904265896459273,0,0,2.3325463345531814,2.4167816118314542,NRP1
negative regulation of cell growth (GO:0030308),2/126,0.35514153137614557,0.39059152163546274,0,0,1.619321922317314,1.6763850278346477,BCL6;FHL1
chemical synaptic transmission (GO:0007268),4/306,0.35941425003470145,0.3951122793835206,0,0,1.3313306479142486,1.362323567295407,RPS6KA3;SNAP25;PRKAR2B;SNCG
action potential (GO:0001508),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,DMD
regulation of DNA repair (GO:0006282),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,EGFR
chromosome condensation (GO:0030261),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,PLK1
microtubule bundle formation (GO:0001578),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,PLK1
mitotic G2/M transition checkpoint (GO:0044818),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,PLK1
neural crest cell development (GO:0014032),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,SOX10
positive regulation of nervous system development (GO:0051962),1/45,0.36123247173310896,0.39586006690824493,0,0,2.279418550992155,2.320980470207381,MME
regulation of double-strand break repair via homologous recombination (GO:0010569),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,PPP4C
regulation of fibroblast proliferation (GO:0048145),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,AQP1
erythrocyte differentiation (GO:0030218),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,KIT
establishment of protein localization to extracellular region (GO:0035592),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,ABCA1
regulation of telomerase activity (GO:0051972),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,KLF4
interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,ARF1
postreplication repair (GO:0006301),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,UBE2L6
posttranscriptional regulation of gene expression (GO:0010608),1/46,0.3675705199058439,0.40136063496445284,0,0,2.228652002256063,2.2305242656976114,PER1
regulation of cellular metabolic process (GO:0031323),1/47,0.3738459943589709,0.4074820932247512,0,0,2.1800926947693666,2.145017938066358,ARF1
regulation of synapse assembly (GO:0051963),1/47,0.3738459943589709,0.4074820932247512,0,0,2.1800926947693666,2.145017938066358,MEF2C
histone deacetylation (GO:0016575),1/47,0.3738459943589709,0.4074820932247512,0,0,2.1800926947693666,2.145017938066358,PER1
positive regulation of cell-cell adhesion (GO:0022409),1/47,0.3738459943589709,0.4074820932247512,0,0,2.1800926947693666,2.145017938066358,MDK
cellular response to alcohol (GO:0097306),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,GNG2
regulation of interleukin-10 production (GO:0032653),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,TLR4
regulation of mitochondrion organization (GO:0010821),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,SREBF1
regulation of protein metabolic process (GO:0051246),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,KLF4
Golgi to plasma membrane transport (GO:0006893),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,SPTBN1
histone H4 acetylation (GO:0043967),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,PER1
negative regulation of mitotic cell cycle (GO:0045930),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,BCL6
nucleus organization (GO:0006997),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,SYNE1
positive regulation of DNA repair (GO:0045739),1/48,0.3800595097723944,0.41259246825491763,0,0,2.133599740792742,2.064102922116796,EGFR
adherens junction organization (GO:0034332),1/49,0.3862116748146341,0.418338713600371,0,0,2.0890439932318103,1.9874531142481775,CDH5
regulation of cellular protein metabolic process (GO:0032268),1/49,0.3862116748146341,0.418338713600371,0,0,2.0890439932318103,1.9874531142481775,KLF4
RNA catabolic process (GO:0006401),1/49,0.3862116748146341,0.418338713600371,0,0,2.0890439932318103,1.9874531142481775,ZFP36
secondary alcohol metabolic process (GO:1902652),1/49,0.3862116748146341,0.418338713600371,0,0,2.0890439932318103,1.9874531142481775,ABCA1
negative regulation of catabolic process (GO:0009895),1/49,0.3862116748146341,0.418338713600371,0,0,2.0890439932318103,1.9874531142481775,EGFR
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),2/136,0.3905308761822869,0.4228291167202617,0,0,1.4977155041120926,1.4082243735012472,GNG2;PRKAR2B
actin polymerization or depolymerization (GO:0008154),1/50,0.39230309216925463,0.4241820734600955,0,0,2.0463068476121413,1.914771355908193,GSN
regulation of cellular component movement (GO:0051270),1/50,0.39230309216925463,0.4241820734600955,0,0,2.0463068476121413,1.914771355908193,EGFR
iron ion transport (GO:0006826),1/50,0.39230309216925463,0.4241820734600955,0,0,2.0463068476121413,1.914771355908193,TF
regulation of inflammatory response to antigenic stimulus (GO:0002861),2/137,0.3940240073765334,0.4258537318960758,0,0,1.4865457294028723,1.384484612020455,GNG2;PRKAR2B
DNA duplex unwinding (GO:0032508),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,ANXA1
regulation of protein modification process (GO:0031399),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,CDH5
gonad development (GO:0008406),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,KIT
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,BCL3
negative regulation of protein ubiquitination (GO:0031397),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,CAV1
positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.39833435868049344,0.42936881956042566,0,0,2.005279187817259,1.845786358238875,NRP1
regulation of cellular component organization (GO:0051128),2/139,0.40098299385461583,0.43203256196282724,0,0,1.464695367197974,1.338491739204385,CD36;SGK1
amide biosynthetic process (GO:0043604),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,DMD
regulation of exocytosis (GO:0017157),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,ANXA1
regulation of telomere maintenance via telomerase (GO:0032210),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,CCT3
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,CRYAB
plasma membrane bounded cell projection morphogenesis (GO:0120039),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,SGK1
protein homotetramerization (GO:0051289),1/52,0.4043060652476696,0.4344595184810571,0,0,1.96586045585747,1.7802500069596723,PKD2
regulation of DNA replication (GO:0006275),1/53,0.4102187971882732,0.44061877862966264,0,0,1.9279578289730575,1.717934990867154,EGFR
nitrogen compound transport (GO:0071705),2/143,0.41478742661276047,0.4453295343042644,0,0,1.4228542480822115,1.252096250562335,TXNIP;AQP1
striated muscle contraction (GO:0006941),1/54,0.4160731339213949,0.44651303706416773,0,0,1.891485489895604,1.6586327150113274,DMD
regulation of cardiac conduction (GO:1903779),1/55,0.42186964934739063,0.4519369098816085,0,0,1.8563639781913894,1.6021514538791723,ANK2
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.42186964934739063,0.4519369098816085,0,0,1.8563639781913894,1.6021514538791723,PPARG
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/55,0.42186964934739063,0.4519369098816085,0,0,1.8563639781913894,1.6021514538791723,CAV1
positive regulation of response to DNA damage stimulus (GO:2001022),1/55,0.42186964934739063,0.4519369098816085,0,0,1.8563639781913894,1.6021514538791723,EGFR
protein-containing complex disassembly (GO:0032984),1/56,0.42760891156016617,0.45728050050461333,0,0,1.8225196123673282,1.548314718948253,CAV1
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",1/56,0.42760891156016617,0.45728050050461333,0,0,1.8225196123673282,1.548314718948253,MUC1
sensory organ development (GO:0007423),1/56,0.42760891156016617,0.45728050050461333,0,0,1.8225196123673282,1.548314718948253,BMPR1B
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",1/56,0.42760891156016617,0.45728050050461333,0,0,1.8225196123673282,1.548314718948253,ZFP36
regulation of reactive oxygen species metabolic process (GO:2000377),1/57,0.4332914832901502,0.4625448320085558,0,0,1.7898839738941261,1.4969598067303158,TGFBR2
icosanoid metabolic process (GO:0006690),1/57,0.4332914832901502,0.4625448320085558,0,0,1.7898839738941261,1.4969598067303158,MAPKAPK2
monocarboxylic acid transport (GO:0015718),1/57,0.4332914832901502,0.4625448320085558,0,0,1.7898839738941261,1.4969598067303158,CD36
negative regulation of cell cycle G2/M phase transition (GO:1902750),1/57,0.4332914832901502,0.4625448320085558,0,0,1.7898839738941261,1.4969598067303158,FHL1
brain development (GO:0007420),2/150,0.43855675022045876,0.46752630766038294,0,0,1.3550744622173194,1.1169418833292173,CXCR4;TGFBR2
cellular iron ion homeostasis (GO:0006879),1/58,0.4389179216885566,0.46752630766038294,0,0,1.758393445542791,1.4479365100929313,TF
chordate embryonic development (GO:0043009),1/58,0.4389179216885566,0.46752630766038294,0,0,1.758393445542791,1.4479365100929313,PKD2
regulation of neurotransmitter receptor activity (GO:0099601),1/58,0.4389179216885566,0.46752630766038294,0,0,1.758393445542791,1.4479365100929313,MEF2C
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.4389179216885566,0.46752630766038294,0,0,1.758393445542791,1.4479365100929313,FADD
protein polymerization (GO:0051258),1/59,0.4444887784531854,0.4728397446629561,0,0,1.7279887974794328,1.4011059682473626,GSN
selective autophagy (GO:0061912),1/59,0.4444887784531854,0.4728397446629561,0,0,1.7279887974794328,1.4011059682473626,VIM
phospholipid transport (GO:0015914),1/59,0.4444887784531854,0.4728397446629561,0,0,1.7279887974794328,1.4011059682473626,ABCA1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),1/60,0.45000459991217345,0.47808080313531515,0,0,1.6986148154521208,1.356339639850197,AKAP12
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.45000459991217345,0.47808080313531515,0,0,1.6986148154521208,1.356339639850197,PECAM1
peptidyl-threonine phosphorylation (GO:0018107),1/60,0.45000459991217345,0.47808080313531515,0,0,1.6986148154521208,1.356339639850197,TGFBR2
regulation of endocytosis (GO:0030100),1/61,0.4554659269521106,0.4830398659095772,0,0,1.6702199661590524,1.313518384672778,LRP1
iron ion homeostasis (GO:0055072),1/61,0.4554659269521106,0.4830398659095772,0,0,1.6702199661590524,1.313518384672778,TF
negative regulation of response to stimulus (GO:0048585),1/61,0.4554659269521106,0.4830398659095772,0,0,1.6702199661590524,1.313518384672778,KLF4
O-glycan processing (GO:0016266),1/61,0.4554659269521106,0.4830398659095772,0,0,1.6702199661590524,1.313518384672778,MUC1
glucose metabolic process (GO:0006006),1/62,0.4608732953304373,0.4883492054523999,0,0,1.6427560955313305,1.2725316388995522,IRS2
negative regulation of kinase activity (GO:0033673),1/62,0.4608732953304373,0.4883492054523999,0,0,1.6427560955313305,1.2725316388995522,IRS2
cellular response to starvation (GO:0009267),2/158,0.4650685656148285,0.49252204704890723,0,0,1.2850601779173207,0.9838040746928887,SREBF1;FOXO1
cell cycle G1/S phase transition (GO:0044843),1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,CCND1
COPII vesicle coating (GO:0048208),1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,F8
vesicle coating (GO:0006901),1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,F8
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,F8
monocarboxylic acid biosynthetic process (GO:0072330),1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,LPL
positive regulation of Ras protein signal transduction (GO:0046579),1/63,0.4662272355021483,0.49252204704890723,0,0,1.6161781562141804,1.2332766761682552,IRS2
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/64,0.47152827265030506,0.4970438718196939,0,0,1.5904439610023366,1.1956579419721822,CXCL10
regulation of cellular ketone metabolic process (GO:0010565),1/64,0.47152827265030506,0.4970438718196939,0,0,1.5904439610023366,1.1956579419721822,CAV1
regulation of cilium assembly (GO:1902017),1/64,0.47152827265030506,0.4970438718196939,0,0,1.5904439610023366,1.1956579419721822,YAP1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.47152827265030506,0.4970438718196939,0,0,1.5904439610023366,1.1956579419721822,CXCL12
protein catabolic process (GO:0030163),1/64,0.47152827265030506,0.4970438718196939,0,0,1.5904439610023366,1.1956579419721822,CTSD
regulation of cellular catabolic process (GO:0031329),1/65,0.47677692695547874,0.5023590727549073,0,0,1.565513959390863,1.159586453002292,DEPP1
regulation of protein localization (GO:0032880),1/66,0.48197371337921646,0.5073955867178522,0,0,1.54135103475205,1.1249792565126313,CTSD
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),1/66,0.48197371337921646,0.5073955867178522,0,0,1.54135103475205,1.1249792565126313,FHL1
transcription elongation from RNA polymerase II promoter (GO:0006368),1/67,0.4871191419956142,0.5121481479962524,0,0,1.5179203199507767,1.0917589397373917,ELOB
peptidyl-threonine modification (GO:0018210),1/67,0.4871191419956142,0.5121481479962524,0,0,1.5179203199507767,1.0917589397373917,TGFBR2
positive regulation of catabolic process (GO:0009896),1/67,0.4871191419956142,0.5121481479962524,0,0,1.5179203199507767,1.0917589397373917,FOXO1
interferon-gamma-mediated signaling pathway (GO:0060333),1/68,0.4922137176728752,0.5172811404978209,0,0,1.4951890294719297,1.059853187664649,STAT1
"DNA-templated transcription, elongation (GO:0006354)",1/69,0.4972579405637863,0.5221315589792236,0,0,1.4731263063601074,1.029194379515607,ELOB
positive regulation of protein transport (GO:0051222),1/69,0.4972579405637863,0.5221315589792236,0,0,1.4731263063601074,1.029194379515607,EZR
cellular response to light stimulus (GO:0071482),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,AQP1
COPII-coated vesicle budding (GO:0090114),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,F8
regulation of plasma membrane bounded cell projection assembly (GO:0120032),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,CAV1
establishment of protein localization to membrane (GO:0090150),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,EGFR
sterol metabolic process (GO:0016125),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,ABCA1
wound healing (GO:0042060),1/70,0.5022523058176744,0.5260147805015214,0,0,1.4517030824689179,0.9997192245802698,DST
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),2/171,0.5065374571593556,0.5295992429885573,0,0,1.1854244656442459,0.8062747543215021,S100A4;FADD
protein tetramerization (GO:0051262),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,PKD2
fatty acid biosynthetic process (GO:0006633),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,LPL
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,PIK3R1
regulation of TOR signaling (GO:0032006),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,LEP
histone acetylation (GO:0016573),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,PER1
response to metal ion (GO:0010038),1/71,0.5071973037574192,0.5295992429885573,0,0,1.430891950688905,0.9713684296427824,CAV1
cell junction organization (GO:0034330),1/72,0.5120934198937148,0.5335675983916113,0,0,1.4106670479731178,0.9440863965597768,SNCG
Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.5120934198937148,0.5335675983916113,0,0,1.4106670479731178,0.9440863965597768,PIK3R1
response to ionizing radiation (GO:0010212),1/72,0.5120934198937148,0.5335675983916113,0,0,1.4106670479731178,0.9440863965597768,ANXA1
positive regulation of neurogenesis (GO:0050769),1/72,0.5120934198937148,0.5335675983916113,0,0,1.4106670479731178,0.9440863965597768,MME
positive regulation of secretion by cell (GO:1903532),1/72,0.5120934198937148,0.5335675983916113,0,0,1.4106670479731178,0.9440863965597768,EZR
cation transport (GO:0006812),2/174,0.5158088204898285,0.5372089298086965,0,0,1.1645704793545326,0.7709678832539664,SGK1;AQP1
regulation of actin filament polymerization (GO:0030833),1/73,0.5169411349805915,0.5372392930762869,0,0,1.3910039481105472,0.9178209463511099,CCL11
regulation of hydrolase activity (GO:0051336),1/73,0.5169411349805915,0.5372392930762869,0,0,1.3910039481105472,0.9178209463511099,CAV1
endoplasmic reticulum organization (GO:0007029),1/73,0.5169411349805915,0.5372392930762869,0,0,1.3910039481105472,0.9178209463511099,CAV2
neurotransmitter transport (GO:0006836),1/73,0.5169411349805915,0.5372392930762869,0,0,1.3910039481105472,0.9178209463511099,SNAP25
positive regulation of synaptic transmission (GO:0050806),1/73,0.5169411349805915,0.5372392930762869,0,0,1.3910039481105472,0.9178209463511099,CCL2
regulation of peptide hormone secretion (GO:0090276),1/74,0.5217409250967877,0.5415341656482003,0,0,1.3718795633127043,0.8925230671939328,SNAP25
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.5217409250967877,0.5415341656482003,0,0,1.3718795633127043,0.8925230671939328,PIK3R1
negative regulation of protein binding (GO:0032091),1/74,0.5217409250967877,0.5415341656482003,0,0,1.3718795633127043,0.8925230671939328,CAV1
glycerophospholipid biosynthetic process (GO:0046474),2/177,0.5249648899479097,0.5446482773852408,0,0,1.1444314868804664,0.7374989962406235,ARF1;PIK3R1
fibroblast growth factor receptor signaling pathway (GO:0008543),1/75,0.5264932617585523,0.5457688771315772,0,0,1.353272053779668,0.8681466839460674,FGFR3
positive regulation of immune response (GO:0050778),1/75,0.5264932617585523,0.5457688771315772,0,0,1.353272053779668,0.8681466839460674,FADD
negative regulation of immune response (GO:0050777),2/178,0.5279910685516253,0.5470886178396628,0,0,1.1378710575139146,0.7267308343047355,GNG2;PRKAR2B
phospholipid metabolic process (GO:0006644),1/76,0.5311986116109761,0.5501780600904835,0,0,1.335160744500846,0.8446484482402136,LPL
purine ribonucleotide metabolic process (GO:0009150),1/77,0.5358574369263035,0.5540606619598935,0,0,1.3175260486240983,0.821987544086677,RHOQ
cholesterol metabolic process (GO:0008203),1/77,0.5358574369263035,0.5540606619598935,0,0,1.3175260486240983,0.821987544086677,ABCA1
negative regulation of developmental process (GO:0051093),1/77,0.5358574369263035,0.5540606619598935,0,0,1.3175260486240983,0.821987544086677,FGFR3
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.5358574369263035,0.5540606619598935,0,0,1.3175260486240983,0.821987544086677,CAV1
protein modification process (GO:0036211),1/78,0.5404701953926593,0.5585929226575235,0,0,1.3003493967960973,0.8001255112715814,UBE2L6
negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/79,0.5450373402761145,0.5630742144982346,0,0,1.283613171938045,0.7790260822318089,KLF4
antigen receptor-mediated signaling pathway (GO:0050851),2/185,0.5488083418386306,0.5667295641972289,0,0,1.0939556150328984,0.656379935535036,MEF2C;PIK3R1
negative regulation of cellular component organization (GO:0051129),1/80,0.5495593203888742,0.5672644956112373,0,0,1.2673006489751333,0.7586550325138808,CRYAB
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),1/81,0.554036579997623,0.5716436747009374,0,0,1.2513959390862943,0.7389800432450613,ESR1
regulation of mitotic cell cycle phase transition (GO:1901990),2/188,0.5575321329203323,0.5750066682172847,0,0,1.076146587667325,0.6287226520734442,PRKAR2B;PLK1
glycoprotein biosynthetic process (GO:0009101),1/83,0.5628586938880342,0.5802544113536678,0,0,1.2207502785687756,0.7015977426384541,BMPR1B
anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.5672044153065768,0.5842397425006407,0,0,1.2059812855482845,0.6838342246417898,PLK1
nuclear export (GO:0051168),1/84,0.5672044153065768,0.5842397425006407,0,0,1.2059812855482845,0.6838342246417898,CALR
G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.5715071508482795,0.5879256072309086,0,0,1.1915639352187575,0.6666541450436337,CCND1
"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",1/85,0.5715071508482795,0.5879256072309086,0,0,1.1915639352187575,0.6666541450436337,KLC2
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",1/85,0.5715071508482795,0.5879256072309086,0,0,1.1915639352187575,0.6666541450436337,FZD4
negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.575767323420109,0.5920580373851204,0,0,1.1774858166616902,0.6500329906392318,CALR
protein modification by small protein conjugation (GO:0032446),4/409,0.5791525063666126,0.5952876120737449,0,0,0.987501590938017,0.5393629409033145,EPAS1;PLK1;DTX1;ELOB
calcium ion transmembrane transport (GO:0070588),1/87,0.5799853520992417,0.5956407981280699,0,0,1.1637350962106008,0.6339475224236494,PKD2
sodium ion transmembrane transport (GO:0035725),1/87,0.5799853520992417,0.5956407981280699,0,0,1.1637350962106008,0.6339475224236494,PKD2
regulation of establishment of planar polarity (GO:0090175),1/88,0.5841616516113389,0.5994241979239824,0,0,1.1503004842756286,0.6183756974104047,FZD4
positive regulation of neuron projection development (GO:0010976),1/88,0.5841616516113389,0.5994241979239824,0,0,1.1503004842756286,0.6183756974104047,MDK
regulation of type I interferon production (GO:0032479),1/89,0.5882966327203135,0.603412932044635,0,0,1.1371712044300877,0.6032965943094887,UBE2L6
regulation of macromolecule metabolic process (GO:0060255),2/200,0.5912247998288709,0.6061610052982318,0,0,1.010307153164296,0.5309759786558154,ARF1;SIRPA
"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.592390702164663,0.6065901428809733,0,0,1.1243369645810757,0.58869034541816,QKI
negative regulation of translation (GO:0017148),1/90,0.592390702164663,0.6065901428809733,0,0,1.1243369645810757,0.58869034541816,CALR
protein complex oligomerization (GO:0051259),1/90,0.592390702164663,0.6065901428809733,0,0,1.1243369645810757,0.58869034541816,PKD2
modification-dependent protein catabolic process (GO:0019941),2/201,0.5939452154101985,0.6079262713425109,0,0,1.0051789560045123,0.523666265177651,PLK1;UBE2L6
sensory perception of sound (GO:0007605),1/91,0.5964442626887184,0.6102276385071551,0,0,1.1117879300620417,0.574538073155522,KIT
protein ubiquitination (GO:0016567),5/525,0.5971252506114904,0.6106677804447623,0,0,0.9606416899163013,0.4953341256090908,EPAS1;PLK1;DTX1;UBE2L6;ELOB
positive regulation of cellular component biogenesis (GO:0044089),1/92,0.6004577130728141,0.6138180232293462,0,0,1.0995146984994701,0.5608218310496504,CDH5
cellular macromolecule biosynthetic process (GO:0034645),3/314,0.6037704450175931,0.6169454610230127,0,0,0.9641850111303487,0.4864903570421452,THRB;BCL3;DTX1
regulation of heart contraction (GO:0008016),1/93,0.6044314482795703,0.6173618190271617,0,0,1.0875082763186934,0.5475245486104855,ANK2
interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.6083658592709782,0.6208595420472892,0,0,1.0757600567654604,0.5346299805772539,EGR1
negative regulation of cell death (GO:0060548),1/94,0.6083658592709782,0.6208595420472892,0,0,1.0757600567654604,0.5346299805772539,AGR2
organelle assembly (GO:0070925),4/425,0.6094824864987508,0.6217385230936147,0,0,0.9491882361583858,0.4699858705899958,ABLIM1;GSN;RFX2;PARVA
regulation of cell cycle phase transition (GO:1901987),1/95,0.6122613332929504,0.6240503752902195,0,0,1.0642617993303813,0.5221226587890779,PLK1
mRNA metabolic process (GO:0016071),1/95,0.6122613332929504,0.6240503752902195,0,0,1.0642617993303813,0.5221226587890779,ZFP36
regulation of vesicle-mediated transport (GO:0060627),1/96,0.6161182537368698,0.627718806631497,0,0,1.0530056104728827,0.5099878480309171,NRP1
phosphate-containing compound metabolic process (GO:0006796),2/212,0.6229815422098366,0.6344458616817031,0,0,0.9519922254616132,0.45051926607565235,PTPRB;LPL
sensory perception of chemical stimulus (GO:0007606),1/99,0.6274614713313367,0.6384741674432949,0,0,1.0206153527400808,0.4756812696365203,CD36
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.6274614713313367,0.6384741674432949,0,0,1.0206153527400808,0.4756812696365203,LEP
protein O-linked glycosylation (GO:0006493),1/102,0.6384711526539916,0.6488636296796617,0,0,0.99014926873398,0.44425897026876343,MUC1
intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.6384711526539916,0.6488636296796617,0,0,0.99014926873398,0.44425897026876343,PPP1R15A
mitotic sister chromatid segregation (GO:0000070),1/102,0.6384711526539916,0.6488636296796617,0,0,0.99014926873398,0.44425897026876343,PLK1
chromatin remodeling (GO:0006338),1/103,0.6420686222871914,0.6522474323192787,0,0,0.9803921568627451,0.43437263990835,ESR1
mRNA transport (GO:0051028),1/104,0.6456304733483079,0.6555922446218222,0,0,0.9708245034744468,0.42476286602560065,ZFP36
chromosome organization (GO:0051276),1/106,0.6526487199201279,0.6621665137522964,0,0,0.9522359197486101,0.406334533654951,TCF7L2
small GTPase mediated signal transduction (GO:0007264),1/106,0.6526487199201279,0.6621665137522964,0,0,0.9522359197486101,0.406334533654951,JUN
regulation of protein ubiquitination (GO:0031396),1/109,0.6629176117202255,0.6720251392750828,0,0,0.9256439180297048,0.3805364378597602,CAV1
modulation of chemical synaptic transmission (GO:0050804),1/109,0.6629176117202255,0.6720251392750828,0,0,0.9256439180297048,0.3805364378597602,MEF2C
cellular amide metabolic process (GO:0043603),1/115,0.6825579475161955,0.6910721838677488,0,0,0.8766586517054057,0.33480282150683616,MME
cellular response to lectin (GO:1990858),1/115,0.6825579475161955,0.6910721838677488,0,0,0.8766586517054057,0.33480282150683616,MUC1
stimulatory C-type lectin receptor signaling pathway (GO:0002223),1/115,0.6825579475161955,0.6910721838677488,0,0,0.8766586517054057,0.33480282150683616,MUC1
tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.6857187849837366,0.6939838908709055,0,0,0.8689913926285588,0.32785973753884723,STAT1
gene expression (GO:0010467),3/356,0.6875267790137554,0.6955245977974633,0,0,0.8476356504685116,0.31757050988220753,THRB;BCL3;DTX1
innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.6950146336739874,0.7028075718422588,0,0,0.8467693366600706,0.30807363367521096,MUC1
protein homooligomerization (GO:0051260),1/121,0.7010593623607333,0.7086257979860463,0,0,0.8325719120135364,0.29569849915095225,PKD2
synapse organization (GO:0050808),1/126,0.7156547340556769,0.7230785383508602,0,0,0.7990659898477157,0.2673334746158674,SNCG
microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/128,0.7212923540600442,0.7281703491443647,0,0,0.7864023342259883,0.2569260883564558,PLK1
plasma membrane bounded cell projection organization (GO:0120036),1/128,0.7212923540600442,0.7281703491443647,0,0,0.7864023342259883,0.2569260883564558,PKD2
Golgi organization (GO:0007030),1/130,0.7268187513323243,0.7334453624095358,0,0,0.7741313500964073,0.24700839358123403,SYNE1
potassium ion transmembrane transport (GO:0071805),1/139,0.7503687097494234,0.7568963580115352,0,0,0.723313470168469,0.2077288152036726,PKD2
chromatin organization (GO:0006325),1/142,0.7577607888371841,0.7640362405045728,0,0,0.7078158188429275,0.19633927825456832,ESR1
neuron development (GO:0048666),1/143,0.7601760907860682,0.7661542967980447,0,0,0.7027954529205691,0.19271014955075425,MEF2C
regulation of signal transduction by p53 class mediator (GO:1901796),1/156,0.7894782819789434,0.7953577230528454,0,0,0.6434255772064844,0.15209483877441415,SGK1
mitotic spindle organization (GO:0007052),1/157,0.791578815660227,0.7971440926934048,0,0,0.6392685149030327,0.1494135623408729,PLK1
T cell receptor signaling pathway (GO:0050852),1/158,0.7936584952845764,0.7985778661231172,0,0,0.6351644088072682,0.14678777597142362,PIK3R1
organonitrogen compound biosynthetic process (GO:1901566),1/158,0.7936584952845764,0.7985778661231172,0,0,0.6351644088072682,0.14678777597142362,DMD
peptide biosynthetic process (GO:0043043),1/162,0.8017727633561472,0.8064092023016185,0,0,0.619257811268405,0.13681265841651122,DMD
double-strand break repair (GO:0006302),1/164,0.8057100340323957,0.8100346543637009,0,0,0.6115972719628787,0.13212419072152404,CIB1
cellular protein-containing complex assembly (GO:0034622),1/168,0.8133526537930473,0.8173808138613579,0,0,0.5968266512659959,0.12329871330322538,DMD
neuron projection development (GO:0031175),1/171,0.818887639336178,0.8222644955808633,0,0,0.5862048372648552,0.11712864887599077,SGK1
nuclear-transcribed mRNA catabolic process (GO:0000956),1/171,0.818887639336178,0.8222644955808633,0,0,0.5862048372648552,0.11712864887599077,ZFP36
mitochondrion organization (GO:0007005),1/175,0.8260143746356982,0.8290787313429204,0,0,0.5726121710718245,0.10945086714036857,CAV2
intracellular protein transport (GO:0006886),2/336,0.8483004600381735,0.8510966708664822,0,0,0.5947696443847,0.09785173377261229,ARF1;CALR
ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.8682384578871978,0.8707416165384376,0,0,0.5638334879406308,0.07966340257159703,PLK1;UBE2L6
protein deubiquitination (GO:0016579),1/267,0.931049185342049,0.9333490186528981,0,0,0.3728101980840426,0.026634743270283076,ESR1
inorganic cation transmembrane transport (GO:0098662),1/274,0.9357493156531264,0.9376747257676389,0,0,0.3631208047451702,0.02411400422335804,PKD2
protein modification by small protein removal (GO:0070646),1/276,0.9370326676576861,0.93857447377477,0,0,0.3604430087678819,0.023442179992335544,ESR1
DNA metabolic process (GO:0006259),1/277,0.937664746415394,0.9388214052308735,0,0,0.35911866401824466,0.02311388528616369,TCF7L2
DNA repair (GO:0006281),1/298,0.949572236940133,0.9503528142002565,0,0,0.33336751610863286,0.01724965964159056,CIB1
protein polyubiquitination (GO:0000209),1/314,0.9570997226474992,0.9574929435688827,0,0,0.3160668818215728,0.013858802515751795,UBE2L6
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),1/321,0.960030789903339,0.960030789903339,0,0,0.3090418781725888,0.012605794172949571,PLK1